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Abstract
As the first line of defence against external stimuli, the airway epithelium
undergoes frequent injury during an adult life. This is countered by repair
mechanisms that ensure the integrity of the epithelium. It has been established
that there are resident stem/progenitor cells localized within specific niches
throughout the respiratory tract. Stem/progenitor cells are activated according to
the severity of the insult and are thought to be responsible for repairing the airway
epithelium. It has been difficult to isolate those stem cells.
In this study, an in vitro human bronchial epithelial model was adapted and
characterised. In culture, a pseudostratified epithelium was observed, with basal,
ciliated, and secretory cells. Mucus production was also seen in this model. A
scrape-wound of the model was employed to study the responses of the airway
epithelium to injury. It was observed that migration and then proliferation, of
CD44 expressing basal cells, are the first events that take place after scrape-
wounding. Up-regulation of CD44 was also observed at the edge of the wounds
early post-wounding. This suggested a key role for CD44-expressing basal cells
in migration and proliferation after wounding, also suggesting this population
may contain a progenitor cell population.
Investigation of the secretory profile of the airway epithelium post-wounding
revealed an increase in a number of cytokines and growth factors. In particular,
IL-6, IL-8, ENA-78, and RANTES were all elevated compared with unwounded
cultures.
A side population (SP) was identified in differentiated and undifferentiated
human bronchial epithelial cells in at least some cultures accounting for 0.1-
1.15% of cells present.
In summary, the epithelium is important in airway wound repair with basal cells
appearing to contain the progenitor population in this human bronchial epithelial
cell (HBEC) model. Moreover, SP studies suggested the presence of SP in at least
some cultures, which might contribute to airway regeneration. The secretory
profile of the airway epithelium post-wounding indicates up-regulation of specific
cytokines, which may be important in the pathogenesis of lung diseases such as
asthma and COPD. This model should prove useful to assess wound repair
pathways and may be of use in the future for proof of concept studies on novel
therapeutic agents.
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Chapter 1 Introduction
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Chapter 1. Introduction
1.1 The respiratory system and airway epithelium
The respiratory tract consists of upper and lower airways. The nose, followed by
the sinuses, mouth, and the throat, make up the upper airways, while the trachea,
bronchi, and lungs and their internal structures are contained in the lower airways.
The bronchi branch into smaller bronchi and then the bronchioles, ending with air
sacs called the alveoli where gas exchange takes place. These are all contained
inside lobes of the lungs (see Figure 1-1). The entire respiratory system is lined
with epithelial cells containing a number of different cell types with specific
structure and function, and this airway epithelium is the focus of this study.
Figure 1-1: The anatomy of the respiratory tract.
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This chapter gives an overview of the airway epithelial functions and structure as
well as the role and potential applications of stem/progenitor cells, with more
detailed information in the chapters following. Chapter 3 describes a human
bronchial epithelial cell (HBEC) wound repair model, where the cell types
involved in wound repair are investigated. Chapter 4 investigates the secretory
profile of the bronchial epithelium post wounding. Finally, chapter 5 investigates
the potential progenitor sub-populations present in the bronchial epithelium post-
wounding. In this chapter, the general aspects of lung disease, epithelial and stem
cell biology, are discussed, and each following results chapter contains details of
my relevant research in specific areas.
1.1.1 Anatomy of the airway epithelium
The respiratory tree is lined with several specialized epithelial cell types that fulfil
a number of functions to ensure lung homeostasis. There are at least 8
morphologically unique epithelial cell types, which can be classified into three
categories: basal, ciliated columnar and non-ciliated secretory columnar cells
(Knight and Holgate 2003) depending on the region in which they are found in
the respiratory system. Immune and inflammatory cells are also seen to migrate to
and remain in the airway epithelium through the basement membrane to aid in
epithelial cell function. Figure 1-2 is a cross-section through the airway wall
showing the different epithelial cell types present and the underlying
mesenchyme, and are discussed further in the following sections.
Chapter 1 Introduction
3
Figure 1-2: Schematic cross-section of the airway wall.
The airway is lined with an epithelium, anchored together with several different junctions. The
underlying mesenchyme is also shown consisting of (myo) fibroblasts, smooth muscle cell
bundles, blood vessels, and afferent nerve endings positioned deep into the airway. Drawing is not
to scale.
As the first site of contact with the outer environment, the airway epithelium is
susceptible to damage, during adult life, from various insults including: toxic
pollutants and chemicals, bacteria and viruses, and smoke particles. However, the
cells in this layer are arranged in an adhesive mechanism to ensure three
dimensional structure and normal function is maintained. Basal cells are strongly
attached to the basement membrane via specialized cell-extracellular matrix
(ECM) junctions, termed hemidesmosomes, which confer additional mechanical
integrity in the tissue (Green and Jones 1996). Similarly, basal-columnar
interactions are ensured via the intercellular adhesion molecules that belong to
cadherin family (desmosomes), which also create trans-cellular networks
throughout the tissue giving it the ability to resist mechanical stress (Green and
Jones 1996). As for columnar-columnar interactions, these depend upon belt like
tight junctions (zona occludens), responsible for cellular transport regulation, and
adherence is also maintained via E-cadherin adherens junctions (Roche 1993).
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Figure 1-2 shows the adhesive mechanisms between epithelial cells and basement
membrane. It is thought that the airway epithelium is pseudostratified in large
airways, becoming columnar and cuboidal as it progresses through the airways to
the lower airways (Crystal, Randell, Engelhardt et al. 2008). .
1.1.1.1 Basal cells
Basal cells are abundant in the conducting airways although their number
decreases according to the size of the region (Wang C. Z. 1992), since cell types’
present in the different regions of the airways vary, and as mentioned before basal
cells are important for attaching other epithelial cells to the BM via
hemidesmosomes (Figure 1-2). They have pyramidal shape with low cytoplasm to
nucleus ratio (Evans MJ 2001). Historically, basal cells were thought to be the
origin of stem cells in the airway epithelium, giving rise to ciliated and secretory
columnar cells in larger airways (Boers, Ambergen and Thunnissen 1998). In
addition to their possible progenitor role and attachment of superficial cells to the
basement membrane, basal cells also secret a number of active molecules
including cytokines, chemokines, and growth factors.
1.1.1.2 Columnar secretory cells
These cells are present at the apical surface of the epithelial layer. In large
airways, mucus-secreting goblet cells are the predominant secretory cells and the
main source of airway mucus. They are characterized by membrane-bound
electron-lucent acidic mucin granules (Jeffery and Li 1997). Mucus is secreted to
trap any toxin and foreign molecules that the airway epithelium comes into
contact with and thus these are the epithelial cell type involved in the mucociliary
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clearance function of the airway epithelium (section 1.1.2). The number of
mucus-secreting cells has been observed to be elevated in chronic inflammatory
diseases, such as asthma and COPD, and these cells are thought to contribute to
the productive cough associated with these diseases (Lumsden, McLean and
Lamb 1984). These mucus goblet cells are seen in larger airways (trachea and
bronchi); while Clara cells are found in smaller airways (terminal bronchioles).
Mucous and Clara cells also contain electron dense granules (Jeffery and Li
1997). Clara cells are believed to metabolize xenobiotic compounds by the action
of p450 mono-oxygenases, and they produce bronchiolar surfactant (Joan Gil
1971) as well as having ion absorbing and secreting properties (Van Scott, Hester
and Boucher 1987). Moreover, Clara cell populations are thought to contain the
stem or progenitor cells of the small airway epithelium where mucus goblet cells
and basal cells are sparse (Hong, Reynolds and Giangreco 2001). Another type of
secretory cell is the serous cell, resembling mucus goblet cells with a difference in
granule content where it is seen to be electron-dense. These cells have only been
found in rodent airways, but two populations of these rare cells have been
observed in small airways of human lung (Rogers, Dewar, Corrin et al. 1993).
1.1.1.3 Columnar ciliated cells
Ciliated cells account for over 50% of all epithelial cells within the airways
(Knight and Holgate 2003). It is thought that these cells arise from secretory or
basal cells and were initially thought to be terminally differentiated. However,
they were observed to undergo trans-differentiation when mice epithelium was
exposed to naphthalene injury (Lawson, Van Winkle, Toskala et al. 2002) (Park,
Wells, Zorn et al. 2006) suggesting their potential involvement in bronchiolar
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epithelial repair. Their primary role is the directional transport of mucus, or any
foreign object, from the lung to the throat.
1.1.1.4 Alveolar type I cells
Covering 90-95% of the alveolar surface, alveolar type I cells are one of the two
types of alveolar epithelial cells (Crapo JD 1982). They are squamous thin cells
that are very susceptible to injury. Alveolar type I cells are unable to divide, and
form a thin blood-gas barrier where gas exchange occurs. They are important in
maintaining the normal cellular composition and function of the alveolar
epithelium (Williams 2003). Compared to their type II neighbours, these cells
have received little attention due to the lack of specific molecular markers and
reproducible methods of isolation in vitro. Recently, it has been clear that alveolar
type I cells are involved in maintaining homeostasis in the alveolar epithelium
(Berthiaume, Voisin and Dagenais 2006).
1.1.1.5 Alveolar type II cells
Type II cells are cuboidal in shape covering 5% of the distal lung. They serve as
stem or progenitor cells for type I cells after alveolar injury and play a major role
in gas exchange (Sugahara, Tokumine, Teruya et al. 2006). One other major
function of type II cells is their surfactant protein (SP) production (especially
SPC), and phospholipids production which line the alveoli differentially reducing
surface tension at different volumes contributing to alveolar stability (Witherden,
Vanden Bon, Goldstraw et al. 2004; Mason 2006).
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1.1.1.6 Pulmonary neuroendocrine cells (PNEC)
In addition to the above main epithelial cell types, pulmonary neuroendocrine
cells (PNEC) are present throughout the bronchial tree either clustered in neuro-
epithelial bodies (NEB) or as individual cells (Gosney, Sissons and Allibone
1988). These cells are thought to be very rare, increasing in number in chronic
bronchitis. PNEC are thought to be involved in the secretion of a number of
amines and peptides vital for foetal lung growth and airway function (Reynolds,
Giangreco and Power 2000) and may play role in localized epithelial cell
regeneration.
1.1.1.7 Other cell types surrounding the airway epithelium
As shown in Figure 1-2, the airway epithelium is underlined by (myo) fibroblasts,
smooth muscle cells, blood vessels, afferent nerve endings, and immune cells.
Briefly, immune cells including mast cells, lymphocytes, dendritic cells, and
macrophages, migrate and reside in the epithelium in response to external insults,
and are involved in airway remodelling and inflammation present in a number of
lung diseases including asthma and COPD (Rennard, Rickard, Spurzem et al.
1992). The bronchial epithelium is rich with intra-epithelial nerves, penetrating
the basement membrane where they spread along the epithelial side of the basal
lamina extending between epithelial cells and the ending of the airway lumen.
This was shown by immunoreactivity for the pan-neuronal marker protein gene
product (PGP) 9.5 at the sub-epithelial level (Dirk Adriaensen 1993). Fibroblasts
are present beneath the basement membrane where the epithelium rests. They
play a role in tissue repair and airway remodelling by secreting growth and
attachment factors (Pollak, Huynh and Lefebvre 1992) and chemotactic cytokines
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stimulating the bronchial epithelium to migrate following injury and thus
contributing to the repair mechanism (Shoji, Rickard, Ertl et al. 1989).
Surrounding the airway wall are airway smooth muscle cells (ASMC) from the
trachea down to the alveolar duct controlling contraction and relaxation of the
airway walls. These responses are regulated by intracellular signalling pathways
(Hall 2000) achieved via a series of homeostatic mechanisms though
phospholipase C, adenyl cyclase, and ion channel pathways. ASMC are important
in the pathology of airway diseases including asthma, a disease characterised by
airway inflammation and increased mass of bronchial SMC (described in more
detail in section 1.2.1.1). Hence it has been proposed that ASMC abnormality
could cause airway hyperresponsiveness in patients with asthma (Borger, Tamm,
Black et al. 2006). ASMC seem to have an immune function as well by
displaying the ability to cytokines which in turn have a bi-directional effect on
ASM constrictor and relaxant responses (Hakonarson, Kim, Whelan et al. 2001).
1.1.1.8 Basement membrane (BM)
Basement membrane (BM), also called the basal lamina, is a thin sheet-like
membrane (40-120 nm thick), upon which basal epithelial cells adhere, consisting
of ECM proteins, anchoring filaments of laminin 5, collagen IV, and
proteoglycans including perlecan (Altraja, Laitinen, Virtanen et al. 1996). BM
consists of a lamina lucida and a lower lamina densa. Below the BM, the reticular
basement membrane – a layer of collagenous matrix – is found where fibroblasts
are embedded. Collagen, proteoglycans, and glycoproteins, are present in all
layers of the BM in differing combinations. BM plays a role in holding all the
epithelial cells together and also in epithelial-mesenchymal interactions. In
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addition to its structural support role, BM facilitates adhesion and migration of
epithelial cells through ECM protein interactions and acts as a reservoir for
growth factors. It is also required for the establishment of correct epithelial
polarity (Howat, Holmes, Holgate et al. 2001). Recently, pores which traverse the
whole BM thickness have been observed, wide enough to allow the cells from the
lamina propria to cross into the epithelium without matrix degradation (Howat,
Holmes, Holgate et al. 2001).
1.1.2 Functions of the airway epithelium
1.1.2.1 Epithelial barrier function and adhesion mechanisms
The primary role of the airway epithelium is protecting the airways, by acting as
the continuous first line of contact with the outside environment. It protects the
respiratory tract from inhaled toxins such as toxic gases and metals, pathogens
such as viruses and bacteria, and inflammatory substances such as dust mite
antigen and pollen. This defence is mediated by the adhesion mechanisms
discussed above in section 1.1.1 and presented in Figure 1-2.
1.1.2.2 Mucociliary clearance and protective factors secretions
In addition to its role as a protective barrier, the airway epithelium is capable of
trapping foreign particles in the mucus that is produced by secretory epithelial
cells, which in turn are transported out of the respiratory tract by the coordinated
beating of cilia (Bals, Beisswenger, Blouquit et al. 2004). Moreover, the airway
epithelium serves as a rich source of anti-oxidants and anti-bacterial agents
including lactoferrin, lysozyme, and opsonins (Velden and Versnel 1998). It also
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produces anti-proteases such as tissue inhibitors of metalloproteinases (Velden
and Versnel 1998).
1.1.2.3 Epithelial inflammatory potential
When the airway epithelium is injured, pro-inflammatory responses are activated,
producing mediators such as arachidonic acid products, TGF-ȕ, cytokines and
chemokines including IL-8 and IL-6. This particular function of the airway
epithelium is discussed in more detail in Chapter 4.
1.1.2.4 Epithelial regeneration and role in repair mechanism
Another major function of the airway epithelium, which is under much recent
focus, is its regenerative potential and role in wound repair. The prevailing view
is that the airway epithelium contains resident stem or progenitor cells which may
be activated after injury and are responsible for maintaining a healthy and
functional epithelium. These stem cells are thought to reside in specific niches
along the respiratory tract and home to the site of injury when necessary (see
Figure 1-7). This regenerative function of the epithelium is discussed further in
Chapter 3.
1.2 Epithelial damage in respiratory disease
Asthma and chronic obstructive pulmonary disease (COPD) are both
inflammatory conditions of the lung involving abnormal structural remodelling
which interferes with normal maintenance and function of the lung. Remodelling
in this context, refers to an alteration in mass and size of tissues and their
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components as a response to injury and/or inflammation. This becomes
inappropriate when the alteration takes place repeatedly leading to chronic
diseases. Distinctions have been made between asthma and COPD reflected in
differences in the severity, origin and nature of the remodelling process, as well as
differing patterns in the expansion of inflammatory cells and cytokines (Jeffery
2000). However, similarities are also emerging between these two clinical
conditions, especially concerning the presence of damaged epithelium in both,
albeit to varying levels. The following sections summarize the remodelling
processes in both asthma and COPD, focusing on the epithelial dysfunction
occurring in both.
1.2.1 Inflammation and its relationship to airway remodelling
The main histologic features of asthma and COPD are epithelial alterations
(discussed in the next sections), sub-mucosal hyperplasia, smooth muscle cell
hyperplasia and hypertrophy, sub-epithelial fibrosis, microvascular proliferation,
airway wall edema, and inflammatory cell permeation (Bergeron and Boulet
2006). The magnitude of these features, however, differs in each condition, and is
discussed in the following sections with emphasis on the epithelial role in both
disorders.
1.2.1.1 Epithelial dysfunction in asthma
Asthma can be defined, according to the American Thoracic Society (ATS) in
1963, and revised in 1987 [ATS 1987] as: “a clinical syndrome characterised by
increased responsiveness of the tracheobronchial tree to a variety of stimuli. The
major symptoms of asthma are paroxysms of dyspnoea, wheezing, and cough,
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which may vary from mild and almost undetectable to severe and unremitting
(status asthmaticus). The primary physiological manifestation of this
hyperresponsiveness is variable airways obstruction. This can take the form of
spontaneous fluctuations in the severity of obstruction, substantial improvements
in the severity of obstruction following bronchodilators or corticosteroids, or
increased obstruction caused by drugs or other stimuli" (M. R. Sears 1993).
Irreversible airway obstruction can be a result of airway remodelling, making it
difficult to treat asthma patients. According to statistics from Asthma UK, 5.2
million people in the UK are currently under treatment for asthma (last updated
on 04 July 2006). One of the hallmarks of asthma is remodelling of virtually
every tissue present leading to structural alterations (Figure 1-3).
Figure 1-3:Remodeling in asthma.
A schematic section through an airway showing structural alterations seen in asthma
Loss of epithelial integrity is evident in asthmatic patients (Naylor 1962).
Moreover, sub- epithelial fibrosis, leading to thickening of the basement
membrane, has been observed in all severities of asthma (Elias, Zhu and Chupp
1999). An increase in macromolecules, including: collagen I, III, and V,
fibronectin, tenascin, lumican, and biglycan (reviewed in (Bergeron and Boulet
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2006)) could also perpetuate inflammation by storing inflammatory mediators
including cytokines and chemokines (discussed further in Chapter 4). Mucus
overproduction is considered one effect of asthma in adult and child airways,
related to goblet cell and submucosal gland hyperplasia (Aikawa, Shimura, Sasaki
et al. 1992). Another observation in asthma is smooth muscle dysfunction and
remodelling, with altered expression of cytokines, chemokines and cellular
adhesion molecules, leading not only to broncho-constriction, but also sub-
mucosal inflammation and airway hyper-responsiveness (Fixman, Stewart and
Martin 2007). Wall stiffness and loss of integrity can also be seen in asthma as a
result of decrease cartilage volume and increased proteoglycan degradation
(Bergeron and Boulet 2006). Finally, change in the microvasculature of the
airway wall can result in airway wall edema, with an increased expression of
vascular endothelial growth factor (VEGF) (Hoshino, Takahashi and Aoike
2001).
Structural changes could, in part, be explained as a result of airway wall
inflammation where inflammatory exudates and infiltrates are present
characterised by the presence of eosinophils and their secreted products. Increased
numbers of activated mast cells, neutrophils, macrophages, lymphocytes, and
spontaneous release of histamine have also been reported in broncheoalveolar
lavage (BAL) collected from patients suffering from mild asthma (Foresi,
Bertorelli, Pesci et al. 1990; Jeffery 1992). A list of some factors seen to be
produced in airways of patients suffering from asthma is presented in
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Table 1-1.
Recently the concept has emerged that the damaged epithelium incompletely
repairs causing chronic wound events, and secretion of secondary mediators;
which may play a role in the structural changes and inflammatory responses seen
in asthma (reviewed in section 1.2.1.1 below) (Holgate 2007). Another concept
involved with asthma biology is that of the epithelial-mesenchymal trophic unit
(EMTU), which when activated is thought to activate the characteristic Th2
related inflammation, seen in asthma (Holgate 2008).
EMTU has been recently described in the upper airways of the lung consisting of
mesenchymal and epithelial layers separated by the BM. It facilitates attachment
of the epithelium to the ECM, binding of growth factors, communication between
cells, and separates the airway lumen from the subepithelial layer. It has also been
observed that EMTU is essential for epithelial development via a number of
signalling mechanisms of the underlying mesenchymal cells (Knight, Lane and
Stick 2004). The intimate communication of the epithelial and mesenchymal cells
has led to believe that during certain lung diseases, epithelial mesenchymal
transition (EMT) occurs during tumour invasion or following wound repair
(Kalluri and Neilson 2003). This relates to the observation that epithelial cells
undergo molecular reprogramming and lose their adherence and polarity, and gain
mesenchymal properties (Knight, Lane and Stick 2004).
Chapter 1 Introduction
15
Table 1-1: List of selected factors produced in asthmatic airways
IL: interleukin, TNF: tumour necrosis factor, RANTES: Regulated on Activation Normal T Cell Expressed and
Secreted, GM-CSF: granulocyte macrophage colony stimulating factor, BHR: bronchial hyperresponsiveness.
1.2.1.2 Epithelial dysfunction in chronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease (COPD) can be defined, according to the
new American Thoracic Society (ATS) guidelines as: “a preventable and treatable
disease characterized by airflow limitation that is not fully reversible. The airflow
limitation is usually progressive and is associated with an abnormal inflammatory
response of the lungs to noxious particles or gases, primarily caused by cigarette
smoking. Although COPD affects the lungs, it also produces significant systemic
consequences." (ATS 2008). It has been ranked amongst the most common causes
of death in western countries (De Boer 2002). There are two conditions thought to
be responsible for the level of COPD severity: mucus hypersecretion, also known
Factor Source Function
Lymphokines
IL-4 Th2 cells, mast cells Cofactor for IgE synthesis
Increase in Th2 cells and decrease in Th1
cells
Eosinophils maturation
IL-5 Th2 cells, mast cells Eosinophill maturation
Increase in Th2 cells
Decrease in Apoptosis
BHR
Pro-infalmmatory cytokines
IL-1 Mast cells, macrophages Growth factor for Th2 cells
Neutophil chemoattractant
Epithelial activation
BHR
IL-6 Mast cells, macrophages, epithelial
cells
T cell and B cell growth factor Epithelial
activation
Increase in IgE synthesis
IL-8 Macrophages, epithelial cells Neutrophil chemoattractant
IL-9 Th2 cells Mucus gene expression in epithelial cells
TNF-Į Mast cells, macrophages Epithelial and macrophage activation
RANTES Epithelial cells Eosinophil chemoattractant
Lymphocyte activation
GM-CSF Mast cells, epithelial cells Leukotriene release
Eosinophil apoptosis and activation
Proliferation of haematopoeitic cells
BHR
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as chronic bronchitis, characterised by presence of a chronic cough, and a
constant increase in sputum production (Bergeron and Boulet 2006), and
emphysema which is characterized by the loss of lung parenchyma and an
increase in airspace size (Jeffery 1998). Remodelling of the airway wall, as seen
in asthma, also takes place in COPD, with differences in the anatomic sites and
the structures affected (Figure 1-4). The single major risk factor of COPD is
smoking. Increased numbers of neutrophils (higher than in asthma depending on
the severity), macrophages, T-cells, and mast cells have been observed in the
airway wall of COPD patients, alveolar compartments and vascular smooth
muscle (Di Stefano, Capelli, Lusuardi et al. 1998), with the presence of
eosinophils being observed when obstruction is partially reversible.
Figure 1-4:Remodeling in COPD.
A schematic section through the airway wall of a patient suffering from COPD showing structural
tissue alterations and inflammation.
As mentioned previously migration and activation of inflammatory cells are
mostly controlled by cytokines and chemokines (discussed in detail in Chapter 4),
secreted by various structural cells (Tetley 2005). Monocyte chemoattractant
protein (MCP)-1, macrophage inflammatory protein (MIP)-1Į, TNF-Į, IFN-Ȗ,/-
1ȕ, IL-6, and IL-8 are all associated with COPD (Chung 2001). GM-CSF and/or
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IL-4 but not IL-5 is also found in the inflamed COPD lung. Neutrophils are
thought to be the main cause of tissue damage in COPD through the release of
mediators including metalloproteinases (MMPs), and neutrophil elastase (Chung
2001). Secretion of epithelial-derived neutrophil activator (ENA)-78, as well as
IL-8, from the alveolar macrophages, is enhanced (Morrison, Strieter, Donnelly et
al. 1998). RANTES mRNA expression has also been shown to be up-regulated in
patients with chronic bronchitis (Chung 2001; Chang, Summer and Sun 2005).
Thus it can be seen that whilst there are some common features present in asthma
and COPD, the cytokine profiles of both are different.
1.3 Stem cells of the airway epithelium
1.3.1 What are stem cells?
Stem cells are the basic cellular unit needed to produce embryos, and regenerate
adult tissues. For a cell to be termed a stem cell, it has to possess two fundamental
characteristics. First, it must be unspecialized and have the ability to self renew
indefinitely. Second, it must be able to differentiate under appropriate conditions
into any type of cell in the body. There are three main classes of stem cells
identified depending on their multilineage differentiation potential: firstly,
totipotent stem cells, that can give rise to an entire embryo and placenta,
characterized by unlimited capacity; secondly, pluripotent stem cells, that have a
more restricted developmental potential and have the ability to produce most, but
not all, tissues of an organ; and finally, multipotent stem cells, which give rise to
the three germ layers: endoderm, mesoderm, and ectoderm, as well as organ
specific cell lineages, and have a commitment to producing cells with a specific
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function (Borok, Li, Liebler et al. 2006). As for their developmental potential,
stem cells can be divided into two major types: adult and embryonic stem cells,
described in the following sections.
1.3.1.1 Embryonic stem cells (ESC)
Embryonic stem cells (ESC) come from the inner cell mass of the 4-5 days old
embryo, the blastocyst. ESCs are pluripotent long-term self renewable cells with
normal karyotype, and can differentiate into any cell type of the three germ layers.
The internal layer, the endoderm, gives rise to the lung, respiratory epithelium,
thyroid, liver, and pancreas. The external layer, the ectoderm, gives rise to the
skin, neural tissues, adrenal medulla, pituitary glands, and the connective tissues
of the head and face, eyes, and ears. Finally, the middle layer, the mesoderm,
gives rise to the bone marrow (blood), adrenal cortex, lymphatic tissues, skeletal,
smooth, and cardiac muscles, connective tissues including bone and cartilage,
urogenital system, and heart and blood vessels. ESC can be induced to
differentiate into various cell types in the body under the correct conditions. One
such example comes from the work of Coraux et. al., whereby murine ESC were
generated into airway epithelial tissue in vitro (Coraux, Nawrocki-Raby,
Hinnrasky et al. 2005). Briefly, they were able to culture murine ESC cells into
embryoid bodies, and they observed growth of Clara cells (determined by clara
cell secretory protein (CCSP) mRNA expression). They then tested the potential
of Clara cells to differentiate further by growing them on porous membranes at an
air liquid interface condition, and finally they observed a fully differentiated
pseudostratified epithelium (Coraux, Nawrocki-Raby, Hinnrasky et al. 2005).
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1.3.1.2 Adult stem cells (ASC)
On the other hand, adult stem cells (ASC) are undifferentiated cells found in any
organ of the adult body. They reside in specialized niches in the body, and are
observed to be directed to differentiate into the specified type of tissues in
response to the necessary environmental signal sent by the niche, contributing to
the repair and maintenance of that organ (Borok, Li, Liebler et al. 2006). Figure
1-5 shows the traditional hierarchy of adult renewing tissues such as the
epithelium. One good example of a well-defined niche is the small intestinal and
colonic crypts (Korinek, Barker, Moerer et al. 1998). A new concept has recently
been proposed for ASC, termed trans-differentiation or plasticity, which is the
ability of a stem cell of one type of tissue to differentiate into another type of cell
in another type of tissue, contrary to what was historically believed, that organ
specific stem cells were lineage restricted. This was first shown when bone
marrow derived cells were shown to be able to differentiate into muscle tissues
(Ferrari, Cusella, Angelis et al. 1998).
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Figure 1-5:Traditional stem cell hierarchy in adult renewing tissues.
1.3.2 Stem cells involved in regeneration of the airway epithelium
As mentioned earlier, the airway epithelium is in permanent contact with the outer
environment and thus may be injured frequently. There is a definite repair system
seen after injury ensuring the restoration of a normal healthy epithelium. The
severity of injury could vary from loss of impermeability to partial shedding or
complete denudation of the basement membrane (Puchelle 2000) and involves a
series of cellular events that are discussed in more detail in section 3.1.2 and
presented in Figure 3-1 . The prevailing view is that stem or progenitor cells play
a role in repair mechanism (Neuringer and Randell 2004) either involving resident
stem cells in the airway epithelium (discussed in section 1.3.2.1), or circulating
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stem cells, the latter being much more controversial and discussed in section
1.3.2.2 below. Figure 1-6 below summarizes the possible roles and types of stem
cells involved in lung development and regeneration during adult life.
Figure 1-6:Schematic diagram of stem cell involvement in lung development and
regeneration.
1.3.2.1 Resident epithelial stem cells
Until recently, due to the complexity of the respiratory tree and the lack of
appropriate models, only limited information has been available about
differentiation and regulatory mechanisms of resident respiratory stem cells. As
discussed above, the lung consists of multiple cell types from different germ
layers. Another limitation is the slow turnover and low regeneration potential of
the airway epithelium compared to some other organs such as the liver. However,
when the airway epithelium is injured, proliferation and regeneration rates tend to
dramatically increase. A general idea was that each lung subdivision contains its
own supply of stem cells, thus local repair of the trachea and bronchus is thought
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to occur by mucus and secretory cells (Borthwick, Shahbazian and Krantz 2001),
whereas Clara cells are responsible for the bronchiolar regeneration (Reynolds,
Giangreco and Power 2000). Alveolar type II cells are thought to regenerate the
alveolus (Mason 2006). Figure 1-7 below shows the cell types suspected to be the
stem cells at different areas in the respiratory tree.
Figure 1-7:Resident epithelial stem cells and their niches.
Basal cells are suspected to contain the stem cells of the trachea and proximal airways (green
cells) with the major stem cell compartment possibly residing in sub-mucosal glands. Further
down the respiratory tree, where basal cells are scarce, Clara cells (grey cells) are suspected to
acquire stemness possible residing in neuroepithelial bodies (NEB). Some investigators have
proposed that variant Clara cell secretory protein (CCSP)-expressing (vCE) cells reside in
broncheoalveolar duct junctions (BADJ) and co-express CCSP and surfactant protein C (SPC)
(yellow cells) and that these cells are the main stem cell compartment at this end. Moving down to
the alveolus, type II cells are thought to contain the stem cell population (blue cells).
Two origins have been reported for the tracheal epithelial stem cells: some
suggested that it is the tracheal gland ducts (Duan, Sehgal and Yao 1998), while
others think it is tracheal lining epithelial cells (Boers, Ambergen and Thunnissen
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1998) mostly located at or near the basement membrane. The latter are thought to
be more the transient amplifying (TA) cells rather than the more primitive stem
cells. Clara cells, however, are said to be TA cells if not the stem cells of the
bronchioles (Hong, Reynolds and Giangreco 2001). Most recent research has
shown that a subset of Clara cells achieved the criteria of adult, niche-specific
stem cells. This subset was described as expressing the Clara cell secretory
protein (CCSP) mentioned earlier (Hong, Reynolds and Giangreco 2001). Hong
et. al. and other studies have demonstrated that there was a pollutant resistant
subpopulation of Clara cells (variant CCSP-expressing cells or vCE cells) and
calcitonin gene-related peptide (CGRP)-expressing PNEC in the neuroepithelial
bodies (NEB) microenvironment which serve as a location of pluripotent
regenerative cells in naphthalene treated mice (Hong, Reynolds and Giangreco
2001) (Reynolds, Giangreco and Power 2000).However, PNEC could not
repopulate the epithelium after CCSP expressing population depletion, concluding
that the CCSP positive Clara cells must contain the stem cell population rather
than PNEC. Finally, alveolar stem cells are thought to be contained within the
type II cell population: these have been reported to express CD44 that mediates
matrix adhesion in the lung. This feature is shared with basal cells of the tracheal
and bronchial epithelium (Wadsworth, Nijmeh and Hall 2006). In addition, the
vCE cell population residing within NEB , have also been shown to reside at the
broncheoalveolar duct junctions (BADJ) in mice airways, and are able to repair
the epithelium after naphthalene injury (Giangreco, Reynolds and Stripp 2002).
These have been termed broncheoalveolar stem cells (BASC) and were observed
to be expressing both CCSP and surfactant protein C (SPC).
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One strategy to identify organ stem cells is based upon the capacity of
hematopoietic stem cells (HSC) to efflux Hoechst dye, via ATP-binding cassette
transporter (ABCG2), also called breast cancer resistance protein (Bcrp1)
(Goodell, Brose, Paradis et al. 1996). These cells were termed the side population
(SP) cells because they could be isolated by dual-wavelength flow cytometry
where Hoechst staining was absent. This is discussed in more detail in Chapter 5.
In the adult lung, SP was seen to comprise 0.03-0.07% of total mouse lung cell
suspensions (Summer, Kotton, Sun et al. 2003).
Recently, mouse lung airway digests were found to contain SP cells, with a
phenotype of vCE of NEB (Giangreco, Shen and Reynolds 2004). Although the
role of SP cells in tissue regeneration is the subject of much current research,
there are no conclusive functional studies thus far to show that these cells are lung
stem cells.
1.3.2.2 Circulating stem cells
A series of studies have argued against the original hypothesis which states that
adult tissues are thought to be renewed only by progenitor cells originating from
the same germ layer. Circulating cells derived from bone marrow and from the
mesoderm, can directly regenerate a number of non-hematopoietic tissues, such as
neurons which come from the ectoderm (Eglitis and Mezey 1997), and
hepatocytes which come from the endoderm (Petersen, Bowen, Patrene et al.
1999). When the lungs of chimeric mice were analyzed after a single bone-
marrow-derived HSC was transplanted there, 20% of type II alveolar epithelial
cells and 4% of the airway epithelial cells were derived from that donor marrow
cell (Krause, Theise, Collector et al. 2001). However, because transplantation
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experiments are inevitably to some extent artificial, investigators have employed a
parabiotic mouse model, where two mice were joined together by stitching their
flanks so that their circulation is gradually merged (Wagers, Sherwood,
Christensen et al. 2002). They found that trans-differentiation of circulating HSC
and their progeny is an extremely rare occurrence, if it exists at all. Moreover, one
study showed no evidence of epithelial reconstitution of tracheal xenografts when
HSC purified from mouse bone marrow by the Hoechst efflux method was
delivered. However, these cells may require factors in vivo to enable them to
acquire the characteristics of this tissue (Macpherson, Keir, Webb et al. 2005).
There is thus considerable controversy regarding whether cells from bone marrow
contribute to regeneration of the lung epithelium. The predominant view is that
local cells within the lung are responsible for repairing the lung epithelium, while
bone-marrow derived cells contribute very few cells directly to the airway or
alveolar epithelium structure (Kotton and Fine 2008).
Despite this controversy, it is agreed that bone-marrow-derived cells may have
some role during lung repair. One proposal for this role was immune modulation
of mesenchymal stem cells (MSC), whereby Aggarwal et. al.examined culture-
expanded hMSC and different immune cells. They observed that hMSC have the
ability to control or inhibit inflammatory responses and activate the anti-
inflammatory pathways (Aggarwal and Pittenger 2005), which in theory could aid
in the reduction of transplantation complications such as rejection, as one
example. In addition, functional rescue has also been seen after infusion of bone
marrow cells into the right and left main bronchi of rabbit lungs suffering from
emphysema, by reducing inflammation and apoptosis, as well as enhancing the
proliferation of alveolar cells (Yuhgetsu, Ohno, Funaguchi et al. 2006). The
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mechanism of this protective effect is not fully known but was suggested to
involve paracrine effects (Shigemura, Okumura, Mizuno et al. 2006). Moreover,
following HSC transplantation, studies on humans have shown proof of
chimerism in the lung, where 2% and 6% of Y-chromosome-positive epithelial
cells were seen in female recipient lung tissue sections, suggesting a possibility
that circulating stem cells can differentiate into lung epithelial cells (Mattsson,
Jansson, Wernerson et al. 2004). One other example came from work of Spencer
et. al. to asses long term lung engraftment following sex-mismatched lung
transplantation (Spencer, Rampling, Aurora et al. 2005). In one study, following
female lung transplantation into male donors, transbronchioal biopsy specimens
were examined from two boys with cystic fibrosis (CF). Median of 8.2% of all
lung cell nuclei were positive for Y-chromosome, with 1.4% of those being
inflammatory cells. 3.6% Y-chromosome-positive epithelial cells were located in
the alveolar region and 1.4% in the bronchial region (Spencer, Rampling, Aurora
et al. 2005), detected as early as 3 weeks following engraftment and were seen to
be constant till up to 37 months. This suggested long term chimerism in lung
epithelium.
1.4 Potential applications of stem cells in lung diseases
Intense research over the last decade has focused on studying development,
morphological and physiological mechanisms of organ formation, maintenance,
regeneration, and repair after injury. A recent focus has also been on the
investigation of stem cells and their role in the above processes. But, how could
these stem cells be of potential value in relation to therapeutic opportunities?
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The first possible application of stem cells could be providing novel methods to
assess wound repair pathways, which are central to the functions of the airways.
As described previously, loss of normal airway integrity can be seen in a number
of airway diseases including asthma and COPD. Many attempts have been carried
out to try and develop appropriate models of the airway wall in vitro and in vivo,
using human and animal tissues (discussed in detail in chapter 3). Stem cells are
characterised by self-renewal and undifferentiated capabilities, and thus if airway
stem cell populations can be identified, they could be induced in vitro to
differentiate into physiologically relevant (non-transformed) models of airway
tissue which would be valuable in vitro models.. These models could lead to
better understanding of the cellular and molecular events of cellular repair and
wound healing processes. More in-depth knowledge is needed about the specific
cell types involved in wound repair, and the inflammatory processes and airway
remodelling, such as those seen in asthma and COPD. In addition, these models
might prove useful in the investigation of resident lung stem cells and their role in
tissue regeneration. Thus far, a lack of specific stem cell markers has been an
obstacle in respiratory research, due to the fact that it is thought that different
stem cell populations are involved in regenerative responses in different regions
of the respiratory tract.
The second possible application of stem cells, following the development of such
models, could be to assess the toxicity of environmental and therapeutic agents.
These models can be exposed to various toxins, such as those thought to be
responsible for the development of lung diseases (e.g. cigarette smoke). This
would potentially allow in vitro assessment of the mechanisms underlying the
injury and repair responses to such agents in physiologically relevant models.
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These injury models (discussed in chapter 3) could also be used to assess efficacy
of existing and novel therapeutics agents to study their potential use in the
management of airway diseases.
The third possible use of stem cells could be to manipulate them directly as a
novel therapeutic approach. They could either involve inhibition of cell
proliferation, or the use of stem cell for tissue regeneration. As an example: one
hallmark of COPD is mucus over-production, possibly due to proliferation of
mucin-producing epithelial cells. If mucin-producing epithelial cell differentiation
was clearly understood, inhibition of proliferation could potentially be used in
order to manage this feature of COPD. However, this might prove difficult as
suppressing differentiation of these cells might lead to suppression of
differentiation of other epithelial cell types needed for re-epithelisation. Another
potential approach would be the use of BASC (as previously identified by Kim et.
al., located in the BADJ) (Kim 2007) to try and aid repair of the severely
destroyed alveoli seen in emphysema after prolonged periods of inflammation and
tissue damage. If BASC could be stimulated to migrate over the BM to replace
the damaged cells and efficiently repair the alveolar epithelium, at least
potentially lung regeneration might be observable. This could prove difficult
however, if the injury was severe to an extent where the underlying cell scaffolds
was damaged.
A fourth potential application of stem cells is that they could be tissue-engineered
into complex tissues in order to reconstitute the lung. Tissue-engineering refers to
the formation of a manmade functional organ by autologous cells introduced into
biologic carrier structures, referred to as matrices. This possibility may seem far
from reality since the respiratory system is very complex involving multiple cell
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types and tissues interacting with the surrounding vasculature, in order to ensure a
functioning gas exchange unit. However, expansion of stem cell pools in vivo or
ex vivo, and differentiation into functional cell lineages capable of regenerating
damaged tissues, have been described previously. Certain adult stem cells
including the bone marrow (BM)-derived stem cells (described in section 1.3.2.2),
have been observed to circulate under appropriate conditions in the blood and
home to distant tissues promoting repair of sites of damage, including the liver,
heart, lung, skin, eyes, and gastrointestinal tract (reviewed in (Mimeault, Hauke
and Batra 2007)). A recent development was from a group of German researchers,
where patients with myocardial infraction were injected with autologous bone
marrow into their coronary arteries (Strauer, Brehm, Zeus et al. 2001). Although
improvement in the myocardial function was noted, the study did not carry out
morphological analysis, and thus it was not conclusive that the bone marrow had
trans-differentiated into cardiomyocytes. More relevantly to this thesis, recently, a
cellular, tissue-engineered airway functionally normal and free from host
rejection, was produced and transplanted back into a 30-year old female suffering
from end-stage bronchomalacia after severe tuberculosis infection (Macchiarini P.
2008). In bronchomalacia, a deficiency in tracheal or bronchial cartilaginous wall
is observed, which may lead to obstructive emphysema. A trachea obtained from
a deceased subject was denuded of all epithelial cells and human leukocyte
antigen (HLA), and seeded with the recipient’s epithelial cells and chondrogenic
mesenchymal stem cells. This was introduced into a bioreactive device where the
airway construct was rotated in culture medium tailored to suite the requirements
of both medium and gas phases. The graft was then shaped according to the
patients requirements and after dissecting the old damaged trachea, was
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introduced to the patient. The patient was then monitored for 4 months, and a
functional airway was observed with normal appearance. If it became possible to
expand alveolar tissues ex vivo, as well as appropriate surrounding vasculature,
these could also, in theory, be transplanted into the lungs, as a novel approach in
the management of emphysema and COPD. However, gas exchange units are
very complex, and would be much more difficult to engraft than the trachea due
to their location in the lungs.
Fifthly, recent research has identified potential cancer stem cells. These cells were
observed to have a defect in their self renewal regulation. This concept provides
potential tools that could be used in cancer therapy. This could be facilitated by
identifying the cell types that produce tumours, and whether or not those actually
originate from stem cell pools. For example, in a report by Kannan et. al., the type
II cell marker SPC and the proliferation marker Ki-67 were seen in human
adenocarcinoma cells and squamour cell carcinoma (Ten Have-Opbroek,
Benfield, van Krieken et al. 1997). Stem cells could potentially be useful as a
therapeutic modality in cancer if carrying and delivering specific genes and drugs
to the malignancies were achievable. The alternative approach would be to
attempt and inhibit amplification of stem cell derived populations in tumours by
cell-based therapeutic strategies.
Finally, the ultimate aim is not only to identify stem cells, but to understand
where they go and how they recreate the alveolar septal architecture to be able to
understand how restoration of a functional three dimensional relationship
amongst the alveoli, airways and surrounding vessels, occurs, since they are all
vital for an appropriate gas exchange unit. In conclusion, stem cell biology holds
promise in regenerative medicine, cell-based therapies, and tissue engineering. A
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greater in-depth knowledge of the respiratory system, tissue damage, lung disease
environment, and stem cell niches and fate, needs to be available in order to
investigate all the potential therapeutic applications and manipulate them
successfully in the clinic.
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Chapter 2. Materials and Methods
To investigate the airway epithelial wound repair mechanism and the potential
role of stem or progenitor cells in repair, an in vitro model of primary human
differentiated bronchial epithelial cells (HBEC) was used. The method in which
cells are grown at an air liquid interface (ALI), which mimics the airway
epithelium in vivo, was adapted from Danahay et. al. (Danahay, Atherton, Jones
et al. 2002). The following sections describe the general techniques used, further
specific details can be found within the relevant chapters. Suppliers of chemicals
and media are listed in Appendix A.
2.1 Cell culture
2.1.1 Human bronchial epithelial cells (HBEC)
2.1.1.1 Recovery of preserved cells
Primary human bronchial epithelial cells (HBEC) were obtained commercially
from Lonza, Clonetics frozen in cryovials and these were assigned as passage
(p) 0 in this study. Frozen cells were introduced back into culture by rapidly
thawing the cryovials at 37º C. Once completely thawed the cell suspension was
diluted in the appropriate volume of media and mixed gently. The cells were
seeded into T-25 flasks (5 ml per flask unless stated otherwise), when purchased
(p0), in specialized bronchial epithelial growth medium (BEGM, section 2.1.1.5)
and media was changed after 24 hrs to remove Dimethyl sulphoxide (DMSO)
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which was used to cryopreserve the cells (section 2.1.1.4). Two HBEC donors
have been used in this study and the details of the number of subjects for each
experiment it mentioned in the specific section. Table 2-1 describes the details of
the donors.
Table 2-1: HBEC donor information
2.1.1.2 Harvesting cells
Cells were cultured in T-25 cell culture flasks during p1 and p2 and were then
grown in T-75 cell culture flasks up to p3 in specialized BEGM (section 2.1.1.5).
When cells reached confluency, they were dissociated by rinsing with 500 µl of
0.5 mg/ml warm 10x trypsin-EDTA solution (5 g porcine trypsin and 2 g EDTA)
diluted to 1x in 1x PBS, for 30 seconds and was aspirated off. This was followed
by re-incubation with 5 ml per T-75 flask or 2 ml per T-25 flask of fresh trypsin
for 5 min at 37ºC until cell-substrate attachments are loosened. Trypsin was then
neutralized (1:1 volume) with 0.5 mg/ml soybean trypsin inhibitor in 1x PBS; and
cells were re-suspended in fresh media and collected by centrifugation at 1200
rpm for 8 min at 37 ºC. The cell pellet was then re-suspended in the desired media
at the appropriate cell density required and seeded into new cell culture flasks or
plates. All cells were incubated at 37 ºC in humidified 5% CO2 incubators.
Donor Age Sex Race
4F0507 (Donor 1) 51 Female Asian/Oriental
5F0750 (Donor 2) 8 Female Caucasian
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2.1.1.3 Determination of cell counts
Cell counts were routinely determined prior to seeding cells into fresh media as
required in order to maintain a constant cell number for each experiment. After
harvesting and re-suspending, 10 µl aliquots of cells were placed in the chambers
of a hematocytometer. Cells in each corner quadrant of the grid were counted and
multiplied by 10
4
to give the number of cells per ml since the area of the 4 corner
squares is 1 mm
3
(0.1 mm
3
x 10
4
= 1 ml). Volumes of cells were then adjusted to
give the desired seeding densities.
2.1.1.4 Cryopreservation of cells
Approximately 4x10
6
cells per ml were harvested as in section 2.1.1.2 and the cell
pellet was re-suspended in cold 10% dimethyl sulphoxide (DMSO, diluted in 1ml
of the desired media). Cell suspensions were placed in a sterile cryovial and
immediately stored at -80°C for freezing for four hours then transferred to liquid
nitrogen (-179°C).
2.1.1.5 Maintenance of HBEC in culture
Routine culturing of HBEC was performed in T-75 cell culture flasks in
specialized bronchial epithelial growth medium (BEGM), prepared by adding the
supplements provided in singlquots® bulletkits containing: 5.0 µg/ml insulin, 52
µg/ml bovine pituitary extract (BPE), 0.5 ng/ml human recombinant epidermal
growth factor (hEGF), 0.5 µg/ml hydrocortisone, 0.5 µg/ml epinephrine, 10.0
µg/ml transferrin, 0.1 ng/ml retinoic acid (RA), 6.5 ng/ml triiodo-L-thyronine,
and 50.0 µg/ml gentamycin and amphotericin-B (GA), (all final concentrations),
to bronchial epithelial basal media (BEBM). GA can affect the growth of cells
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and since it is stable for 3 days at 37ºC, it was not used for more than 3 passages.
HBEC were passaged when the cells reached 80-90% confluency. The cells were
then harvested as explained in section 2.1.1.2 and seeded into appropriate plates
depending on the experiment to be carried out. These cells were either used
directly as undifferentiated HBEC or differentiated as explained in the next
section.
2.1.1.6 Differentiation of HBEC into a pseudostratified airway epithelium
The method of Danahay et. al. was used to generate a multi-cellular layered
culture representative to that in vivo (Danahay, Atherton, Jones et al. 2002).
Bronchial epithelial differentiation media (BEDM) is a 1:1 mixture of BEBM and
Dulbecco’s modified eagle's medium (DMEM) with the singlequot bulletkit
supplements as above (section 2.1.1.5) but omitting triiodo-L-thyronine and the
GA mix. RA was also not added and substituted by a higher final concentration of
50 nM. It has been shown previously that the airway epithelium becomes
squamous without RA and mucin secretionfalls dramatically (Gray, Guzman,
Davis et al. 1996). Figure 2-1 is a schematic diagram explaining the technique of
HBEC differentiation in vitro.
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Figure 2-1: Differentiation of HBEC in vitro.
Primary human bronchial epithelial cells (HBEC) were cultured in vitro on microporous polyster
membranes in submerged culture using bronchial epithelial differentiation media (BEDM) for 7
days (left) after which they were raised to air liquid interface (ALI) for a further 21 days to
differentiate (right).
P4 HBEC were seeded at 0.8-1.7 x 10
5
cells per transwell insert in 500 µl BEDM
onto polyester tissue culture inserts (0.4 µm pore size) in 12-well cell culture
plates. These were cultured at 37ºC, 5% CO2 for 7 days, changing the media
every 48 hrs. 500 µl of cell suspension in BEDM was added to the apical layer
per insert and 1 ml per insert BEDM only was added to the basal compartment.
The cells were maintained in submerged cultures for 7 days. After the cells had
reached complete confluency, they were raised to air liquid interface (ALI) by
adding media only to the basal compartment and the apical compartment was
briefly rinsed with 250 µl per well fresh sterile phosphate buffered saline (PBS) to
remove any mucus build-up, and differentiated for a further 21 days. Every 48
hrs, the media was replaced and the apical compartment was washed as above.
2.1.1.7 Wound repair model of HBEC
The wounding process explained below was adapted from a previously published
method (Kim, McKinnis, Nawrocki et al. 1998) (Wadsworth, Nijmeh and Hall
2006)(White et. al., 1999).
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For wounding experiments with undifferentiated HBEC, when cells reached
confluency in 24-well plates, they were wounded in two parallel lines using a
sterile p200 Gilson pipette tip making sure the cells at the site of the wound were
completely denuded down to the surface of the plate. The cell layer was wounded
after aspirating off old media and adding 250 µl per well sterile PBS. PBS was
then aspirated off to remove any cell debris and fresh BEGM was then added.
Similarly, for wounding experiments with differentiated HBEC, the cell layers on
the inserts were carefully wounded in two parallel lines as above. Again, this was
done after aspirating off the old media and adding 250 µl per well fresh PBS;
which was then aspirated off and fresh BEGM was added to the basal
compartment only. Wounding experiments for both differentiated and
undifferentiated HBEC were done on donor 1 only.
Images of the wounds were captured using an inverted Nikon Diaphot 300
microscope with a Plan PhL x2.5 objective (Nikon) and a digital camera (Insight
QE model 4.2). Analysis of wound healing quantification was carried out using
SpotCam Advanced software , Image solutions, diagnostic instruments Inc.,
Chorley, Lancashire, UK) by measuring the area of the wound. Examples of
wound images and area measurements are provided in section 3.4.2.
2.1.2 Epithelial cells from lung biopsies:
Biopsies were acutely derived from bronchial tissue obtained at bronchoscopy
with full local ethical approval from healthy, non-smoking subjects. This was
carried out by Dr. Claudia Ceresa and Dr. Mark Roberts. Briefly, at the time of
bronchoscopy the endobronchial samples were taken at first division subcorina
(i.e proximal part of the airway). The biopsies were then placed into a 5ml bijou
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tube with approximately 3 ml of sterile PBS without antibiotics, at room
temperature. The bijou should be sealed inside a ‘Blood Form Bag’ and placed
inside a second, sealed container. The sample was then transferred from the
endoscopy suite directly to the laboratory and placed in a petri-dish and dissected
under the microscope using fine dissecting tools and needles where the epithelial
cells were carefully separated from the rest. The sample was then placed in a 6-
well plate using 1 ml BEGM per well and the media was replaced every 7 days.
Cells generally reached confluency within approximately 10-14 days. Cells were
harvested as in section 2.1.1.2. Cells (from each biopsy) were then seeded into T-
25 flasks (p1) until confluent after which they were split again into T-75 flasks.
When they reach p4, differentiation of the epithelial cells was carried out as
described in section 2.1.1.6. Undifferentiated and differentiated cells were
characterised for epithelial and differentiation markers to determine the type and
the purity of the cells grown, as well as their differentiation potential (refer to
section 5.4.4 for more details). Cells were maintained at 37ºC in a 5% CO2,
incubators at all times.
2.1.3 Isolation of single cells
To investigate the clonogenic potential of the various cell types present in cell
populations obtained during this project, two methods for single cell isolation
were used: dilution cloning and fluorescence-activated cell sorting (FACS).
First, dilution cloning was carried out after cells were harvested as described in
section 2.1.1.2. Dilution cloning is the process of obtaining a monoclonal cell
population starting from a polyclonal one and this is achieved by sequentially
diluting the cells until 1 cell per well is obtained. Starting from 2x10
6
cells per ml,
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the cell suspension was diluted to 2000 cells per ml and then 5 cells per ml in
BEGM. 200µl of the diluted cell suspension was added to each well of a 96-well
plate. Wells were then checked for cells under a phase-contrast microscope for
colonies every 3-4 days and the media was changed after 10-14 days.
Another method of serial dilution, known as limiting dilution, was carried out by
counting then diluting the cells to 1000 cells per ml suspension. Figure 2-2 gives a
summary of the 96-well plate layout .96-well plates were prepared by adding 200
µl of the desired media in wells A1-H8 and 100 µl in the rest of the well. 100 µl
of the diluted cell suspension was added to A1 with gentle mixing after which 100
µl was removed from A1 and added to B1 with mixing to give a 1:2 dilution,
another 100 µl was removed from B1 and placed into C1 and so on until H1
(serial dilution 1). Dilution across the plate was then carried out in an analogous
way using a multichannel pipette (serial dilution 2). This was carried out in 96-
plates to study HBEC clonogenic potential (section 5.4.1). These studies only
included donor 1.
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Figure 2-2: Cloning of HBEC using limited diltution.
Serial dilution 1 was first carried out down A1-H1 starting from A1 (containing 1000 cells/ml)
removing 100µl and placing it into B1 with mixing and so on. Then serial dilution 2 was done
across the plate using a multichannel pipette replacing 100 µl in each well.
Finally, single cell sorting was also carried out using a fluorescent-activated cell
sorter (FACS, Coulter Altra Flow Sorter, Beckman Altra) using a blue UV laser.
The cells from donor 1 were harvested as described above, centrifuged and re-
suspended in fresh media at 1x10
6
cells per ml and then sorted using the FACS
machine into 150µl of fresh media per well.
2.2 Protein analysis
2.2.1 Immunofluorescence (IF)
To carry out immunofluorescence staining on undifferentiated HBEC, the
procedure explained below was carried out on cells grown on plastic 24-well
plates. However, for differentiated HBEC, microporous membranes were cut out
carefully from the transwells, after the staining procedure was completed, using a
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sterile blade and placed on glass slides with cells facing down on one drop of
mounting media to preserve the cells on slides. Another drop was added over the
membrane placed on the slide and a cover slip was then put on top, ensuring no
bubbles were produced.
To visualize the expression and/or the cellular distribution of proteins of interest,
antigens were detected using specific primary antibodies and dye-coupled
subsequent secondary antibodies. The following is a summary of the protocol
used to immunostain undifferentiated and differentiated HBEC.
250 µl per well of any of the solutions used in the protocol was added to
undifferentiated HBEC unless stated otherwise. When handling differentiated
HBEC, 250 µl per well of solution was added to both apical and basal
compartments. Cells were washed with PBS three times (5 min each time)
between each step to remove any residual solution from the previous step.
Moreover, solutions were aspirated off in-between steps using an aspirator.
Fixation:
Cells were fixed by incubation with 4 % formaldehyde in PBS for 15 min at room
temperature or overnight at 4 ºC.
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Permeabilization:
To expose the intra-cellular antigens to the antibodies, cells were incubated with
0.15% triton X-100 in PBS for 10 min at room temperature
Blocking step and antibody addition:
To avoid non-specific antibody binding, cells were incubated with10% goat
serum in 1% bovine serum albumin (BSA)/PBS for 15 min at room temperature
or can be stored at 4 ºC until staining.
Primary antibody (diluted in 1% BSA/PBS at the desirable working
concentration) was added to the fixed cells either for 1 hr at 37ºC or overnight at
4ºC. The primary antibody was subsequently detected using a suitable secondary
fluorophore at 1:250 dilution 1%BSA/PBS and incubated for 30-45 min at 37ºC
in the dark to minimize photo bleaching. Most steps from this point onwards were
carried out in the dark by wrapping the samples with aluminium foil. The
appropriate primary and secondary antibodies used, the working concentrations,
and their sources are mentioned in the relevant chapters where IF was carried out
Fluorescence and confocal microscopy:
Immunofluorescent-labelled samples were imaged and analyzed using
fluorescence and confocal microscopy. For fluorescence microscopy, a Nikon
Diaphot 300 epifluorescence microscope (Surrey,UK) with a mercury lamp was
used with a SPOTCam software to capture images. For confocal microscopy, a
laser scanning Zeiss Axiovert 100 inverted microscope, with a Zeiss LSNM510
UV combi spinning disk attached (Carl Zeiss Ltd, Hertfordshire, UK) was used to
capture Z-sections through the cultures for three dimensional images. Further
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details can be found in specific sections where characterisation of epithelial cells
was carried out.
All immunofluorescence was carried out on donor 1.
2.2.2 Luminex assays
The Luminex® system was employed to investigate cytokines, chemokines, and
growth factors secreted by differentiated HBEC, grown at ALI, before and after
injury. The principle of this technology is the ability to measure multiple analytes
simultaneously in single-reaction well (see Figure 2-3). Molecular reactions on
the surface of colour-coded microspheres, using different fluorescent intensities
of two dyes, take place. The fluorescently-labelled microspheres, tagged to a
reporter tag, capture the sample. The microspheres are then applied to the
instrument by focusing them in a single file, where they pass two lasers. One
illuminates the microsphere identifying the read bead, and the second excites the
colour on the surface. Colour signal is captured, translated digitally into real time
and the data is then quantified. The technology has the ability to detect at least 1
pg/ml of analyte in as small a volume as 25 µl per well.
This multiplex immunoassay is based on xMAP® detection technology,
combining a flow cytometer, a fluorescent-dyed beads, lasers and digital signal
processing. The assay was carried out according to the manufacturer’s protocol
using a pre-mix human Procarta® Cytokine Assay kit, 28-plex (cat # 1PC1028), a
vacuum filtration system, Millipore (P/M MAVM0960R and WP6111560), a
microplate shaker, labline model 4625 with 3mm orbit, and a Bioplex® plate
reader (luminex machine) with a Bioplex manager version 2, BioRad.
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Pre-mixed standards were reconstituted in 125 µl of cell culture media (BEDM)
gently vortexed for 10 sec and incubated on ice for at least 10 min. Serial
dilutions of the premixed antigen standards were prepared in cell culture media.
Figure 2-3: Basic Principle of Luminex System.
(A) shows the magnetic beads with an inner fluorescent dye, bound to antibodies against target
proteins to be measured in the sample. A fluorescently labeled reporter antibody then binds to the
target analyte. The beads are run through the luminex machine in a single file where one laser
identifies the bead itself (laser detector 1) and another laser identifies the fluorescent detector
antibody (laser detector 2)(B).
2.2.2.1 Luminex assay
Standards and samples were placed in 96-well plate with filter bottoms in
duplicates and any unused wells were sealed before starting the assay. At the end
of each step, solutions were removed by vacuum, and the samples were washed
three times with 150 µl 1x wash buffer per well (salts were dissolved by vortexing
10x wash buffer, then 20 ml of 10x wash buffer was mixed with 180 ml deionised
water). The bottom of the filter plate was then blotted thoroughly to remove
excess buffer and returned to the filter plate holder. All reagents mentioned in the
protocol are provided with the kit. Two subject samples were used for these
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studies (donor 1 and donor2). Each included two replicates and the Luminex
assay was carried out in duplicate.
Filter plate pre-wetting:
150 µl of reading buffer was added to each well and incubated for 5 min.
Antibody beads addition: Premixed antibody beads were vortexed for 30 sec at
and 50 µl of antibody beads were added to each well.
Samples/standards loading:
75 µl Assay buffer and 25µl of standards or samples were added to each well and
the plate was sealed, completely wrapped with aluminium foil, shaken for 30 sec
at 500 rpm at, and the plate seal was carefully removed.
Detection antibody addition:
25µl of detection antibody was added to each well and the plate was again sealed,
completely wrapped with aluminium foil, shaken for 30 min at 500 rpm at, and
the plate seal was carefully removed.
Streptavidin-PE (STPE) addition:
STPE beads were vortexed to re-suspend and 50 µl was added to each well. The
filter plate was again sealed, completely wrapped with aluminium foil, shaken for
30 min at 500 rpm, and the plate seal was carefully removed.
Plate reading: 120 µl of reading buffer was added to each well and the plate was
sealed, completely wrapped with aluminium foil, shaken for 5 min at 500 rpm at,
and the plate seal was carefully removed before analyzing on the Bioplex luminex
machine. A standard curve for each analyte, using the 5PL-(parametric logistic)
regression fit, was created from the standards, and this was used to determine the
final concentration (pg/ml) in the samples. This was done using Bioplex manager
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version 2 software (BioRad). An example standard curve is presented in Figure
2-4. Finally, the data was plotted as time points post wounding vs. cytokine
observed concentration (pg/ml) and statistical analysis was done using Prism 5.0
software.
Figure 2-4: A representative standard curve created after luminex experiment (IL-6).
A standard curve was created from the standards included, using 5PL-(parametric logistic)
regression fit. Outliers as determined by the software (shown as x) were excluded from the fit .
Samples were measures as duplicates at each concentration.
2.3 FACS-based Hoechst efflux method of stem cell purification
Flow cytometry is used to analyze the expression of cell surface markers and
intracellular molecules, as well as characterising different cell types in
heterogeneous cell populations. This is achieved by measuring the fluorescence
intensity produced by fluorescent-labelled antibodies detecting proteins bound to
specific cell-associated molecules. The single cell suspension is focused to a thin
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stream of single cells with a laser light directed to it as the sample flows through a
chamber. A number of detectors are used to detect any light scattered from cells
as they flow through the beam. One detector is placed in front of the light beam
(forward scatter (FSC)) and several at the side (side scatter (SSC)). Fluorescent
detectors are used for detecting fluorochromes (Figure 2-5).
Figure 2-5: Basic principle of FACS.
Cells are sorted on the basis of light scatter (size and shape) and fluorescence by deflection of a
thin stream of cell suspension.
FSC is correlated with cell size and shape while SSC depends on the density of
the cell. The fluorochromes emit light when excited by a laser with the
corresponding excitation wavelength. Fluorescence-activated cell sorting (FACS)
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does not only quantify the signal but also separates the cells from a mixed
population of cells based on the fluorescence profile. There are direct and indirect
approaches to staining. Direct FACS staining involves the incubation with an
antibody conjugated to a fluorochrome directly, while in indirect FACS staining,
the primary antibody is detected by a specific secondary fluorochrome-labelled
antibody.
2.3.1 Identification of side population (SP)
A ‘side population’, characterised by its ability to rapidly efflux the DNA-binding
Hoechst 33342 dye through ABCG2 transporter, has been defined recently in a
number of tissues (Terunuma, Jackson, Kapoor et al. 2003; Budak, Alpdogan,
Zhou et al. 2005). This population is thought to be rich with primitive stem cells.
Hoechst is excited at UV lengths 351-364 nm to emit a blue fluorescence at
465nm. Goodell et. al. in 1996 were first to introduce this FACS-based Hoechst
efflux method to isolate the side population that can be detected on a dual
wavelength profile (Hoechst red vs Hoechst blue) from murine bone marrow
(Goodell, Brose, Paradis et al. 1996). An adaptation of this method was used to
isolate and attempt to characterise the side population from undifferentiated and
differentiated HBEC, and epithelial cells derived from lung biopsies. More details
can be found in sections 5.4.2 and 5.4.3.
For these studies, cells were harvested (section 2.1.1.2) and re-suspended in fresh
media (BEGM) at 1x10
6
cells/ml. Incubation of the cells with 5 µg/ml Hoechst
33342 was carried out for exactly 90 min at 37°C, shaking continuously. As a
negative control, duplicate samples were treated with 50 µM verapamil
hydrochloride, a calcium ion influx inhibitor, for 5 min prior to incubation with
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the Hoechst dye. After incubation, cells were cooled on ice, centrifuged (1200
rpm for 8 min at 4°C), and re-suspended at 0.5x10
6
cells/ml in Hank’s balanced
salt solution (HBSS) containing: (HEPES), 1 mM Magnesium chloride (MgCl2),
2mM Calcium chloride (CaCl2), 2% foetal calf serum (FCS). In order to
discriminate cells 2 µg/ml propidium iodide (PI), which binds to the DNA, was
also included. Cells were kept on ice at all times after incubation to prevent
further dye efflux. A Coulter Altra Flow Sorter (Beckman Coulter Altra) was used
to analyze cells and to isolate the side population for further characterisation. A
FSC vs SSC plot was generated to gate the live population depending on PI
staining (live cells stain positive for PI). Then, a Hoechst Red vs Hoechst blue
profile (emission detections were 670/30-nm band-pass and 450/65-nm band-pass
filters) was generated. Statistical analysis was generated using winMDI 2.8
software. All side population experiments were carried out on cells from donor 1.
2.4 Molecular methods
To investigate the effect of injury on the relative expression of specific epithelial
genes from HBEC using mRNA levels, reverse transcription; combined with
quantitative real time polymerase chain reaction (qPCR) were utilised. Details of
the target genes investigated are found in specific sections dealing with epithelial
stem/progenitor characterisation in wound healing.
2.4.1 Total RNA preparation from animal cells
RNA was extracted from cells after experimental treatment using RNeasy mini kit
and RNase-Free DNase Set purchased from Invitrogen. All steps were carried out
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at room temperature according to the manufacturer’s protocol on clean bench
surfaces and equipment to minimize contamination by RNases and human RNA.
All centrifugation steps were carried out at 13000 rpm.
Cells were lysed by adding 600 µl RLT buffer, containing ß-mercaptoethanol
(100:1), directly to plates or flasks (40 ul per transwell was used for differentiated
HBEC). Cells were then harvested using a cell scraper and stored in eppendorf
tubes at -80ºC until RNA extraction. The lysates were next briefly spun,
homogenised by passing through a QIAshredder column and centrifuged for
2min. 600µl of 70% ethanol was added to the samples, mixed well, and was
applied to RNeasy mini column and centrifuged for 1 min.
DNA digestion was performed using the Qiagen RNase-free DNase set as
follows: 350 µl Buffer RW1 was added to the RNeasy mini column and
centrifuged for 1 min discarding the supernatant. Meanwhile, 10 ul of the DNase I
stock was mixed gently with 70 µl buffer RDD, applied directly onto the RNeasy
silica-gel membrane. After incubation at 30°C for 15 min, 350 µl buffer RW1 was
added to the RNeasy mini column and centrifuged for 1 min discarding the
supernatant. The RNeasy column was then transferred into a new 2 ml eppendorf
tube and washed twice by adding 500 µl buffer RPE onto the column,
centrifuging for 1 min, and discarding the supernatant. The RNeasy column was
again placed into a new 2 ml tube and centrifuged for 2 min to remove residual
RPE. Finally, to elute the RNA, the RNeasy column was transferred into a 1.5 ml
eppendorf tube and 40 µl RNase-free water was added directly onto the RNeasy
silica-gel membrane and centrifuged for 1 min. The supernatant was transferred to
a new labelled eppendorf tube and stored at -80°C.
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2.4.2 Complimentary DNA (cDNA) synthesis
2.4.2.1 Polymerase chain reaction (PCR)
Polymerase chain reaction involves three main steps, denaturation of the template
complimentary DNA (cDNA) strands, annealing of the primer pairs added to the
template DNA strands and finally the elongation of the primers by the RNA
polymerase to create nascent copies of the template strands. These steps are
usually repeated 20-30 times to give an exponential increase of the target
sequence flanked by the opposing primer pairs.
2.4.2.2 Primer design
Primers were designed with the aid of Beacon designer 6.0 software (Premier
Biosoft International). The following were used as a guide when primers were
designed: An optimal size of 18-20 base pairs (bp) (longer primers would have
high annealing temperatures), and similar annealing temperatures of forward and
reverse primers, 50% G/C content (since a higher percentage might lead to non-
specific annealing, the 3’ end of the primers should not be rich with G/C), and
finally the specificity of the primers to the desired genes were checked using the
Basic Local Alignment Search Tool (BLAST) (Altschul, Madden, Schaffer et al.
1997) (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Lists of the primers used can be
found in the specific chapters.
2.4.2.3 Reverse Transcription
Complimentary DNA (cDNA) is synthesized from a single stranded mRNA
template using reverse transcription (RT). RNA concentration was first measured
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using a Nanodrop spectrophotometer (ND 1000 (Wilmington, USA)). 1 µl sample
was added onto the Nanodrop for measurement after blanking the machine with
DEPC-treated water. The purity of RNA was indicated by the A260nm/A280nm ratio
which should be 1.8 and 2.0 since this ratio is used to assess the purity of RNA
(or DNA). For all experiments, this ratio was 1.87-2.16.
cDNA was then prepared using the Superscript 1st Strand System (VX11904018)
according to the manufacturer’s protocol. Table 2-2 lists the reagents to prepare
Mix 1 and Mix 2 respectively for 20 µl cDNA.
Table 2-2: Mix 1
Non-template controls (NTC) were prepared in parallel by leaving out the RNA.
Each sample was incubated at 65°C for 5min to denature the RNA secondary
structure, chilled on ice for 1 min and centrifuged briefly. Mix 2 was then
prepared (Table 2-3).
Table 2-3: Mix 2
1 µl
2 µl
0.5 µg
up to 10 µlDEPC-water
10 µl RT reaction
10 mM dNTP mix
50 ng/ µl Random hexamers
RNA
2 µl
4 µl
2 µl
1 µl
10 µl RT reaction
10X RT buffer
25 mM MgCl2
0.1 M DTT
RNAse OUT
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In order to anneal the random hexamers to RNA, 9 µl of the Mix 2 was added to
each of the denatured samples, mixed gently by pipetting, and centrifuged briefly.
The samples were incubated for 2 min at 25°C and 1 µl of SuperScript. II RT was
added to each sample by gentle pipetting. A duplicate set of samples was also
prepared as above leaving SuperScript II RT enzyme out as negative controls
(RT-). Reverse transcription reactions were carried out (Table 2 3: RT-PCR
cycling conditions) in a Techne Gradient PCR block (GMI, Minnesota).
Table 2-4: RT-PCR cycling conditions
After the reaction was complete, the samples were chilled on ice for 2 min and
centrifuged briefly to ensure all contents were at the bottom of the tube. RNaseH
(1 µl) was then added to each sample and incubated for 20 min at 37°C. The
samples were again centrifuged briefly, and stored at 4°C for short term (2 weeks)
or at -20°C for long term storage.
2.4.2.4 Verification of cDNA
Synthesized cDNA was then checked for the expression of the housekeeping gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). A polymerase chain
reaction (PCR) was carried out to amplify GAPDH.
(5’TCTAGACGGCAGGTCAGGTCCACC forward in exon 4, and
3’CCACCCATGGCAAATTCCATGGCA reverse, in exon 8). and Table 2-6 list
the reagents used to prepare the master mix and the cycling conditions at which
25°C for 10min
42°C for 50min
70°C for 15min to inactivate
4°C to hold
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PCR was run, respectively. PCR products from cDNA samples were separated
and analyzed by agarose gel electrophoresis. 1% agarose tris acetate-EDTA
(TAE)-gels were used to run the samples with 0.5 µg/ml ethidium bromide added
to the agarose gel mixture to permit visualisation of the cDNA with a UV
transilluminator. TAE buffer was prepared by mixing 242 g of tris base with
57.1ml glacial acetic acid and 100 ml 0.5 M EDTA (pH:8); and deionized
distilled water was then added to make up 1 L of solution. A Syngene gel doc
with a GeneSnap acquisition, GeneTools analysis, and GeneDirectory database
software (Cambridge, UK) was used to record images. Meanwhile, 10 µl of
sample was added to 3 µl Orange G loading dye to monitor the progress of the gel
electrophoresis. Gels were then run horizontally in TAE buffer for 30-40 min at
40-50 volts. A 1 kb DNA ladder was used for comparison to determine the
concentration and molecular weights of cDNA fragments (suitable for DNA sized
between 500 – 1 kb). Figure 2-6 below shows differentiated HBEC cDNA
GAPDH expression, verifying the cDNA with good quality for investigation.
Table 2-5: GAPDH PCR master mix
PCR Reaction (1X) µl
10x PCR buffer 5
50mM stock Mg2
+ 1.5
5µM stock dNTPs 2
100µM stock GAPDH forward 1
100µM stock GAPDH reverse 1
DEPC-water 37.5
taq 1
cDNA template 1
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Table 2-6: GAPDH PCR cycling conditions
Figure 2-6: GAPDH expression in differentiated HBEC cDNA.
Wounded and unwounded samples in duplicates were used per donor. The image shows RT+ and
RT- samples at different time points post-wounding.
2.4.3 Quantitative real time PCR (qPCR)
DNA amplification monitoring in real time is the basis of quantitative PCR
(qPCR). Currently, there are four chemistries for qPCR: Taqman® (Applied
Biosystems, Foster City, CA, USA), Molecular Beacon, Scorpions® and SYBR®
Green (Molecular Probes), all of which detect the PCR product via a fluorescence
signal. Taqman®, Molecular Beacon, and Scorpions® are dependant on
fluorescence resonance energy transfer (FRET) to produce a signal. This is
achieved via a fluorogenic coupled dye and a quencher moiety. However,
SYBR® Green is a fluorogenic dye that fluoresces when in solution but emits
94°C 1.30 min
50°C 1.30 min
72°C 1.30 min
72°C 10 min
4°C HOLD
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strong signal when bound to double-stranded DNA. Taqman® probes, used in
real-time experiments in this project, have a fluorescent reporter dye (R) attached
to the 5’ end and a quencher coupled to the 3’ end hybridized to an internal region
of the PCR product (Figure 2-7). The probe depends on the 5’ activity of the Taq
polymerase used to hydrolyse an oligonucleotide hybridized to the target
amplicon. In close proximity, in the unhybridized state, the quencher and reporter
dyes do not produce a fluorescent signal. As the polymerase replicates on the
template where the Taqman® is bound (5’ to 3’), the probe is cleaved releasing
the reporter and quencher dyes, generating a fluorescence signal. Thus, with each
cycle, depending on the amount of cleaved probe, the fluorescence increases
proportionally.
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Figure 2-7: Taqman® probe design and function.
This fluorescence signal is detected using a laser light distributed on thin-walled
reaction tubes with optical fibres. The fluorescence emission is directed to a
spectrograph with charge-coupled device camera. Mx2005 QPCR system
(Stratagene, Agilent Technologies UK Limited, Cheshire, UK) was used in this
study and quantification was monitored using MxPro QPCR software. The
number of threshold cycles (Ct) was measured and quantification was calculated
using the ¨FRPSDUDWLYHPHWKRGDVIROORZVǻ&W = Ct of target gene – Ct of
housekeeping gene, obtaining a final value via 2
-ǻ&W
. Hypoxanthine
ribosyltransferase (HPRT) and 18S were used as endogenous housekeeping genes
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for data normalization (de Kok, Roelofs, Giesendorf et al. 2004). Human HPRT1,
FAM / MGB Probe, Non-Primer Limited, cat# 4333768T, Applied Biosystems.
Total RNA, from differentiated HEBC grown at ALI and wounded, was collected
at 0, 24, 48, and 72 hrs post-wounding, after which cDNA was synthesized as
described above, then were run in triplicates in 96-well optical plates. A master
mix (Table 2-7) was prepared (20 µl per well) and then run at the cycling
conditions shown in Table 2-8.
Table 2-7: Quantitative PCR (qPCR) master mix
Table 2-8: qPCR cycling conditions
A standard curve was plotted to determine the efficiency of the reaction and to
ensure similar efficiencies and conditions for all primers and probes used. This
was carried out by setting up 2-fold dilutions in triplicates (1:2, 1:4, 1:8, 1:16,
1:32) of the samples for each of the primer sets and running the reaction as in
Table 2-7 and Table 2-8. Ct values were normalized against either HPRT and 18S
housekeeping genes, at each time, and Figure 2-8 compares the results for 18S
20 µl Real Time reaction µl
2x Taqman Universal Master mix 10
900 nM Forward Primer 1.8
900 nM Reverse Primer 1.8
250 nM Probe 0.5
dH2O 1.9
cDNA (diluted at 1:10 in DEPC water) 4
50 °C 2 min 1 cycle
95 °C 10 min 1 cycle
95 °C 15 sec
60 °C 1 min
40 cycles
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(A) and HPRT (B) mRNA expression by wounded and unwounded differentiated
HBEC used in these studies. Analysis was done using the comparative
TXDQWLILFDWLRQǻ&WPHWKRG6WDQGDUGFXUYHVIRUDOODVVD\VDUHVKRZQLQWKH
relevant following sections. For molecular work, RNA was extracted from the
same samples of which the supernatants were collected from for Luminex
analysis. These included donor 1 and donor 2 differentiated HBEC, each done in
2 replicates. Real time PCR was carried out in triplicate.
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Figure 2-8: Housekeeping genes mRNA expression.
(A) is showing donor 1 while (B) is donor 2 18 s and HPRT mRNA expression. Both graphs are
representative of the mean of two replicates per donor for each housekeeping genes for both
wounded and unwounded cultures.
2.5 Statistical analysis
Statistical analysis was carried out on raw data using two-way ANOVA followed
by a Bonferroni multiple comparison post-hoc test. For wound area
measurements, a one-way ANOVA followed by Dunnett’s multiple comparison
post-test was used to calculate the date. GraphPad PRISM version 5.0 was used
for all statistical analysis, with values representing the mean ± standard error of
mean (SEM) of n separate experiments.
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Chapter 3. Characterisation of a Differentiated Human
Bronchial Epithelial Wound Repair Model in vitro
3.1 Introduction
As discussed in chapter 1, the airway epithelium has been proven to have an
important role in both the normal and the diseased lung. The epithelium protects
the lung from inhaled toxic particles such as smoke, bacteria, and viruses. It also
serves anti-microbial, regulatory, and pro-inflammatory functions. Moreover, it
possesses regenerative capabilities in order to maintain its integrity and fulfil
these functions successfully. It is thought that resident stem or progenitor cells are
present in specific niches along the respiratory tree and are responsible for the
repair of the multi-layered epithelium’s structure under normal wear and tear, as
well as in diseased lungs.
As the airway epithelium is critical to the normal functioning of the lung, many
attempts to study this tissue layer have been carried out since the late 1970s and
early 1980s (Mathias, Yamashita and Lee 1996). A number of animal and human
in vivo and in vitro models have been evaluated which mimic the airway
epithelium in the adult body and which might contribute to an in-depth level of
understanding of wound repair mechanism. Relevant models of the airway
epithelium could also enable drug metabolism studies, the dissection of pathways
important in control of permeability, and the study of a wide range of cellular
processes at the molecular level.
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3.1.1 Airway epithelial models
Historically, a number of models have been established to study the airway
epithelium. These have been used to investigate the function, growth and self
renewal of airway epithelium and to study differentiation, clonogenic potential,
and characterisation of the resident stem or progenitor cell pools responsible for
wound repair and their niches. These models include human and animal species
both in vitro and in vivo and relevant examples are discussed below.
3.1.1.1 Animal and human in vivo models
Table 3-1: In vivo models of the airway epithelium
McDowell et. al. were able to regenerate a female Syrian Golden Hamster
tracheal epithelium after mechanical injury by scraping with a blunt probe
(McDowell, Becci, Schurch et al. 1979), (Keenan, Combs and McDowell 1983).
Studies in this model have shown a sequential repair mechanism starting with
(McDowell et al. 1979),
(Keenan et al. 1983)
(Shimizu et al. 1992)
(Dupuit et al. 2000) Human airway epithelial cells seeded onto rat tracheas and
implanted into SCID mice
HBEC: human bronchial epithelial cells
SCID: severe combined immuno-deficient
(Engelhardt et al. 1992)
(Engelhardt et al. 1995)
(Zepeda et al. 1995)
 Foetal human epithelial cells seeded onto human foetal
tracheas and implanted into SCID mice
(Delplanque et al. 2000)
Animal tracheal generation
 Scrape-wound of the Syrian Golden Hamster trachea
Animal airway xenograft models
 Rat tracheas
Human airway xenograft models
 Primary HBEC seeded into denuded rat trachea then grafted
into nude mice
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dedifferentiation, followed by spreading and migration at wound edges,
proliferation, and finally redifferentiation again.
Animal tracheal xenograft models have also been developed to study the repair
mechanism and the role of airway epithelial resident stem and progenitor cells.
One such example was carried out by Shimizu T. where rat tracheas were
denuded by repeated thawing and freezing after which they were seeded with
adult rat tracheal epithelial cells and implanted subcutaneously into syngeneic
hosts (Shimizu, Nettesheim, Ramaekers et al. 1992). Briefly, cellular
differentiation of tracheal epithelial regeneration was then investigated using a
number of epithelial cell-specific markers to identify basal, ciliated, and secretory
cells. They observed that at day 4 following implantation, epithelial cells were
squamoid with around 1-3 cell layer thick, and contained one cell type, therefore
were termed poorly differentiated cells expressing keratin 14 and GSI-B4. The
epithelium looked pseudostratified by day 7 with secretory cell-specific marker
expression on top of the columnar ciliated cells. Basal cells were also observed by
this stage. Therefore, they concluded that all secretory and ciliated cells were
derived from the poorly differentiated intermediates observed at day 4.
However, as useful as the above models have proved to be, the histological
differences that exist between animals and human airways should be taken into
account. The model of Shimizu T. has been adapted for human studies by
Engelhardt J.F. (Engelhardt, Yankaskas and Wilson 1992) (Engelhardt,
Schlossberg, Yankaskas et al. 1995), (Zepeda, Chinoy and Wilson 1995) to try
and identify and characterise the human epithelial progenitors. Dissociated human
airway epithelial cells were introduced into rat trachea depleted of its own
epithelial layer which was then grafted into a recipient immunodeficient nude
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mouse. This model was first established to evaluate the efficiency of gene transfer
in human airways for cystic fibrosis. However, it was observed that these
therapies were successful only when the recipient airway epithelium was
undifferentiated and regenerating at high levels (Engelhardt, Yankaskas and
Wilson 1992). On the other hand, Zepeda et. al. adapted the xenograft model to
evaluate cellular proliferation and differentiation in human bronchial epithelium.
The individual retrovirus-marked cells were monitored as transgene expressing
cells and it was observed that one cell type within the bronchial epithelium was
responsible for the regeneration via high self renewal capacity and pluripotent
development, but this population remains to be characterised (Zepeda, Chinoy
and Wilson 1995).
A very similar model has also been developed by Deplanque et. al. in humanized
severe combined immunodeficient (SCID) mice to investigate potential airway
progenitor cells (Delplanque, Coraux, Tirouvanziam et al. 2000). Briefly, human
foetal tracheal grafts, from which the native epithelium was eliminated, were
repopulated with total epithelial cells obtained enzymatically from foetal airways.
New formed epithelia were confirmed in sex-mismatched combinations of host
and donor tissues. In similar experiments, embryonic rudiments were used as the
donor tissue which also replenished the denuded host grafts with all epithelial
cells and glands. This open-air xenograft model in nude mice has a very important
potential in elucidating the role of inflammation during epithelial regeneration
from diseased patients. Finally, this humanized SCID (SCID-hu) mice model has
been adapted by Dupuit F. et. al. to study the proliferation activity, the
differentiation level, and the integrity of the barrier in the adult human epithelium.
Similarly to the foetal study, human airway cells were dissociated by enzymatic
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dissociation form fresh human airway tissue and were then inoculated to the
humanized tracheal grafts eliminated from their epithelium by frequent freezing
and thawing (Dupuit, Gaillard, Hinnrasky et al. 2000). They observed that the
regeneration of a well-differentiated human airway epithelium with normal
function in this model followed similar events to the ones seen after injury: cell
migration and proliferation, then stratification, and finally differentiation.
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3.1.1.2 Animal and human models in vitro
Table 3-2: In vitro models of airway epithelium
Submerged primary cultures
 HBEC seeded on feeder cell layers in low serumgrowth
medium
(Lechner et al. 1981)
 HBEC seeded on collagen gels in serumfree medium
supplemented with growth factors
(Lechner et al. 1982)
 HBEC seeded on surface coated tissue culture dishes in serum
free mediumwith growth factors
(Masui et al. 1986)
 HBEC seeded on plastic tissue culture plates in serumfree
mediumwith growth factors
(Chopra D P. 1987)
Air liquid interface (ALI) cultures
 Guinea pig tracheal epithelial cells seeded onto Whitcutt
chamber (with semi permeable gelatin membrane) and fed basally
(surface in contact with air)
(Whitcutt MJ 1988)
 Mice tracheal epithelial cells seeded onto tissue culture semi-
permeable support membranes in culture medium, fed basally
(Davidson et al. 2000)
 HBEC seeded on collagen gel as substratumat ALI for
ciliogenesis
(de Jong et al. 1994)
 Human nasal epithelial grown at ALI in serumfree media
(BEGM:DME/F12 with supplements)
(Lee et al. 2005)
 HBEC (commercially bought) seeded on polyester Transwell
inserts, and fed basally with BEGM:DME/F12 with supplements
(Lin et al. 2007)
 3D tissue model of the human bronchial wall (epithelial cells on
Transwell inserts in BEGM:DMEM) at ALI
(Choe et al. 2006)
Carcinoma cell lines
 Immortalized human bronchial epithelial cell line (BEAS- 2B)
using SV40 and adenovirus 12
(Reddel et al. 1988)
 Transformed bronchial epithelial cells with SV40 (16HBE140-) (Cozens et al. 1994)
 Adenocarcinoma derived epithelial cell line (Calu-3) (Shen et al . 1994)
 Retrovirally infected airway epithelial cells (NuLi-1) (Hahn et al. 1999)
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The use of epithelial cell culture techniques that maintain a polarised and well
differentiated pseudostratified epithelium, containing mucus-producing cells and
cilia on the surface mimicking the epithelium in vivo, has been developed over
recent years. These epithelial cell culture models serve a number of advantages
including: the ability to control the environment for the study of epithelium
maintenance, differentiation, and inflammation in health and disease (e.g. asthma,
COPD, cystic fibrosis) (Holgate, Davies, Puddicombe et al. 2003; Puchelle,
Zahm, Tournier et al. 2006), elucidation of drug transport pathways since both
apical and basolateral membrane surfaces are exposed (Giangreco, Groot and
Janes 2007), prevention of non-epithelial cell contamination that may interfere
with data analysis, extended epithelial cell viability compared to tissue isolation,
and finally minimizing the use of animals (Mathias, Yamashita and Lee 1996).
There are three major cell culture systems of airway epithelial cells: organ culture
and tissue biopsies, primary cultures, and carcinoma cell lines. Organ cultures and
tissue explants were the earliest in vitro systems developed for short-term studies
(Lane, Miller and Drummond 1976). They were maintained confluent on the
basement membrane or on an external substrate respectively. Primary cultures of
airway epithelial cells have been developed using mouse, hamster, guinea pig, rat,
rabbit, dog, pig, cow, horse, and human (see references in Table 3-2). Human
bronchial epithelial cells were usually obtained from outgrowths of normal human
bronchial tissue explants and grown in culture on surface-coated dishes using a
serum-free medium supplemented with insulin (5 µg/ml), epidermal growth factor
(EGF, 5 ng/ml), transferrin (10µ/ml), hydrocortisone (0.2 µM), gentamycin (50
µg/ml), bovine pituitary extract (BPE, 353 µg of protein per ml) on feeder cell
layers and collagen gels (Lechner, Haugen, Autrup et al. 1981; Lechner, Haugen,
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McClendon et al. 1982) and surface coated dishes (Masui, Wakefield, Lechner et
al. 1986). Moreover, in 1987 human airway epithelial cells were cultured and
passaged successfully maintained in serum-free medium on a plastic surface
exhibiting typical in vivo epithelial characteristics (Chopra, Sullivan, Willie, et.al.
1987), these have been used for a number of studies. For example, Neugebauer et.
al. suggested that ECM molecules present in submerged cultures are important for
promoting attachment and confluence while the specific shape of the cells and
the cell-cell contact are one of the most important signals for differentiation and
ciliogenesis (Neugebauer, Endepols, Mickenhagen et al. 2003). For ciliogenesis
to take place mimicking an adult human epithelium, cells should be floating in the
medium forming spheroids (Jorissen, Van der Schueren, Tyberghein et al. 1989),
attached to collagen gels (Chevillard, Hinnrasky, Pierrot et al. 1993) or grown at
ALI culture (de Jong, van Sterkenburg, Hesseling et al. 1994). Serially passaged
normal human bronchial epithelial cells (NHBEC) monolayers were developed in
transwell inserts via ALI for the evaluation of drug absorption (Lin, Li, Cho et al.
2007). Moreover, in 2003, Lopez-Sonza et. al. were able and for the first time to
successfully culture cells from nasal or bronchial brushings in vitro to create
polarozed ciliated cell sheets of human bronchial epithelium, enabling the
investigation of electrical and secretory properties of the airway epithelium with
an added advantage of comparing the role of the epithelium in health and disease
(Lopez-Souza, Avila and Widdicombe 2003). Brieflly, they grew the cells on
inserts using specialized differentiation media at ALI.
HBEC lines: BEAS-2B (immortalised human epithelial cells using adenovirus 12
and simian virus 40), 16HBE14o- (bronchial epithelial cells obtained form a 1-
year old male heart-lung transplant patient and transformed with SV40 large
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antigen) and Calu-3 (human bronchial epithelial cell line derived from an
adenocarcinoma of the lung) and a relatively new NuLi-1 (infected airway
epithelial cells with retroviruses) exist to date with the latter closest to a primary
human bronchial epithelium (Ehrhardt, Forbes and Kim 2008). BEAS-2B are
grown using submerged culture rather than at an ALI (Ehrhardt, Kneuer, Fiegel et
al. 2002). One advantage of these cell lines is to reduce the variability that might
arise from donor to donor when culturing primary epithelial cells. However, since
they are transformed cells, it has to be argued that there is a limit to their value as
a model of the epithelium in vivo. These cell lines have been used previously to
investigate physiological processes in the airway epithelium. 16 HBE14o- and
Calu-3 cell lines have been identified as the better differentiated cell lines due to
their ability to form polarized cell layers and the ability to express major
intercellular junctions including desmosomes and functional tight junctions, and
thus are considered suitable drug absorption models (Gruenert, Finkbeiner and
Widdicombe 1995). On the other hand, although the BEAS 2B is the cell line
most widely used, they have a limited potential in forming drug junctions, and
might therefore be unsuitable for drug absorption studies (Forbes 2000)
Recently, primary HBEC were immortalized by retrovirus infection to express
cell cycle protein cdk4 in order to stop the inhibition of cells growing on plastic in
normal atmospheric conditions via inhibitory effects of p16 and over-expression
of the catalytic component of human telomerase reverse transcriptase (hTERT)
(Vaughan, Ramirez, Wright et al. 2006). The cells were then grown on top of a
type I collagen gel containing fibroblasts. In these cultures, a pseudostratified
columnar epithelium with cilia, goblet cells and basal cells was established.
Further studies using organotypic constructs or xenograft models will help
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determine the potential use of tissue engineering in vivo as a therapy for damage
or diseased organs replacement.
Choe et. al. in 2006, described a protocol to establish a 3-D tissue model of the
human bronchial wall which includes a well-differentiated epithelium, sub-
epithelial fibroblasts and type I collagen, useful for physiological and
pathophysiological studies (Choe, Tomei and Swartz 2006). They used
commercial HBEC, grown on transwell culture plates using BEGM: DMEM (1:1
ratio) submerged for seven days, and which then were raised to air liquid interface
for a further seven days. This system could easily be adapted for work with
biopsy-derived cells or embryonic stem cells for tissue engineering work.
3.1.2 Regeneration of the airway epithelium after injury
3.1.2.1 Repair of the airway epithelium via migration and proliferation
The integrity of the airway epithelium is compromised frequently during adult life
as a result of continuous exposure to various inhaled toxins and pathogens present
in the atmosphere. It is well adapted to maintaining its function and structure via
an established reparative mechanism involving epithelial cells and potential
resident stem or progenitor cells present in their niches throughout the airway
lining. Very little is known about the mechanisms underlying epithelial repair
processes due to the complexity of the respiratory tree.
The structure and functions of the airway epithelium are discussed in the chapter
1. Briefly, there are eight morphologically distinct epithelial cell types that could
be classified into three groups according to their functional and biochemical
criteria: basal, columnar ciliated and secretory (mucous goblet and serous) cells
(Knight and Holgate 2003). Of those in the basal layer may be the most important
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in wound repair. They are attached to the basement membrane via
hemidesmosomes (Wang, Evans, Cox et al. 1992) anchoring the columnar and
secretory cells through desmosomes providing an anchoring junction of the
columnar cells to the basement membrane through the basal cells (see Figure
1-2).
Several in vivo and in vitro assays and wound models have been developed
historically to study human airway epithelial biology and wound repair. In vitro,
confluent cell monolayers have been mechanically wounded by gently scraping
the layer using a fine pipette tip (Leir, Baker, Holgate et al. 2000). Another
wounding technique involves the deposition of a drop of 1 M sodium hydroxide
(NaOH) on the primary cell layer followed by phosphate buffer saline (PBS) or
normal media to neutralise it (Puchelle 2000) (Zahm, Kaplan, Herard et al. 1997)
creating a standard wound every time. Another approach to investigate the role of
the epithelium alone, without other outside interference, involved collected
human bronchial tissues which were injured with a frozen 2 mm diameter metallic
probe thus only the epithelium is eliminated leaving the ECM healthy (Legrand,
Gilles, Zahm et al. 1999). In vivo injury models have also been used by Pilweski
et. al. in 1997 to study the integrin expression of the damaged epithelium
(Pilewski, Latoche, Arcasoy et al. 1997). Human bronchial sections were
transplanted into SCID mice after which an injury was created using gauge needle
on the walls of the xenograft (Pilewski JM 1994).
The airway epithelial repair mechanism has been extensively investigated
previously either through following repair processes histologically over time or
through cell culture models. The injury level can vary from the loss of surface
epithelial permeability, loss of airway epithelial cells, to partial shedding or
Chapter 3 Differentiated HBEC wound repair model
71
complete denudation of the basement membrane. A series of cellular events take
place following injury starting with dedifferentiation of cells, rapid spreading and
migration of the cells at the edge of the wound, proliferation, and then
differentiation again (McDowell, Becci, Schurch et al. 1979). These events have
been observed in both in vivo and in vitro models (Figure 3-1) but still very little
is known about the specific molecular mechanisms controlling these events.
Spreading and migration of cells
It has been established that migration of cells at the edge of the wound is the first
step after desquamation of the epithelium in the repair process through the
protrusion of lamellipodium extension (plasma membrane) due to cytoskeleton
reorganization. This takes place after G actin and filamentous (F)-actin
polymerization leading to an in increase in F actin in the lamellipodia of the basal
cells forming adhesions with ECM (Puchelle 2000) suggesting a role for basal
cells in wound repair. To study the migratory potential of epithelial cells, Zahm
et. al. were able to track the spreading cells using the DNA binding Hoechst
33258 fluorescent dye after which fluorescence images were captured (Zahm,
Kaplan, Herard et al. 1997). A trajectory-based method and video microscopy
techniques were adapted to investigate the rate of spreading of the migratory cells.
It was observed that the higher the migration speed, the closer the distance from
the wound edge. In 1998, Kim S.J. et. al. demonstrated a role for EGF in wound
healing through a concentration dependant stimulation of guinea pig tracheal
epithelial cells (GPTEC) migration. A small mechanical wound was created on
GPTEC monolayer followed by capturing video microscopy over a 24 hr period
to calculate the wound area remaining. In addition, collagen/laminin-binding
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integrins Į2ȕ1, and Į6ȕ4 altered distribution facilitated spreading and migration
in epithelial cells (Pilewski, Latoche, Arcasoy et al. 1997).
New epithelial cell proliferation and re-differentiation
Following migration of cells to cover an injury in the lung, proliferation takes
place to replace cells and maintain the structure of the epithelium. The airway
epithelium is amongst the slowly renewing organs together with the pancreas,
liver, and thymus. Rapid renewing organs, such as the intestinal epithelium, are
believed to turn over with very high kinetics in the normal steady state being
replaced every 5 days approximately (Stripp 2008). Another distinction between
rapid and slow turnover tissues is their response to injury where in the slow
turnover seen in lung epithelium, proliferation is stimulated after injury and is
dramatically increased following the migration and spreading of cells to cover the
particular wound depending on the level and position of damage (Puchelle 2000).
Several reports, including data from our laboratory in Nottingham, have
suggested the presence of resident stem cells proliferating in response to injury in
the airway epithelium (Stripp and Reynolds 2008) (Neuringer and Randell 2004)
(Wadsworth, Nijmeh and Hall 2006). Resident adult stem cells can be defined as
a self-renewing population of cells undergoing division throughout the adult
lifetime giving rise to more differentiated cell types within a specific organ where
each system has been evolved to suit its own unique environment (Rawlins 2008).
Transient amplifying (TA) cells are one level down the hierarchical stem cell
organization defined as the immediate daughter of all adult stem cells which
divide and gives rise to the differentiated cell types to maintain the tissue but with
a more limited self-renewal capacity (Stripp 2008). However, since the lung
epithelium is considered a slowly self-renewed organ, one type of cell population
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suspected to be responsible for the repair mechanism are called ‘facultative
progenitor cells’. This population was observed to have roles in the normal and
damaged airway as shown in unpublished data by Stripp and Reynolds, and were
seen to have differentiated characteristics when quiescent (Stripp 2008).
Several growth factors have been noted to mediate bronchial epithelial repair via
cell migration or proliferation stimulated by injury. EGF is able to accelerate
wound repair in the airway epithelium independently of cell proliferation (Kim,
McKinnis, Nawrocki et al. 1998). For example, BrdU incorporation into
undifferentiated and differentiated human bronchial epithelial cells (HBEC) was
seen to be reduced at 24 hrs post injury after EGF treatment and an increase in
cellular BrdU labelling in wounded cultures treated with anti-EGFR antibody
suggesting a repair effect of EGF at early time points via migration independent
of cell proliferation (Wadsworth, Nijmeh and Hall 2006). The potent endothelial
cell mitogen, VEGF, has been observed to increase cell proliferation and thus
may assist in the wound repair process where BrdU-labeled epithelial cells
increased in VEGF-treated lung tissues (Wadsworth, Nijmeh and Hall 2006)
although the mechanism is not known yet.
Additional studies here evaluated the potential role of nitric oxide in repair
processes. Physiological concentrations of nitric oxide (NO) can promote airway
epithelial wound repair via migration in vitro which is associated with increased
expression of MMP-9 (Bove, Wesley, Greul et al. 2007). On the other hand, it has
been observed that increased synthesis of NO has been associated with altered
wound healing, reduced epithelial wound repair and thus may contribute to the
remodelling process seen in chronic inflammatory conditions (Guo, Comhair,
Zheng et al. 2000). Elevated levels of NO inhibit epithelial cell migration and
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wound repair via the mitogen-activated protein kinase (MAPK) phosphatase
(MKP)-1 mechanism, inhibition of extracellular-regulated kinase 1 and 2
(ERK1/2) activation, as well as activation of the transcription factors hypoxia-
inducible factor 1Į (HIP-1Į) and p53 (Bove, Hristova, Wesley et al. 2008).
As discussed earlier, a number of inflammatory cells such as neutrophils are
recruited to the site of injury as a host-defence mechanism. One group of products
that are released by neutrophils to kill microorganisms at the site of inflammation
are called defensins, and recent data have suggested that they may also contribute
to epithelial repair (Aarbiou, Ertmann, van Wetering et al. 2002). After scrape-
wounding the NCI-H292 cell line, it was observed that defensins induce airway
epithelial wound closure in a dose and time-dependant manner, via activation of
the ERK1/2, p38, c-jun N-terminal kinase (JNK), and the EGFR. As wound be
expected, wound closure involved cell migration and proliferation. Moreover,
neutrophil defensins were observed to elevate mucin gene expression of airway
epithelium (Aarbiou, Verhoosel, van Wetering et al. 2004).
Airway epithelial cells also continuously interact and detect microorganisms
through Toll-like receptors (TLRs) leading to induction of pro-inflammatory
mediators. It has been observed that activation of TLR2 and TLR 5 (after
infecting human airway epithelial cells in vitro with Staphyococcus aureus)
induce cell migration, wound repair, and proliferation (Shaykhiev, Behr and Bals
2008). Thus, epithelial cells are able to sustain their integrity in a non-
inflammatory manner by sensing microbes via TLRs.
The expression of a family of zinc-dependant neutral endopeptidases that degrade
the ECM, called matrix metalloproteinases (MMP), has been observed in injured
airway epithelium. For example, MMP-7 and -9 are produced by epithelial cells
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after mechanical wounding, and are required for cellular migration (Legrand,
Gilles, Zahm et al. 1999). Another MMP present in pathological states is
membrane type 1 MMP (MT1-MMP) and this is also produced in the abnormal
airway epithelium. MT1-MMP is not present in normal airway epithelium but is
upregulated in airways of subjects suffering from COPD and asthma (Ohuchi,
Imai, Fujii et al. 1997). When MT1-MMP knockout (KO) mice were exposed to
naphthalene, a decrease in airway epithelial cell proliferation was observed. In
addition a novel role for MT1-MMP in airway epithelial repair has been
established via a keratinocyte growth factor receptor (KGFR)-dependant role in
clara cell proliferation (Atkinson, Toennies, Holmbeck et al. 2007).
Moreover, TGF-ȕ and hepatocyte growth factor (HGF) are secreted and activated
following injury to the airway epithelium. HGF is secreted by fibroblasts while
the HGFR is expressed at the basolateral surface of human bronchial cells, thus
HGF is essential for normal epithelial integrity in the airways (Myerburg,
Latoche, McKenna et al. 2007). In addition, it has been observed that in response
to mechanical wounding, a rapid induction of integrin-dependant activation of
TGF-ȕ occurs, leading to slower wound closure (Neurohr, Nishimura and
Sheppard 2006).
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Figure 3-1: A schematic diagram of airway epithelial regeneration after injury
(A) is a representation of an airway epithelium consisting of basal, ciliated, and secretory cells
attached to the basement membrane via hemidesmosomes. When the airway epithelium is injured
(B), cells at the edge of the wound undergo de-differentiation (1), migration (2), activation and
proliferation of quiescent resident stem cells away from the wound (3) (C). Re-differentiation of
the epithelial cells takes place, with ciliated and secretory cells (D).
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3.1.2.2 Epithelial cell-extracellular matrix (ECM) interactions in airway
epithelial regeneration
As described above, the airway epithelial regeneration is clearly a complex
process involving both resident stem/progenitor cells (discussed in the next
section) and also factors able to control this process. Secretion of ECM proteins
and their interactions with ECM is a part of the wound healing process together
with the release of cytokines and chemokines and modulators of cell migration,
proliferation and differentiation (Sacco, Silvestri, Sabatini et al. 2004). An up-
regulation of cell adhesion receptors, not normally observed in the normal
basement membrane, binding to the inflammation matrix proteins has been found
post injury of the airway epithelium.
On the other hand, matrix metalloproteinases (MMP), secreted by repairing cells,
have a direct role in wound healing in remodelling the provisional matrix. One
example is MMP9 (or gelatinase B) involvement in the repair program through
migration of basal cells (Buisson 1996). Others are MMP3, 11, and 7, all
expressed by epithelial cells. MMP7 plays a role in the repair through migration
as well as the shedding of E-cadherin which is required for the repair process
(McGuire, Li and Parks 2003). MMP3 and 11 are also involved in epithelial cell
migration and ECM remodelling, however, these MMPs are expressed by basal
cells that also express the mesenchymal marker vimentin suggesting a
mesenchymal phenotype is important for cell migration (Buisson AC 1996). In
addition to the role of MMPs in migration, MMP2, and 9 are also involved in cell
proliferation during wound healing (Sigurdson, Sen, Hall Iii et al. 2003).
Non-integrin mediated cell-ECM interactions have also been shown to have a
potential importance in affecting bronchial epithelial repair. Hyaluronic acid (HA)
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receptor CD44 is a cell surface receptor for the matrix proteoglycan hyaluronate
as well as collagen I, IV, and fibronectin (Sacco, Silvestri, Sabatini et al. 2004)
and is thought to be involved in cell-cell adhesions, cell-ECM interactions,
homing and cell migration. CD44 expression has been observed to be altered after
cell damage specifically its interaction with HA ; it was up-regulated in the
epithelium of asthma subjects (Leir, Baker, Holgate et al. 2000). We have also
shown CD44 up-regulation at the margins of scrape-wounded bronchial epithelial
cells in vitro with a role in cell migration and other processes in the late phases of
epithelial repair (Wadsworth, Nijmeh and Hall 2006). It has also been shown that
cytokine expression during inflammation of the airway epithelium plays a role in
the general modulator of epithelial wound healing- CD44-HA interactions,
regardless of CD44 expression (Leir, Holgate and Lackie 2003). CD44 includes a
family of glycoproteins, all encoded by the same gene, with 80-200kDa protein
size. A role for CD44 in leukocyte activation and in tumour progression, as well
as re-epithelisation of corneal epithelium has been suggested previously (Marhaba
and Zöller 2004) (Yu, Guo and Zhang 1998).
3.1.2.3 Resident stem/progenitor cells of the airway epithelium
Basal cells and non-ciliated secretory epithelial cells have been shown to exhibit
proliferative capacity and progenitor characteristics (Keenan, Combs and
McDowell 1983; Boers, Ambergen and Thunnissen 1998; Borthwick, Shahbazian
and Krantz 2001). Stem cells niches were investigated in transgenic mice by
Borthwick et. al. (Borthwick, Shahbazian and Krantz 2001) by studying a subset
of cells identified as the label retaining cells (LRC), characterized by their ability
to retain a label of bromodeoxyuridine (BrdU) or [3H] thymidine (both are
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proliferation markers that are incorporated into cell DNA). A short pulse of label
can be used to identify rapidly proliferating TA cells, while a long-term pulse will
mark progenitor/stem cells with slower turnover (Borthwick, Shahbazian and
Krantz 2001). Borthwick et. al. used LRC to determine which murine tracheal
epithelial cells were retaining a long-term BrdU labelling. An injury was required
to stimulate proliferation in normal epithelium. BrdU positive cells were noted
alongside the basal and luminal tracheal positions with LRC localized to gland
ducts. Schoch et al were able afterwards to isolate basal cells using the Keratin 5
promoter driven enhanced green fluorescent protein (EGFP) expression as a
marker and observed a 12-fold increase in the ability to generate large colonies in
vitro compared to EGFP-negative basal cells (Schoch, Lori and Burns 2004).
These studies were a step closer to isolating the airway epithelial stem/progenitor
cells which were suspected to be basal cells. Another approach to investigating
the airway epithelial stem/progenitor cells responsible for restoration following
injury is by the use of cell-surface antigens. A study by Hajj et. al. demonstrated
that basal cells are at least TA cells of the airway epithelium (Hajj, Baranek, Le
Naour et al. 2007) by using CD151 and tissue factor (TF), both basal cell
markers, for epithelial sorting after which the sorted basal cells were able to
regenerate a pseudostratified epithelium capable of expressing MUC5AC (a
mucin marker) and cystic fibrosis transmembrane receptor (CFTR, a chloride
channel expressed on the surface of ciliatedcells) amongst other specific epithelial
differentiation markers when grown on collagen IV-coated membranes. A study
by Hong et. al. was carried out using dual immunofluorescence of mice airway
epithelial tissues treated with naphthalene using the biotinylated Griffonia
Simplicifolia isolectin B4 (GSI-B4, a specific epithelial basal marker), Clara cell
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secretory protein (CCSP), keratin-14 (K14, another basal cell marker), with BrdU
(Hong, Reynolds and Watkins 2004). They observed an increased proliferation of
non-ciliated basal cells following injury (by depletion of CCSP-expressing cells
(CE)) leading to a restoration of the epithelium.
However, the strong proliferative capacity of secretory cells following physical or
chemical injury has also suggested their definition as progenitor candidates. In an
attempt to select a subset of airway epithelial cells, Deplanque et. al. followed a
flow cytometry approach using an array of cell surface markers including, lectin
ligands, CD44 and CD166, adhesion molecules and the aquaporin-3 (AQP3)
water channel (Avril-Delplanque, Casal, Castillon et al. 2005). They implanted
human foetal tissues subcutaneously into SCID mice flanks after being sorted
using a flow cytometry. They observed that AQP3
+
(a basal cell marker) cells
grafted were not as efficient as AQP3
-
cells in their epithelium restoration
concluding that secretory cells had progenitor cell activity. However, it was still
suggested that progenitor cells are present on both basal and supra-basal subsets
within the human airways, despite the fact that basal cells took five months to
eventually differentiate into a healthy epithelium. Moreover, both Clara cells
(most abundant in distal human lung and proximal and distal rodent and rabbit's
lung) and pulmonary neuroendocrine cells (PNEC) have been proposed as
progenitors of the airway epithelium. Using naphthalene treated mouse airway, a
rare population of dual positive cells (co-expressing both Clara cell secretory
protein (CCSP) and calcitonin gene-related peptide (CGRP)) were localized to
neuroepithelial bodies (NEB) suggesting NEBs serve an environment for the
variant Clara cells (vCE) progenitor population that are resistant to naphthalene
injury (Reynolds, Giangreco and Power 2000). Following that observation, Hong
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et. al. , in an attempt to prove that PNECs are a stem cell pool capable of re-
epithelisation, tested the rate of cell proliferation within the NEB
microenvironment and demonstrated that NEB contains slow-cycling populations
(LRCs) but that PNECs failed to renew the epithelium after CE ablation (Hong,
Reynolds and Giangreco 2001). Finally, another microenvironment besides NEB
recently thought to provide a stem cell niche is the broncheoalveolar duct junction
(BADJ) thought to contain broncheoalveolar stem cells (BASC) in mice co-
expressing both surfactant protein C (spc), and CCSP (Kim 2007).
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3.2 Objectives
The aim of the studies described in this chapter was to further characterise the
differentiated human bronchial epithelial wound repair model in vitro, using
primary epithelial cell cultures grown under air liquid interface (ALI) conditions.
This model was then used to investigate repair mechanisms, proliferation and to
attempt identification of the epithelial cell types responsible for healing the
injured epithelium.
Chapter 3 Differentiated HBEC wound repair model
83
3.3 Methods
Primary human bronchial epithelial cells (HBEC, donor 1) were cultured as
described in section 2.1.1.5 and differentiated as described in section 2.1.1.6. For
wounding experiments, differentiated HBEC were wounded as described in
section 2.1.1.7 in 12-well transwell plates while undifferentiated HBEC were in
24-well plates. Measurements of wound area were done using SPOTCam
software at the times specified in the relevant following sections. An outline of
the wound was created using the software tools and measurements of the wound
area were given. This was done at different times post-wounding (0-28 hrs range).
3.3.1 Characterisation of in vitro differentiation HBEC model at ALI
To determine the differentiation level of HBEC grown at ALI, cells were fixed at
week 1, week 2 and week 3 of ALI using 4% formaldehyde at 4ºC overnight.
Immunofluorescence was carried out on the fixed cultures as described in section
2.2.1 then treated with the following primary mouse monoclonal antibodies: anti-
MUC5AC (for mucin cells, at 1:1500 dilution), anti-ȕ-tubulin IV (for ciliated
cells, at 1:1500 dilution). Goat-raised anti-mouse secondary antibody conjugated
to Alexafluor488 (1:250) was then added to detect the bound primary antibodies.
To visualize filamentous (F) actin, cells were incubated with 1:40 dilution of
AlexaFluor488-conjugated phalloidin (Molecular Probes) for 30 min at room
temperature (Kikuchi, Shively, Foley et al. 2004). Nuclei were counterstained
using 1 µg/ml DAPI. Undifferentiated cultures in 24-well plates were also treated
with the above antibodies as control cultures and all sources of antibodies
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purchased are listed in Appendix A. Laser scanning confocal microscopy was
performed using a Zeiss Axio Observer D1, Hamamatsu electron multiplier CCD
Camera C9100-13, with a Yokogawa spinning disk system. Volocity 4.2.1
analysis software (Improvision) was used to analyze the images.
3.3.2 Proliferation assay
To study the proliferation capacity of HBEC in undifferentiated or differentiated
states, cells were grown in 24-well plates or 12-well transwell plates in BEGM (1
ml per well) or BEDM respectively (section 2.1.1.5). Cell layer(s) were wounded
and then fixed at 0, 4, 8, 16, 24, and 48 hrs post-wounding using 4%
formaldehyde at 4ºC overnight. Unwounded controls were also set up for each of
the time points. Immunofluorescence (IF) was then carried out on all cultures
according to section 2.2.1 using the nuclear proliferation marker Ki-67. Primary
antibodies used were: mouse monoclonal anti-Ki-67 (1:100 dilution, MIB-1,
Abcam) for undifferentiated cultures, and rabbit polyclonal anti-Ki-67 (1:50,
ab833, Abcam) for differentiated cultures that were dual stained with epithelial
markers and thus the need for both monoclonal and polyclonal mouse and rabbit
proliferation antibodies. The relative specificity of both antibodies was first
investigated by dual staining HBEC cultures with both the monoclonal and
polyclonal primary anit-Ki67 antibodies. Bound primary antibodies were detected
using goat-raised anti-mouse and anti-rabbit secondary antibodies conjugated to
Alexafluor488 and RhodamineRedX, respectively (Molecular Probes, 1:250).
Eight random fields per well were digitally captured with a 20x objective lens.
Ki-67 labelling index was expressed as the mean number of labelled cells per
field ± SEM at each time point.
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3.3.3 Dual staining of HBEC with ki-67 and specific epithelial cell markers
To investigate the cell types involved in wound repair of the airway epithelium in
vitro, differentiated HBEC were wounded and fixed at different times post-
wounding, and were studied using a panel of airway epithelial specific markers
shown in Table 3-3 together with the proliferation marker Ki-67 in Table 3-4.
Dual staining was performed by treating the samples first with rabbit polyclonal
antibodies detected with RhodamineRedX secondary antibody, and then by
treating with the mouse monoclonal primary antibodies where detection was done
by AlexaFluor488.
As previously described, laser scanning confocal microscopy was performed
using a Zeiss Axio Observer D1, Hamamatsu electron multiplier CCD Camera
C9100-13, with a Yokogawa spinning disk system. Images were captured in slices
which were around 0.1 µm thick. Volocity 4.2.1 analysis software, Improvision,
was used to analyze the images.
Table 3-3: Specific epithelial cell markers
Table 3-4: Proliferation markers
Antibody name Concentration Source Characteristic
Mouse monoclonal anti-CD44 1:100 Development Studies Hybridoma
Bank (DSHB), Clone H4C4
Specific for the human hyaluronate
receptor CD44
Mouse monoclonal anti-CK14 1:200 Chemicon, Hampshire, UK Cytokeratin 14, epithelial basal cell
markers
Rabbit polyclonal anti-CC26 1:500 Chemicon, Hampshire, UK Clara cell specific marker
Rabbit polyclonal anti-CCSP 1:100 Abcam Clara cell secretory protein
Rabbit polyclonal anti-AQP3 1:500 Abcam Aquaporin-3, foetal basal cell
marker
Antibody name Concentration Source Characteristic
Mouse monoclonal anti-Ki-67 1:100 DAKO, clone MIB-1 Nuclear proliferation marker
Rabbit polyclonal anti-Ki-67 1:50 Abcam, clone ab8333 Nuclear proliferation marker
Chapter 3 Differentiated HBEC wound repair model
86
3.3.4 Relative CD44 mRNA expression in HBEC
RNA was extract from differentiated wounded HBEC grown at ALI, at 0, 24, 48,
and 72 hrs post-injury as described in section 2.4. Reverse transcriptase (RT)
polymerase chain reaction (PCR) was then carried out as described in section
2.4.2.3 to synthesise cDNA which was then tested using the housekeeping gene
GAPDH as described in section 2.4.2.1. The relative mRNA expression was then
quantified using real-time quantitative PCR (section 2.4.3). Primers/Probe set was
designed using Beacon Designer 5.0 Software and probes were obtained as FAM-
labeled Taqman probes. Table 3-5 lists the sequence of primers and probe. Figure
3-2 shows the standard curved that was used to validate the assay.
Data was analyzed using the comparative ¨&WPHWKRG as described in section
2.4.3. All values were normalised against the endogenous housekeeping genes,
18s or HPRT (see Figure 2-8 in section 2.4.3 for HPRT and 18s mRNA
expression by differentiated HBEC). Final values represent the mean fold
difference, as a percentage compared to 0hrs, of relative mRNA expression ±
SEM of four separate experiments. Two donors were used for these experiments,
each including two replicates.
Table 3-5: Primers and probe used
# of bases Primer Name Primer sequence 5'-3' Position Product length
24 CD44-F1 GCTGCTACTTCTTAAAACCTCTGC exon 1 position 162
24 CD44-R1 GGTTGAAAACAGTGACCTAAGACG exon 1 position 267
# of bases Probe Name Primer sequence 5'-3' Position
24 CD44-P AGCGAGCGAAGGACACACCCAAGC exon 1 position 234
106
Probes were 3' TAMRA, 5' 6-FAM purchased from Eurgentec S.A
CD44 accession number: NM_001001392
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Figure 3-2:Real time PCR standard curve for CD44.
Amplification plot, and a standard curve for CD44 mRNA expression by differentiated HBEC is
shown to assess the efficiency of the real time taqman assay using the CD44 primer/probe set
designed using Beacon Designer 5.0 software. Efficiency of 53.1% (100% is the optimum value)
can be observed with little variability between triplicate repeats.
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3.4 Results
3.4.1 Primary human bronchial epithelial cells (HBEC) are capable of
generating a pseudostratified mucociliated epithelium in vitro
A in vitro model of primary human bronchial epithelial cells (HBEC) was adapted
from Danahay et. al. (Danahay, Atherton, Jones et al. 2002). Undifferentiated
HBEC, purchased commercially from Lonza ,were grown in submerged culture
on polyester microporous membranes in transwell inserts for seven days followed
by air liquid interface (ALI) for a further 21 days for differentiation (as described
in section 2.1.1.6). A pseudostratified epithelium was observed at day 28 with
well developed ciliated cells present on the surface, as seen in the scanning
electron micrographs taken by Dr. Samuel Wadsworth in our laboratory (Figure
3-3 below) (Wadsworth, Nijmeh and Hall 2006). Accumulation of mucus on the
surface of the transwell membranes was observed during the time course of
differentiation.
Differentiated HBEC were characterised by studying their expression of the
differentiation markers MUC5AC (for mucin cells), ȕ-tubulin IV (for ciliated
cells), and filamentous (F) actin (for organization and inter-connectedness),
demonstrated by laser confocal microscopy images in Figure 3-4, Figure 3-5, and
Figure 3-6. Undifferentiated HBEC, grown on plastic in submerged conditions,
demonstrated a different phenotype to differentiated cells grown on polyester
microporous inserts at ALI for one, two, or three weeks (designated as ALI 1, 2,
or 3 respectively). An increase in cell density in ALI conditions was observed,
marked by nuclear counter-staining using DAPI (blue, Figure 3-4). Stronger inter-
connectedness in ALI 3 cultures was observed compared to undifferentiated and
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ALI 1 and 2 cells, indicated through F-actin phalloidin staining (Figure 3-4 A, B,
C, and D).
Figure 3-3:Ciliated nature of HBEC in vitro.
Scanning electron micrographs of differentiated HBEC at ALI demonstrate the ciliated nature of
the apical cells (A). Higher magnification shows well developed cilia in this in vitro model (B). C
and D were taken from http://remf.dartmouth.edu/images/mammalianLungSEM/, A and B were
taken from (Wadsworth, Nijmeh and Hall 2006).
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Figure 3-4: Representative F-actin fluorescence images of HBEC.
Confocal images show F-actin phalloidin staining (green 2°) of HBEC in undifferentiated cells
(A), and differentiated cultures at ALI 1, ALI 2, and ALI 3 (B-D). Cells were counterstained with
DAPI (blue). Images are representative of two individual experiments each done in duplicates and
random images were chosen. (x40 magnification).
Moreover, expression of the ciliated marker ȕ-tubulin IV was not detected in
undifferentiated or ALI weeks 1 and 2 cultures, as observed in the images of side
projections of the cultures (Figure 3-5 B, C, and D). ȕ-tubulin IV positive cells
(Figure 3-5 A), however, were seen on the apical surface of ALI 3 cultures
(Figure 3-5 E). Similarly, side projections of images of undifferentiated ALI 1
and 2 cells did not show expression of MUC5AC (Figure 3-6 B, C, and D), while
positive expression of MUC 5AC was seen at the apical layer of ALI 3 cells only
(Figure 3-6 A and E). Side projections demonstrated that HBEC grown in
submerged conditions on plastic formed a monolayer of cells compared to late
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ALI conditions whereby a multi-cellular layer was apparent (Figure 3-5 B-E,
Figure 3-6 B-E).
Figure 3-5: Representative ȕ-tubulin IV fluorescence images of HBEC.
ȕ-tubulin IV positive expression (green) was seen only in differentiated cultures at ALI 3 (A + E).
B-E are side projections of the cultures showing expression of ȕ-tubulin IV only at ALI week 3 (E,
green) on the apical surface (arrow in E). Side projections also show a multi-cellular epithelium
when differentiated (C-E), compared to a monolayer of cells in undifferetiated HBEC (B). Cells
were counterstained with DAPI (blue). Images are representative of two individual experiments
each done in duplicate and random fields were chosen (x40 magnification).
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Figure 3-6: Representative MUC 5AC fluorescence images of HBEC.
MUC 5AC positive expression (green) was seen only in differentiated cultures at ALI 3 (A + E).
B-E are side projections of the cultures showing expression of MUC 5AC only at ALI week 3 (E,
green) on the apical surface (arrow in E). Side projections also show a multi-cellular epithelium
when differentiated (C-E), compared to a monolayer of cells in undifferentiated HBEC (B). Cells
were counterstained with DAPI (blue). Images are representative of two individual experiments
each done in duplicate and random fields were chosen(x40 magnification).
3.4.2 Bronchial epithelium wound repair model
In order to reach a better understanding of wound repair, either in a healthy or a
diseased epithelium, appropriate models were established to study the mechanism
in vitro (as discussed in section 3.1.1.2). The in vitro model established in our
laboratory was discussed in section 3.4.1. HBEC were allowed to reach complete
mucociliary differentiation at ALI and were then scrape-wounded using a sterile
p200 pipette tip. Scanning electron microscopy (SEM) images (Figure 3-7,
obtained by Dr. Samuel Wadsworth) of differentiated HBEC grown at ALI show
the scrape-wound (0.5 mm thickness) where the cell layers have been scratched
down to the porous polyester membrane (red arrow, Figure 3-7 A). It can also be
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observed that repair takes place by 24 hrs post-wounding leaving a ‘scar’ on the
original wound area (Figure 3-7 B)(Wadsworth, Nijmeh and Hall 2006).
Figure 3-7: Wounding model of HBEC.
Scanning electron micrographs showing differentiated HBEC ALI cultures with a scrape-wound
removing all cells down to the porous membrane (red arrow) of the transwell inserts with an
approximately 0.5mm wound thickness (A). Rapid repair takes place with complete wound
healing by 24 hrs (B) leaving a ‘scar’ on the original wound area. (Wadsworth, Nijmeh and Hall
2006)
The time course of wound repair was then studied using undifferentiated HBEC
grown in 24-well plates and differentiated HBEC on 12-well transwell inserts.
These were scrape wounded as described in section 2.1.1.7 and digital images
were captured using a x2.5 objective lens at 0-48 hrs post-wounding (Figure 3-8
A-F and Figure 3-9 A-F). The area of the wound was measured using SPOTCam
Advanced software and graphs were plotted with time point post-wounding
versus the wound area in microns
2
. Statistical analysis was done with one-way
ANOVA and Dunnett’s multiple comparison post-test using GraphPad Prism 5.0
software. Analysis was carried out on four different experiments each containing
two wounds for undifferentiated cultures (a total of 8 wounds); and six individual
experiments with two wounds each (a total of 12 wounds) for differentiated cells.
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The graphs in Figure 3-8 and Figure 3-9) are representative of mean ± SEM of n
wounds.
Complete wound closure occurred more rapidly in differentiated cultures than in
undifferentiated cells (compare Figure 3-8 and Figure 3-9). For example, at 20 hrs
post-wounding, all differentiated cultures showed 100% healing (n=12) whereas
undifferentiated cultures (n=8) showed an average of 87 ± 96% of the wound area
covered only by a later time point (48 hrs). In undifferentiated HBEC, healing
starts at 4 hrs post-wounding followed by a significant decrease in wound surface
area at 8, 16, 24, and finally 48 hrs (all p <0.05 of baseline). In differentiated
HBEC, the wound area was seen to significantly decrease (p<0.0001) by 8hrs
followed by 100% wound closure by 20 hrs post-wounding.
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Figure 3-8: Wound healing of undifferentiated HBEC.
Brightfield images show the two parallel scrape wounds on undifferentiated HBEC at 0 hrs (A), 4
hrs (B), 8 hrs (C), 16 hrs (D), 24 hrs (E), and 48 hrs (F) post-wounding. The graph shows the
mean wound area at each time point ± SEM of 8 separate wounds (in 4 different experiments).
Statistics were calculated with a one-way ANOVA analysis and Dunnett’s multiple comparisons
post-test representing repair vs. 0hr baseline . *, **, and *** all represent p <0.05.
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Figure 3-9: Wound healing of differentiated HBEC.
Brightfield images show the two parallel scrape wounds on differentiated HBEC at 0 hrs (A), 4
hrs (B), 8 hrs (C), 16 hrs (D), 24 hrs (E), and 48 hrs (F) post-wounding. The graph shows the
mean wound area at each time point ± SEM of 12 separate wounds (of 6 experiments). Statistics
were calculated with a one-way ANOVA analysis and Dunnett’s multiple comparisons post-test
representing repair vs. 0hr baseline. *** represents p <0.05.
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3.4.3 New cell proliferation post HBEC wounding
Having demonstrated that complete wound healing in differentiated HBEC
cultures occurs by 20 hrs post-injury and at a faster rate than undifferentiated
cultures, the cellular events involved in repair mechanism were then investigated,
beginning with proliferation. Following migration of cells at the edge of a wound
as a first step in the repair mechanism, proliferation of new cells away from the
wound might be expected to maintain a constant supply of epithelial cells capable
of regenerating a healthy epithelium. Proliferation assays were carried out on both
undifferentiated and differentiated HBEC (section 3.3.2) using the proliferation
marker Ki-67. Ki-67 is a protein present in the nuclei of human cells in all phases
of the cell cycle except the resting stage G0 and thus is a widely accepted
proliferation marker (Gerdes 1990). Figure 3-10 A and B are representative
immunofluorescence images of undifferentiated and differentiated HBEC,
respectively, stained for nuclear Ki-67 (green). An increase in proliferation was
seen in differentiated HBEC post-wounding which was significant (p <0.001,
n=6) by the 24 hrs time-point compared to its unwounded control culture (Figure
3-10). Interestingly, an immediate significant increase in proliferation was
observed in wounded differentiated HBEC compared to unwounded cells (Figure
3-10 C, p=0.024, paired t-test) but this remains to be further investigated. These
experiments were then repeated in undifferentiated HBEC, and in contrast to the
differentiated model, no significant increase (p >0.05) in proliferation was seen
following wounding, although an increase in proliferation compared with basal
was seen in both wounded and unwounded cultures at 48 hrs (Figure 3-10 D) as
would be expected for normal growth of these cells in culture.
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Figure 3-10: Proliferation of HBEC post-wounding.
A and B are representative immunofluorescence images of fields of cells distant from the wound
margin showing nuclear Ki-67 staining (green, x20 magnification) of differentiated and
undifferentiated HBEC respectively. Graphs show mean Ki-67 counts ± SEM of 6 separate
experiments in differentiated (C) and undifferentiated (D) HBEC. Statistical analysis was done by
a two-way ANOVA and a Bonferroni post-test for both graphs and a paired t-test at 0hrs in C. ***
represents p<0.001, * represents p=0.024.
3.4.4 Characterisation of human bronchial epithelial cells (HBEC) involved
in wound repair in vitro
The previous figures show an increase in proliferation taking place at around 24
hrs post-wounding for differentiated HBEC which is after complete wound
closure, which occurred by 20 hrs post-injury. The next step was to determine
which types of cells were proliferating or migrating in the wounded cultures. To
this end, differentiated and undifferentiated HBEC were immunofluorescently
stained with antibodies against epithelial cell-specific markers (Table 3-3), as well
as the proliferation marker Ki-67. Two antibodies against Ki-67 were used, a
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mouse monoclonal (detected with an AlexaFluor 488 secondary antibody, green)
and a rabbit polyclonal (detected with a RhodamineRed X secondary antibody,
red). This was important since dual staining experiments required both secondary
antibodies depending on which primary antibodies were used against the different
epithelial cell-specific markers. Thus, it was important to first validate the two Ki-
67 antibodies, by dual staining HBEC with both. It was confirmed that both the
antibodies were recognizing the same set of cells (Figure 3 11).
Figure 3-11: Dual Staining with Ki-67 monclonal and polyclonal antibodies.
Mouse monoclonal MIB1 (A, green secondary), rabbit polyclonal ab833 (B, red secondary), and
merged (C, yellow). (x40 magnification)
It was observed that both cell populations were stained positive for basal cell
markers CD44 and CK14 (Figure 3-12 A-D) but not the basal marker, AQP3.
Moreover, to detect non-ciliated Clara cells, Clara cell-26 (CC26), and Clara cell
secretory protein (CCSP) expression were investigated. Positive expression of
CC26 was observed in both undifferentiated and differentiated cultures (Figure
3-12 E and F), although CCSP expression was not detected (possibly due to the
quality of the antibody used in immunofluorescence technique).
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Figure 3-12: Staining for epithelial cell specific markers.
Immunofluorescence images of undifferentiated (A, C, E) and differentiated (B, D, F) HBEC
using basal and non-ciliated cell markers. Both cell cultures were positive for basal cell markers
CD44 (green, A and B), CK14 (green, C and D), and the non-ciliated Clara cell marker CC26 (red,
E and F). Nuclei were counterstained with DAPI (blue). The images are representative of two
separate experiments both carried out in duplicates and random fields were digitally captured.
Staining for the basal marker AQP3 and the non-ciliated cell marker CCSP was not detected.
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presence of new cells. We have previously observed that basal cells migrate
towards the denuded area by 8 hrs post-wounding, with lamellopodia following
visible filopodia and extending out from the migratory cells towards the
wound.(Wadsworth, Nijmeh and Hall 2006).
Figure 3-14: CD 44 and CK14 expression at wound edge.
CD44 (green, A) and CK 14 (green, B) increased staining at wound edges of differentiated HBEC
at 0 and4 hrs post-wounding respectively. Wound is marked by white arrows. Few basal cells
were seen proliferating at the wound edge: CD44/Ki-67 double positive (green/red) and CK14/Ki-
67 double positive (green/red) cells. Nuclei were counterstained with DAPI (blue). (40X
magnification, n=2).
3.4.5 CD44 mRNA expression post-wounding HBEC
CD44 was seen to be up-regulated at wound margins post-wounding, and was
seen to be present in both migration and proliferation during wound repair.
Determination of relative CD44 mRNA labels by differentiated HBEC at a range
of time points post-wounding was carried out. Total RNA was extracted from
wounded differentiated HBEC, at 0, 24, 48, and 72 hrs post-wounding as
described in 2.4.1. This was followed by reverse transcriptase to synthesize
cDNA, then real time PCR was carried out on the samples. Validation for the
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assay was performed by assessing the efficiency of the CD44 assay and
determining the optimum sample dilution, via a standard curve created with
cDNA from differentiated HBEC (Figure 3-2). Relative mRNA values were
calculated using the comparative ¨&WPHWKRG. Initial experiments were performed
to assess the use of 18S and HPRT as housekeeping genes (Figure 2-8). HPRT
was chosen for two reasons: first, the Ct values obtained were closer to those for
CD44, and second, because there was less variation observed between sample
measurements in values. Thus; Figure 3-15 shows normalization against HPRT.
Statistical analysis was calculated using a two-way ANOVA with a Bonferroni
multiple comparison post-test, using GraphPad Prism 5.0 software.
No significant increase (p=0.173) in CD44 mRNA expression was seen post-
wounding compared to unwounded cultures (Figure 3-15), suggesting that the
increase in CD44 protein determined by immunofluorescence seen in the previous
section may not be related to increased gene expression. However, the increase in
CD44 above was seen in the time range of 0-24 hrs post-wounding, and CD44
mRNA expression was not investigated at those early time points.
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Figure 3-15: Relative CD44 mRNA expression by differentiated HBEC post-wounding.
No significant difference in CD44 mRNA expression in injured cultures (p=0.173). Statistical
analysis was carried out using a two-way ANOVA with a Bonferroni multiple comparisons post-
test. Graph shows mean fold difference (percentage) ± SEM of four separate experiments carried
out in triplicates and data was normalized to HPRT.
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3.5 Discussion
3.5.1 A primary human bronchial epithelial cell (HBEC) wound repair
model
A primary differentiated human bronchial epithelial cell (HBEC) model, adapted
from previously published methods (Danahay, Atherton, Jones et al. 2002), was
established and characterised to assess differentiation and reliability of the model
for epithelial function studies. This model employs the air liquid interface (ALI)
condition, seeding epithelial cells on transwell inserts, using specialized bronchial
growth medium. Compared to other in vitro and in vivo models (described in
Table 3-1 and Table 3-2), this model serves several advantages, including: easy
access to cells with the ability to control environmental conditions, less use of
animals with the added advantage that findings in human primary cell systems are
likely to be more physiologically relevant, and finally ease of individual cell
measurements. When characterising this model, a pseudostratified multilayered
epithelium, similar to that in vivo, can be observed, containing ciliated cells (ȕ-
tubulin-IV at the apical layer), secretory cells (MUC5Ac at the apical layer), and
basal cells (CD44 and CK14 on the basal layer). Filamentous actin also proves the
interconnectedness of the cells in culture. In asthma and COPD, it has been shown
that the airway epithelial damage contributes to airway remodelling possibly due
to altered regulation of the repair process (Holgate 2008) (Jeffery 2001). In order
to study the effects of injury, a scrape wound was created on the surface of cells
and the healing process was monitored. This was used as it was felt to be a closer
representative of the epithelial desquamation seen in asthma than the damage that
is caused for example by toxic insults. It was observed the wound was completely
healed by 20 hrs post-wounding in differentiated cultures leaving a ‘scar’ where
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the original wound was created. However, the scrape wound was not healed even
at a later time (48 hrs post-wounding) in undifferentiated HBEC.
3.5.2 Proliferation as one mechanism of scrape-wound repair in vitro
Repair involves two potential processes; cell migration and cell proliferation. In
the differentiated cultures, epithelial cells were seen to start migrating at 0-4 hrs
post-wounding up until 20 hrs, where complete wound closure was apparent in all
wounded cultures. This was followed by a five-fold increase in proliferation at
around 24 hrs post-wounding compared to normal controls (monitored by
labelling with anti-Ki-67 antibody), to potentially maintain a constant number of
cells during the healing process. It was interesting to see that there was a
significant increase in proliferation in wounded cultures immediately after
wounding (0hrs) compared to unwounded controls. This could be explained by an
immediate response to loss of epithelial cell-cell contact resulting in intracellular
signalling throughout the cultures as a result of injury. In undifferentiated HBEC,
no change in proliferation was detected between wounded and unwounded
cultures, although there was an overall increase in proliferation at late time points
(by 48 hrs). This agrees with the hypothesis that the epithelium has a slow
turnover of cells in the steady state. The increase in proliferation observed with
time in undifferentiated cultures might be due in part to culture conditions since
the wound was still not completely healed at 48 hrs post-wounding; proliferation
was increased at that time point in both uninjured and injured cultures.
Previous studies have also shown that the first step of repair is migration of cells
at the wound margins by lamellipodia (Zahm, Kaplan, Herard et al. 1997). This
work used an in vitro model of human respiratory epithelium wound repair, where
Chapter 3 Differentiated HBEC wound repair model
107
epithelial cells were dissociated from human nasal polyps and cultured on
collagen I matrix and chemically wounded. Migration was followed by
proliferation of cells away from the wound (Puchelle 2000).
The wound model described can also potentially be used to reflect diseases
characterised by repeated injury such as asthma and COPD (Wadsworth, Nijmeh
and Hall 2006). It was possible to repeatedly wound these differentiated cells in
vitro every 48-72 hrs (ensuring at least 75% of the wound was healed by that
time) 8-12 times, creating a chronic injury model to study potential therapeutic
agents which might influence repair, as well as defining the key pathways
involved in epithelial repair. It was observed that the healing process following
chronic wounding is similar to the process seen with acute wounding as described
in this thesis, at least for the first 8-12 wound cycles, after which the cultures
reached a repair ‘crisis’, where they were incapable of further repair. It was also
observed that cultures treated with dexamethasone (an anti-inflammatory
glucocorticosteroid) were able to repair over increased cycles of injury before
reaching ‘crisis’.
3.5.3 Basal cells are responsible for repairing the wound by migration
followed by new cell proliferation in vitro
The findings described above were followed by investigating the phenotype of
cells seen to repair the acute wound. In the HBEC model, dramatic CD44 and
CK14 up-regulation at wound edges was observed as early as 0-4 hrs post-
wounding, suggesting a role for migratory basal cells, at the early stages of wound
repair. CD44 and CK14 expression was also detected at the basal layer of the
cultures, and Ki-67 positive cells were co-expressing CD44 or CK14, suggesting
that basal cells are also involved in proliferation. There were more proliferating
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cells away from the wound, with very few Ki-67 positive cells at the wound
edges. These findings suggest the migration and proliferation are two separate
events taking place independently, since both events were taking place at different
times and areas. This suggests a role of basal cells, or at least a subpopulation of
basal cells, as a progenitor (stem) cell population responsible for wound repair in
the bronchial epithelium.
In order to reach a better understanding of the involvement of CD44 in wound
repair, which was seen to be increased at wound edges, as well as being involved
in proliferation, relative CD44 mRNA expression was investigated in wounded
differentiated HBEC. There was no significant difference between uninjured and
injured cultures, which may suggest that the increase seen in CD44 protein
expression was not due to increased gene expression. It has to be noted that since
CD44 protein increase was observed at 24 hrs post-wounding and because CD44
mRNA expression was not investigated for time points earlier than 24 hrs, an
early transient increase in CD44 mRNA cannot be excluded. Some technical
difficulties emerged when carrying out Real Time PCR experiments. It was
difficult to extract RNA from the differentiated HBEC grown on microporous
membranes: this might have an effect on the integrity of the RNA although
240:280 ratios were generally high despite low yields. Moreover, as discussed
before, the 12-well transwell inserts do not contain a large amount of cells
compared to tissue culture flasks, and thus the procedure proved to be time
consuming. CD44 involvement in wound repair has been previously reported
(Leir, Baker, Holgate et al. 2000). It is a major receptor for hyaloronan,
fibronectin, collagen, and some cytokines; and connects the extracellular
environment to the inside of the cell and actin cytoskeleton, thus it may play a
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role in repairing the damaged epithelium (Holgate 2000). Expression of CD44
isoforms was observed to be elevated in the epithelium of subjects with asthma
and a bronchial epithelial repair model (Lackie PM 1997) (Leir, Baker, Holgate et
al. 2000), suggesting a role in the pathology of the disease. However, in vivo
studies show that although CD44 expression is increased, it does not occur in cell-
matrix interaction areas, so the molecule must be participating in cell-cell
communication (Lackie PM 1997). Since in asthma and some other respiratory
diseases, it has been well established that the repair process is altered, the model
described in this chapter could serve as good basis for understanding the
mechanisms involved, investigating different wound responses of the disease, and
possibly test potential therapeutic agents.
In summary, the data presented in this chapter provide characterisation of the
processes involved in and in vitro model for the study of human airway
epithelium wound repair. In the next chapter, the profile of inflammatory
molecules secreted by these cultures following injury has been investigated.
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Chapter 4. Secretory Profile of Bronchial Epithelium
during Wound Healing
4.1 Introduction
In the previous chapter, I described a series of experiments designed to
characterise the properties of a differentiated human bronchial epithelial model
and mechanisms underlying wound repair. The work described in this chapter
examines mediator production in this model.
4.1.1 Inflammatory function of the epithelium
The airway epithelium and its functions have been described in section 1.1.2. As
the first contact with the environment, the epithelium has a number of key
regulatory functions. A range of cytokines are produced by the respiratory tract
epithelium in response to insults and these may either participate in the
maintenance of inflammation in the airway epithelium in airway diseases or
facilitate repair mechanisms. There are extensive data examining the potential
role of both anti and pro-inflammatory cytokines in airway disease such as asthma
and COPD: in both these candidates alteration in epithelial cytokine production
may occur (discussed in detail later in this chapter). This chapter describes the
profile of mediator production by the human airway model system in the presence
or absence of wounding.
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4.1.1.1 Cytokines and chemokines
Cytokines are soluble polypeptides and glycopeptides, usually of < 80 kDa in
mass. They are involved in cell-cell interactions and primarily located in the local
milieu. Cytokines are rarely individually produced, but rather simultaneously with
other cytokines in certain patterns, resulting in amplification loops. These
networks may also be negative in effect, where the production of one cytokine
can inhibit the secretion of another. They generally function by binding to specific
cell-surface receptors. Cytokines can also be classified functionally, as pro-
inflammatory (e.g. lymphokines), chemoattractant (e.g. chemokines), anti-
inflammatory cytokines, and growth factors (Borish and Steinke 2003).
Lymphokines, produced by lymphocytes include: IL-2, IFN, TNF, and these are
secreted by Th1 cells to trigger cell-mediated immunity responses (Viallard,
Pellegrin, Ranchin et al. 1999). IL-4, IL-5, IL-6, IL-10, and IL-13, are secreted by
Th2 cells and are responsible for mast cell and eosinophil recruitment and
activation (Chung, Barnes 1999) (Chung 2001). Amongst the chemokines
involved in airway disease, IL-8, growth related oncogene (GRO)-Į, and ENA-
78, are responsible for neutrophil activation and recruitment to the site of
inflammation (Lukacs, Hogaboam, Kunkel et al. 1998). Chemokines function
through cognate G protein coupled receptors. For example, RANTES is thought
to be a chemoattractant for eosinophils and monocytes, and has been observed to
be secreted by the human bronchial epithelial cell line BEAS 2B when stimulated
by TNF- Į (Stellato, Beck, Gorgone et al. 1995). Finally, MIP-1Į, MCP-1, MCP-
3, MCP-4 have also been seen to be involved in eosinophil recruitment to the
airways which might result in airway epithelial damage (Lukacs, Standiford,
Chensue et al. 1996) (Paine, Rolfe, Standiford et al. 1993)
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This chapter describes the secretory profile of the human bronchial epithelial cell
(HBEC) wound repair model in vitro, emphasizing the airway epithelium as not
just a target for inflammation, but as a potential active source of the cytokines
contributing to the inflammatory processes seen in airway disease.
4.1.1.2 Epithelium dysfunction and cytokine secretions in asthma
In asthma, the bronchial epithelium is structurally disturbed, resulting in
incomplete repair, chronic inflammation, and an altered profile of the secretion of
growth factors and inflammatory mediators. These processes may contribute to
airway remodelling (Naylor 1962) either directly or indirectly. Figure 4-1 below
summarizes some of the important cytokines secreted by the epithelium in
asthma. IL-5, RANTES, and eotaxin have been shown to be secreted by the
airway epithelium, stimulating Th2-like inflammation (Holgate 2007). In addition
to RANTES, IL-16 has also been shown to be produced by epithelial cells; both
can act as chemoattractants for eosinophils. Cultured human bronchial epithelial
cells produce granulocyte CSF (G-CSF), and GM-CSF, promoting the survival of
neutrophils in vitro (Cox G 1992) and eosinophils. The chemokine MCP-1 has
been shown to be secreted on the apical surface of rat alveolar type II cells when
grown in vitro on inserts, potentially activating macrophages in the alveolar space
(Paine, Rolfe, Standiford et al. 1993), and possibly stimulating Th2 polarization.
TNF-Į, IL-1ȕ, and IL-6 are produced by both epithelial cells and macrophages, in
an autocrine loop. Other growth factors have also been observed to be secreted by
the epithelium in asthma, such as platelet derived growth factor (PDGF), and
fibroblast growth factor (FGF), both of which may be responsible for fibroblast
and airway smooth muscle proliferation. The Th1 chemokine, interferon (IFN)-
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inducible protein 10 (IP-10), has been shown to be elevated in a murine asthma
model after exposure to allergen (Medoff, Sauty, Tager et al. 2002). The study
showed that mice over-expressing IP-10 significantly exhibited increased airway
hyperreactivity, eosinophillia, and CD8
+
lymphocyte recruitment compared with
wild-type controls.
Figure 4-1: Overview of epithelial cell-derived cytokine secretion in asthma.
TNF: tumour necrosis factor. IL: interleukin. RANTES: Regulated on activation, normal T-cell
expressed and secreted. MCP: Monocyte chemoattractant protein. MIP: macrophage inflammatory
protein. ENA-78: epithelial-derived neutrophil activator. GRO: growth related protein. IP:
Interferon-inducible protein. GM-CSF: granulocyte-macrophage colony-stimulating factor. PDGF:
platelet-derived growth factor. FGF: fibroblast growth factor, promoting (myo)fibroblasts.
4.1.1.3 Epithelium dysfunction and cytokine secretion in COPD
Tissue damage, airway remodelling and inflammation also appear to have roles in
COPD. Similarly to asthma and other inflammatory diseases, cytokines
participate in the initiation of inflammation in COPD, the main sources being
epithelial cells, macrophages, eosinophils, and neutrophils. Figure 4-2
Chapter 4 Secretory profile of wounded differentiated HBEC
114
summarizes some of the important cytokines released by epithelial cells obtained
from COPD patients.
Cigarette smoke has been observed to induce G-CSF, MCP-1, IL-8, and
leukotrienes (LT) - B4 secretion by the human pulmonary type II epithelial cell
line A549 (Masubuchi, Koyama, Sato et al. 1998); these all participate in
recruitment and activation of neutrophils which in turn can secrete a number of
other mediators, including the neutrophil chemoattractant IL-8; these can lead to
further tissue damage, remodelling, and mucus hypersecretion. RANTES mRNA
expression has been seen to be elevated in the surface epithelium of patients with
chronic bronchitis compared to healthy subjects (Zhu, Qiu, Majumdar et al.
2001), and may be responsible for recruiting eosinophils, thus explaining the
eosinophilia observed in at least a subset of patients with COPD . Moreover,
TNF-Į has been shown to be produced by a range of cells in COPD, including
epithelial cells. It induces the transcription of the IL-8 gene, and up-regulates IL-8
expression in the airway epithelium (Kicic, Sutanto, Stevens et al. 2006). It also
stimulates epithelial cells to produce tenascin (an extracellular matrix protein)
(Khair, Devalia, Abdelaziz et al. 1994). Airway bacterial load in COPD patients
has been correlated with levels of IL-8 (Chung 2001), and up to 43% of
chemotactic activity found in sputum from COPD patients can be attributed to IL-
8 (Woolhouse, Bayley and Stockley 2002).
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Figure 4-2: Overview of epithelial cell-derived cytokines in COPD.
TNF: tumour necrosis factor. IL: interleukin. RANTES: Regulated on activation, normal T-cell
expressed and secreted. MCP: Monocyte chemoattractant protein. MIP: macrophage inflammatory
protein. ENA-78: epithelial-derived neutrophil activator. LT: leukotriene GRO: growth related
protein. IP: Interferon-inducible protein. MIG: Monokine Induced by Interferon-gamma. EGF:
epidermal growth factor. *IL-8 seems to be more extensively secreted by epithelial cells in COPD
than asthma.
Although the precise contribution of each individual cytokine to disease
pathogenesis remains unclear, there seems to be differences in the profiles of
cytokines produced in asthma and COPD (see Table 4-18). Further studies are
needed in order to define these differences more quantitatively. On the other
hand, the identification of some common cytokine pathways involved in both
conditions suggests there may be common pathways controlling both
inflammation and repair as well which contribute to the pathophysiology of both
diseases.
Chapter 4 Secretory profile of wounded differentiated HBEC
116
4.2 Objectives
Since there is great evidence of epithelial derived cytokines and other mediators
in the evolution of airway inflammation and in the injury-repair process in the
human airway, the major aims of the studies described in this chapter were to
define the secretory profile of the human bronchial epithelial cell (HBEC) wound
repair model (described initially in chapter 3). A panel of 28 cytokines,
chemokines, and growth factors, was investigated, including a wide range
generally thought to be important in airway inflammation.
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4.3 Methods
In all, three methods have been used in this study to investigate the secretory
profile of wounded human bronchial epithelial cells (HEBC). Briefly, the
Luminex system was employed to investigate the secretion of a panel of factors
by wounded and unwounded HBEC, and is discussed in more detail in section
2.2.2. The luminex system employs flow cytometry, microspheres, lasers, and
digital signal processing to permit the simultaneous measurement of multiple
cytokines. In addition, an enzyme-linked immuno-sorbent assay (ELISA) was
used to investigate specific individual cytokines, and is described below. Real
time PCR was then performed following protein analysis to study mRNA
expression levels. As mentioned earlier, two donors were used for the Luminex
assay and molecular work (donor 1 and 2), each including two replicates.
4.3.1 Luminex assay
First, 1 ml per well of supernatant was collected from wounded differentiated
HBEC, grown at ALI, at 0, 24, 48, and 72 hrs post-wounding as described in
section 2.1.1.7. Unwounded controls were included for each time point. The
Luminex assay was carried out as described in section 2.2.2.1, using a pre-mix
human Procarta® Cytokine Assay kit (28-plex), to measure the concentration of a
panel of cytokines, chemokines, and growth factors secreted by the scrape
wounded differentiated bronchial epithelium model used in this study (a list of the
analytes measured is given in Table 4-1). The detection limits for this assay were
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0-20 000 pg/ml for each analyte. More details about the technique, standard
curves, and controls are provided in section 2.2.2.
Table 4-1: List of analytes investigated using a commercially available Luminex kit
Analyte Symbol Name and other Nomenclature
IL-8 Interleukin 8: CXCL8, neutrophil activating peptide (NAP)1
IL-6 Interleukin 6: interferon, beta 2
IL-1ɴ Interleukin 1 beta: lymphocyte activating factor (LAF)
ENA-78 Epithelial-neutrophil activating peptide 78: CXCL5
G-CSF Granulocyte colony-stimulating factor
RANTES Regulated upon activation, normal T-cell expressed, and secreted:
CCL5
IP-10 Interferon-inducible protein 10: CXCL10
VEGF Vascular Endothelial growth factor
MCP-1 Monocyte chemotactic protein 1: monocyte chemotactic and
activating factor (MCAF), small inducible cytokine A2 (SCYA2)
IL-2 Interleukin 2: T-cell growth factor (TCGF), lymphokine
IL-4 Interleukin 4; B-cell growth factor (BCGF)
IL-5 T-cell replacing factor (TRF), eosinophil differentiation factor
(EDF)
IL-7 Interleukin 7
IL-10 Interleukin 10: cytokine synthesis inhibitory factor (CSIF)
IL-12P40 Interleukin 12p40: IL-12b
IL-12P70 Interleukin 12p70
IL-13 Interleukin 13: allergic rhinitis (ALRH): bronchial
hyperresponsiveness 1 (BHR-1)
IL-17 Interleukin 17: cytotoxic T-lymphocyte-associated antigen 8
(CTLA8)
FGF-basic Basic fibroblast growth factor; FGF2
NGF Nerve growth factor
Leptin Acts through leptin receptor (LEPR)
Eotaxin CCL-11
MIP-1ɴ Macrophage inflammatory protein 1 beta: CCL-4
MIP-1ɲ Macrophage inflammatory protein 1 alpha: CCL-3
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TNF-ɴ Tumour necrosis factor beta
GM-CSF Granulocyte monocyte colony-stimulating factor
IFN-ɶ Interferon gamma: type II interferon, macrophage activation
protein (MAF)
4.3.2 Enzyme-Linked Immuno-Sorbent Assay (ELISA)
For the quantitative determination of human IL-8 concentrations in cell culture
supernatants from differentiated scrape wounded HBEC, a commercially
available ELISA kit was used to further investigate IL-8 since the values obtained
from the luminex experiment for that particular mediator were above the detection
limit range of the assay. Briefly, this assay involves an analyte-specific
monoclonal antibody pre-coated onto a microplate. After the sample had been
added, the relevant protein present binds to the antibody. An enzyme-linked
analyte-specific detection antibody is added and a substrate solution develops
colour (through its digestion by the enzyme) in proportion to the amount of
protein present in the sample. The intensity of the signal is subsequently measured
(Figure 4 3).
Figure 4-3: Basic principle of ELISA.
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The Quantikine Human CXCL-8/IL-8 Immunoassay (Cat# D8000C was used
following the manufacturer’s protocol in a 96-well microplate. All reagents and
equipment were provided with the kit and prepared according to the
manufacturer’s protocol.
Briefly, after reagents, samples, and standards were prepared, 100 µl Assay
Diluent (buffered protein base with preservatives) was added to each well.
Standard controls (lyophilized recombinant analyte in a buffered protein base
with preservatives) or samples were then added, and incubated at room
temperature for 2-3 hrs according to the specific assay carried out. The wells were
washed four times with Wash Buffer (400 µl, 25x concentrated solution of
buffered surfactant with preservatives), and desired conjugate was added for 1 hr
at room temperature. The wells were washed again, and Substrate Solution was
added and incubated for 20-30 min at room temperature protecting it from the
light. Finally, Stop Solution (2 N sulphuric acid) was added to each well and the
absorbance was read on a plate reader (Multiskan EX, Thermo Scientific, with
Ascent software) DWQPZLWKLQPLQȖFRUUHFWLRQZDVGRQHDWQPRU
570 nm in order to avoid optical imperfections which might occur if the readings
were made at only 450. Data analysis was carried out using the ELISA plate
reader software Ascent. Values for data analysis were done by first creating a
standard curve (presented in Figure 4-4) from the standards that were included,
using 4 parametric logistic fitting and this was used to determine the
concentration of IL-8 in the samples.
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Figure 4-4: ELISA standard curve for IL-8.
A standard curve was generated from the standards included in the experiment, using Ascent
software, using a four parametric logistic fitting. IL-8 concentration in the HBEC supernatants
was determined using this standard curve. Concentrations are in pg/ml.
4.3.3 Quantitative Real Time PCR
To quantify mRNA expression of the cytokines that showed protein increase in
wounded differentiated HBEC, Real Time PCR (Biosystems) was carried out on
cDNA synthesized from RNA collected from differentiated HBEC following the
protocols described in section 2.4. Primers and probes used are listed in Table 4-2
and Table 4-3 below. cDNA quality was validated by running a conventional PCR
using GAPDH as discussed in section 2.4.2.4.
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Table 4-2: Primer information
Table 4-3: Probe information
Standard curves were generated as explained in section 2.4.3 for the following
targets: IL-6, IL-8, ENA-78, and G-CSF, to validate the use of the chosen primers
and probes and the appropriate working concentrations. IL-8 primer/probe set
sequences are not presented in the table above since they were purchased and the
sequences were not available. Optimum amplification efficiencies should be
100% (±10%), however, for the assays used in this study, they were between 75-
90%, which are still considered acceptable. The slope of the standard curve
(optimum is -3.322 for 100% PCR efficiency), showed a range from -3.626 till -
4.074), validating the primers and probes as appropriate to use for experiments.
# of bases Primer Name Primer sequence 5'-3' Position Product length
27 IL-6 F AGAAAGGAGACATGTAACAAGAGTAAC Exon 2 position 266
23 IL-6 R CAACCTGAACCTTCCAAAGATGG Exon 3 position 328
22 ENA-78 F GCCCCTTTCACAGAGTAGAACC Exon 4 position 1676
20 ENA-78 R AAACCCGACAGGCATCTTCC Exon 4 position 1761
20 G-CSF F GCTTCCTGGAGGTGTCGTAC Exon 1 position 615
20 G-CSF R CCGTTCTGCTCTTCCCTGTC Exon 4 position 754
86
140
63
Taqman
®
Gene expression assay for IL-8 was purchased from Applied Biosystems: cat.# HS99999034_m1
# of bases Probe Name Primer sequence 5'-3' Position
27 IL-6 TCTGCCAGTGCCTCTTTGCTGCTTTCA Exon position 298
22 ENA-78 CCCGCTGCCGCTCGTCTTCTGC Exon 4 position1733
24 G-CSF TTCTACGCCACCTTGCCCAGCCCT Exon 4 position 630
Probes were 3' TAMRA, 5' 6-FAM purchased from Eurgentec S.A
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Figure 4-5: Amplification and dilution plots.
IL-6 (A), IL-8 (B), ENA-78 (C), and G-CSF (D). One outlier value was observed for G-CSF
(panel D): this was however included in the fitting of the dilution plot.
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4.4 Results
4.4.1 Cytokine secretion of wounded differentiated HBEC cultures
Quantitative determination of 28 factors (Table 4-1) in supernatants collected
from differentiated HBEC cultures, grown at ALI and scrape-wounded, was
carried out using the luminex assay and ELISA. Detection of 9 factors was
observed including: IL-6, IL-8, ENA-78, G-CSF, IP-10, RANTES, IL-1ȕ, VEGF,
and MIP-1ȕ. The results are discussed in the following sections. Raw data for all
the analytes is presented in Appendix B. Two donors were used for these
experiments each carried out in two replicates and the Luminex assay was done in
duplicate. There were not sufficient values to carry out statistical analysis. Data
are presented in tables as mean concentration (pg/ml) of the two replicates for
each donor and the range is presented in brackets for each average.
4.4.1.1 Interleukin 6 (IL-6) secretion
IL-6 secretion was observed to be increased in wounded HBEC supernatants
compared to unwounded cells at 72 hrs post-wounding in both donors although
the variation between the two donors used was high (1.8 and 9 fold increase in
wounded compared to unwounded cultures at 72 hrs post-wounding respectively).
It was also observed that at each point the concentration level of IL-6 was higher
in wounded cells compared to unwounded counterparts, in both donors. Table 4-4
below shows mean concentration of two replicates per donor as well as the range
of the values. Values that were below the limit of detection was substituted by
zero. The negative control contained an IL-6 concentration of 0.27 pg/ml
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Table 4-4: IL-6 secretion by wounded and unwounded HBEC.
Table shows mean concentration (pg/ml)of two replicates per donor for two donors for wounded
and unwounded cells at different time points. Ranges are presented in brackets showing the
minimum and maximum concentration. Values below the limit of detection were substituted by 0.
Donor 1
Mean of two replicates as pg/ml (range)
Donor 2
Mean of two replicated as pg/ml(Range)
Time
post-
injury
(hours)
Wounded Unwounded Wounded Unwounded
0 0 0 0.55 (0.51-0.59) 0.37 (0.25-0.49)
24 12.64 (0-25.28) 0 17.52 (12.86-21.94) 5.94 (2.26-9.61)
48 49.87 (47.68-52.06) 0 53.24 (40.62-65.86) 12.60 (9.93-15.83)
72 154.5 (121.3-187.7) 88.28 (62.72-113.84) 135.58 (124.45-146.71) 14.33 (9.14-19.51)
4.4.1.2 Interleukin 8 (IL-8) secretion
There was a trend in higher IL-8 concentrations in wounded HBEC compared to
unwounded cells in both donors. In donor 2 however, the concentration of IL-8
was above the limit of detection after the 0 hr time point (Table 4-5). An ELISA
was thus carried out in order to dilute the samples. Generally, it was observed that
IL-8 concentration was higher after wounding HBEC. For example, at 72 hrs
post-wounding in both donors, there was an approximated 1.7 fold increase in IL-
8 concentration in wounded compared to unwounded cells (Table 4-6).
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Table 4-5: IL-8 secretion by wounded and unwounded HBEC measured using the luminex
assay.
Table shows mean concentration (pg/ml) of two replicates per donor for two donors for wounded
and unwounded cells at different time points. Ranges are presented in brackets showing the
minimum and maximum concentration. For donor 1, only one of the values were present and thus
a mean could not be calculated. OOR> represents the values that were above the limit of detection
for the Luminex assay
Donor 1
Mean of two replicates in pg/ml (range)
Donor 2
Mean of two replicated in pg/ml (Range)
Time
post-
injury
(hours)
Wounded Unwounded Wounded Unwounded
0 95.21 (94.46-95.96) 143.94 (132.85-155.03) 5.10 (2.47-7.72) 12.43 (8.05-16.81)
24 2805.25 (2664-2946.5) 1272.86 (926.91-1618.8) OOR> OOR>
48 4289.7 (4180.9-4398.5) 1672 (1648-1696) OOR> OOR>
72 18663 (18663-OOR>) 6372 (5887.3-6856.7 OOR> OOR>
Table 4-6: IL-8 secretion by wounded and unwounded HBEC measured using ELISA.
Table shows mean concentration (pg/ml) of two replicates per donor for two donors for wounded
and unwounded cells at different time points. Ranges are presented in brackets showing the
minimum and maximum concentration. Values below the limit of detection were substituted by 0.
For donor 1, only one of the values were present and thus a mean could not be calculated. OOR>
represents the values that were above the limit of detection for the Luminex assay
Donor 1
Mean of two replicates in pg/ml (range)
Donor 2
Mean of two replicated in pg/ml (Range)
Time
post-
injury
(hours)
Wounded Unwounded Wounded Unwounded
0 0 0 110.5 (98-123) 217.5 (153-282)
24 3544.5 (2371-4718) 1750 (1931-3138) 7196.5 (6538-7855) 2095.5 (0-4191)
48 22380 (17104-27656) 14292 (11513-17071) 8194.5 (7110-9279) 4715.5 (4667-4764)
72 19435 (16392-22478) 10920 (8513-13327) 15227 (11648-18806) 8701.5 (8018-9385)
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4.4.1.3 Epithelial neutrophil-activating peptide 78 (ENA-78) secretion
An increase was seen in ENA78 secretion in wounded HBEC cultures in both
donors by 24hrs post-wounding. For example, at 72 hrs post-wounding, an
approximated 16 fold increase was observed in donor 1 in wounded vs
unwounded cultures, and an 8 fold increase in donor two. Table 4-7 shows the
mean concentration of two replicated per donor in pg/ml in both wounded and
unwounded HBEC. Range of the values are also presented in brackets. Values
that were below the limit detection of the assay were substituted by 0.
Table 4-7: ENA-78 secretion by wounded and unwounded HBEC.
Table shows mean concentration (pg/ml) of two replicates per donor for two donors for wounded
and unwounded cells at different time points. Ranges are presented in brackets showing the
minimum and maximum concentration. Values below the limit of detection were substituted by 0.
Donor 1
Mean of two replicates in pg/ml (range)
Donor 2
Mean of two replicated in pg/ml (Range)
Time
post-
injury
(hours)
Wounded Unwounded Wounded Unwounded
0 0 0 0 0
24 34.06 (0-68.12) 0 184.68 (166.8-202.55) 24.87 (0-49.74)
48 192.32 (151.34-233.3) 0 1168.8 (1088.7-1248.9) 106.58 (101.08-112.08)
72 1207.57 (515.93-1899.2) 73.77 (31.76-115.77) 937.69 (614.97-1260.4) 120.96 (66.67-175.24)
4.4.1.4 Granulocyte colony stimulating factor (G-CSF) secretion
G-CSF secretion was observed to be higher in wounded HBEC compared to
unwounded cells in both HBEC donors by 24 hrs post-wounding. For example, at
72 hrs post-wounding, there was 2.2 fold increase in wounded cultures from
donor 1 compared to unwounded cells, and a 62.8 fold increase in wounded cells
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vs. unwounded cells from donor 2. A high variability can be seen between donors
as well as within donors at some points.
Table 4-8 shows mean concentration of G-CSF in pg/ml, in wounded and
unwounded cultures, of two replication in each donor. A range of the values at
each time point is also presented. Values that were below the limit of detection
were substituted by 0.
Table 4-8: G-CSF secretion by wounded and unwounded HBEC.
Table shows mean concentration (pg/ml) of two replicates per donor for two donors for wounded
and unwounded cells at different time points. Ranges are presented in brackets showing the
minimum and maximum concentration. Values below the limit of detection were substituted by 0.
Donor 1
Mean of two replicates in pg/ml (range)
Donor 2
Mean of two replicated in pg/ml (Range)
Time
post-
injury
(hours)
Wounded Unwounded Wounded Unwounded
0 0 0 0 0
24 32.70 (17.74-47.65) 0 1.22 (0-2.44) 0
48 31.38 (27.09-35.66) 0 202.15 (171.81-232.48) 0.23 (0-0.45)
72 292.60 (182.48-402.71) 130.57 (90.31-170.83) 165.2 (83.68-246.72) 2.63 (0-5.26)
4.4.1.5 Interferon-inducible protein 10 (IP-10) secretion
Wounded and unwounded HBEC both secreted IP-10 at different time points
post-wounding. There was a hint of increase in wounded cells of donor 2 at 72hrs
post-wounding compared to its unwounded counterpart. However, in general, it
seems that wounding HBEC does not affect IP-10 secretion dramatically. Table
4-9 shows IP-10 mean concentration (pg/ml) of two replicates per donor for two
donors in wounded and unwounded HBEC. Range is also presented in brackets to
show the variability between donors and amongst them.
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Table 4-9: IP-10 secretion by wounded and unwounded HBEC.
Table shows mean concentration (pg/ml) of two replicates per donor for two donors for wounded
and unwounded cells at different time points. Ranges are presented in brackets showing the
minimum and maximum concentration.
Donor 1
Mean of two replicates in pg/ml (range)
Donor 2
Mean of two replicated in pg/ml (Range)
Time
post-
injury
(hours)
Wounded Unwounded Wounded Unwounded
0 0 0.01 (0-0.01) 1.08 (1-1.15) 1.47 (0.98-1.96)
24 0.44 (0.29-0.58) 0.14 (0.09-0.19) 61.43 (60.99-61.87) 69.11 (53.24-84.97)
48 3.40 (3.21-3.58 0.21 (0.19-0.23) 335.92 (323.04-348.79) 297.11 (270.06-324.16)
72 30.46 (13.81-47.11) 53.10 (2.47-101.25) 667.94 (643.89-691.98) 480.43 (475.85-485.01)
4.4.1.6 Vascular endothelial growth factor (VEGF) secretion
There was a high variability in VEGF concentration between samples in these
experiments and a high level of VEGF was seen to be secreted by HBEC both
wounded and unwounded. However, there seems to be a hint of increase in VEGF
secretion after wounding especially in donor 2 at 48 and 72 hrs post-wounding.
Table 4-10 shows mean concentration in pg/ml of two replicates per donor in both
donors. Range is also presented in brackets to assess the variability between
samples.
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Table 4-10: VEGF secretion by wounded and unwounded HBEC.
Table shows mean concentration (pg/ml) of two replicates per donor for two donors for wounded
and unwounded cells at different time points. Ranges are presented in brackets showing the
minimum and maximum concentration. OOR> : out of range above.
Donor 1
Mean of two replicates in pg/ml (range)
Donor 2
Mean of two replicated in pg/ml (Range)
Time
post-
injury
(hours)
Wounded Unwounded Wounded Unwounded
0 25.4 (22.49-28.31) 43.07 (41.69-44.44) 5.1 (2.3-5.6) 6.87 (1.95-11.78)
24 277.79 (272.8-282.78) 291.70 (289.07-294.32) 224.2 (97.9-350.5) 296.95 (272.2-321.7)
48 434.82 (429.16-440.48) 354.57 (332.69-376.45) 10792- OOR> 2351 (2089-2613)
72 977.53 (796.95-1158.1) 773.77 (664.53-883.01) OOR> OOR>
4.4.1.7 Regulated upon activation, normal T cell expressed and secreted
(RANTES) secretion
RANTES secretion was observed to be low in HBEC in wounded and unwounded
cultures especially in donor 1, however, it seems to increase in response to
wounding especially at a later time points (such 72 hrs). For example, at 72 hrs
post wounded cultures from donor 2, there was an approximated 4 fold increase in
the wounded cultures compared to unwounded cells. Table 4-11 shows mean
concentration (pg/ml) of two replicates per donor. Two separate donors were used
in this study. Ranges are also included in the table below in brackets. The
variability between samples in RANTES secretion was not high.
Chapter 4 Secretory profile of wounded differentiated HBEC
132
Table 4-11: RANTES secretion by wounded and unwounded HBEC.
Table shows mean concentration (pg/ml) of two replicates per donor for two donors for wounded
and unwounded cells at different time points. Ranges are presented in brackets showing the
minimum and maximum concentration. Values below the detection limit were substituted for by
zero.
Donor 1
Mean of two replicates in pg/ml (range)
Donor 2
Mean of two replicated in pg/ml (Range)
Time
post-
injury
(hours)
Wounded Unwounded Wounded Unwounded
0 0 0 0.03 0.03 (0.02-0.04)
24 0 0 0.69 (0.34-1.04) 0.71 (0.62-0.79)
48 6.11 (0-12.22) 0 5.63 (5.41-5.85) 2.66 (2.09-3.22)
72 31.38 (24.27-38.48) 0 10.78 (9.7-11.86) 3.44 (2.3-4.57)
4.4.1.8 Interleukin 1ȕ (IL-1) secretion
Although IL-1ȕ secretion by differentiated HBEC was observed to be low, there
was a slight increase in wounded cultures compared to unwounded ones
especially in donor 2. In addition, there seems to be a higher increase with time in
the wounded HBEC compared to unwounded cells. Table 4-12 shows mean
concentration (pg/ml) of two replicates per donor for two donors. Ranges are also
provided in brackets. Variability between samples in IL-1ȕ secretions seems to be
low. All values that were below the detection limit of the assay were substituted
by zero. Table 4-12 shows mean concentration (pg/ml) of two replicates per
donor. Two separate donors were used in this study. Ranges are also included in
the table below in brackets
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Table 4-12: IL-1ȕ secretion by wounded and unwounded HBEC.
Table shows mean concentration (pg/ml) of two replicates per donor for two donors for wounded
and unwounded cells at different time points. Ranges are presented in brackets showing the
minimum and maximum concentration. Zero represents the values that were below the detection
limit of the assay.
Donor 1
Mean of two replicates in pg/ml (range)
Donor 2
Mean of two replicated in pg/ml (Range)
Time
post-
injury
(hours)
Wounded Unwounded Wounded Unwounded
0 0 0 0.14 0.06 (0.03-0.08)
24 0 0 0.2 (0.08-0.36) 0.18 (0.14-0.21)
48 0 0 0.57 (0.52-0.61) 0.36 (0.28-0.44)
72 0.33 (0.19-0.46) 0 0.96 (0.91-1.01) 0.4 (0.36-0.44)
4.4.1.9 Macrophage inflammatory protein 1ȕ (MIP-1ȕ) secretion
MIP-1ȕ secretion was observed to be very low in differentiated HBEC. Although
there were none detected in donor 1, donor 2 showed some increase in wounded
cultures compared to unwounded cells at 24, 48, and 72 hrs post-wounding. Table
4-13) shows mean concentration (pg/ml) of two replicates per donor. Two
separate donors were used in this study. Ranges are also included in the table
below in brackets
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Table 4-13: MIP-1ȕ secretion by wounded and unwounded HBEC.
Table shows mean concentration (pg/ml) of two replicates per donor for two donors for wounded
and unwounded cells at different time points. Ranges are presented in brackets showing the
minimum and maximum concentration. Zero represents the values that were below the detection
limit of the assay.
Donor 1
Mean of two replicates in pg/ml (range)
Donor 2
Mean of two replicated in pg/ml (Range)
Time
post-
injury
(hours)
Wounded Unwounded Wounded Unwounded
0 0 0 0.16 (0.15-0.16) 0.17 (0.16-0.18)
24 0 0 1.09 (0.94-1.23) 0.35 (0.3-0.4)
48 0 0 3.56 (3.08-4.02) 1.15 (1.11-1.19)
72 0 0 5.19 (3.75-6.63) 2.33 (1.52-3.13)
4.4.1.10 Cytokines that were not detected in our HBEC cultures
Out of the 28 mediators investigated, only the above cytokines were detected in
HBEC culture supernatants. The rest were below the detected limit range of the
assay. Those cytokines included: IL-2, IL-5, IL-7, IL-10, IL-12 p70, IL-13, IL-17,
MIP-1Į, TNF-ȕ, GM- CSF, MCP3, IFN-Ȗ7KHUHZHUHDIHZF\WRNLQHVWKDWZHUH
detected only in donor 2 but the values were very close to the concentration of the
negative control and thus were not investigated further. These included: IL-4, IL-
12 p40, NGF, leptin, eotaxin. Finally, FGF-basic was detected in donor 2 but
there was a decrease in its concentration observed in both wounded and
unwounded HBEC.
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4.4.2 Cytokine mRNA expression by wounded and unwounded
differentiated HBEC
The trend towards an increase in cytokines secretions described in the previous
section could be explained due to a number of processes. It could be due to an
increase in transcription, an increase in the release of preformed cytokines, or a
decrease in the breakdown of these cytokines by the cells. Hence, the increase
seen in cytokines at the protein level was further studied by the investigation of
IL-6, IL-8, ENA-78, and G-CSF relative mRNA expression using Real Time
PCR; in order to see whether this increase in protein was due to an increase in
transcription. These cytokines were chosen because of the data suggesting these
were most likely to be differentially regulated following wounding. RNA was
extracted from wounded differentiated HBEC, at 0, 24, 48, and 72 hrs, with
unwounded controls provided as described in section 2.4.3. Real time PCR was
carried out using the primers and probes listed in Table 4-2 and Table 4-3. Data
was analyzed using the approaches described in section 2.4.3. HPRT was again
used to normalize the values generated from Real Time PCR experiments for the
reasons explained in section 2.4.3. For each cytokine, values were captured at
relevant time points from the samples obtained from wounded and unwounded
cultures. The tables below show mean fold increase (as a percentage) of 2
-¨&W
normalised to 0hrs and the range of the two replicates in brackets. Two different
donors were used each in two replicates, and the real time PCR was carried out in
triplicate. It has to be noted that no conclusive results could be retrieved from the
real time data since it was technically very difficult to extract RNA from the
transwell inserts and from the tables below, the 24 hrs time point in donor 2 does
not seem reliable in all four cytokines.
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4.4.2.1 IL-6 mRNA expression by wounded and unwounded HBEC
There was a hint of increase in IL-6 mRNA expression in wounded cultures
compared to unwounded cells especially in donor 2. For example, at 24 hrs post-
wounding, a 6 fold increase was observed in the mRNA expression in wounded
cells compared to unwounded controls in donor 2 and a 1.4 fold increase in donor
2 (Table 4-14).
Table 4-14: IL-6 relative mRNA expression by wounded and unwounded HBEC.
The table shows mean fold increase of two replicates per donor of two donors (2
-dCt
) normalized to
0hrs.
Donor 1
Mean fold increase of two replicates in 2
-dCt
as a percentage normalized to 0hr (range)
Donor 2
Mean fold increase of two replicates in 2
-dCt(
as apercentage normalized to 0hr (range)
Time
post-
injury
(hours)
Wounded Unwounded Wounded Unwounded
0 100 100 100 100
24 13.3 (13.2-13.4) 9.7 (1.9-17.5) 955.5 (341-1570.6) 159.1 (66.8-252.2)
48 33.25 (16.6-49.9) 83 (72.4-93.6) 215.7 (184.0-247.4) 57.1 (92.3-201.6)
72 35.7 (26-45.4) 8.25 (5.1-11.4) 933.8 (642.0-1225.5) 277.8 (56.6-498.9)
4.4.2.2 IL-8 mRNA expression in wounded and unwounded cultures
IL-8 relative mRNA expression was seen to be higher in wounded HBEC
compared to unwounded controls especially at 24 hrs post-wounding in donor2.
Although the expression was quite different in two donors, the increase in
expression seen in wounded cells correlates with the increase at the protein level
(Table 4-15).
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Table 4-15: IL-8 relative mRNA expression by wounded and unwounded HBEC.
The table shows mean fold increase of two replicates per donor of two donors (2
-dCt
) normalized to
0hrs.
Donor 1
Mean fold increase of two replicates in 2
-dCt
as a percentage normalized to 0hr (range)
Donor 2
Mean fold increase of two replicates in 2
-dCt(
as apercentage normalized to 0hr (range)
Time
post-
injury
(hours)
Wounded Unwounded Wounded Unwounded
0 100 100 100 100
24 111.75 (72.3-151.2) 69.2 (16.9-121.5) 367.1 (568.3-675.8) 136 (119.4-152.4)
48 41.6 (27.7-79.3) 125.6 (101.2-150) 341.3 (230.5-453.0) 190.1 (185-195)
72 84.6 (80.5-88.7) 25.5 (24.9-26) 486. (281-691) 386.6 (108.1-278.5)
4.4.2.3 ENA-78 mRNA expression in wounded and unwounded HBEC.
ENA-78 mRNA expression was observed to be higher in wounded HBEC
compared to unwounded ones in both donors by 24hrs post-wounding (Table
4-16). At 48 hrs post-wounding in donor 1, there could have been a technical
error in the real time method since in all three cytokines thus far, the unwounded
was higher than the wounded which contrasts all the other time points and the
other donor.
Table 4-16: ENA-78 relative mRNA expression by wounded and unwounded HBEC.
The table shows mean fold increase of two replicates per donor of two donors (2
-dCt
) normalized to
0hrs.
Donor 1
Mean fold increase of two replicates in 2
-dCt
as a percentage normalized to 0hr (range)
Donor 2
Mean fold increase of two replicates in 2
-dCt(
as apercentage normalized to 0hr (range)
Time
post-
injury
(hours)
Wounded Unwounded Wounded Unwounded
0 100 100 100 100
24 838.4 (516.6-1160) 317.4 (16.3-618.4) 931.4 (592-1270.8) 165.2 (71.5-258.9)
48 91.9 (9.8-174.4) 226.4 (210.8-241.9) 531.2 (337.8-724.5) 238.7 (198.2-279.1)
72 792.2 (228.3-1356) 121.5 (80.9-162) 1041.8 (1524.7) 167.9 (0.1-334.9)
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4.4.2.4 G-CSF mRNA expression in wounded and unwounded HBEC
An increase was seen in G-CSF mRNA expression in response to wounding in
both donors by 24 hrs post-wounding (Table 4-17). The problem with the 48 hr
time point in donor 1 remains clear in G-CSF data as well.
Table 4-17: G-CSF relative mRNA expression by wounded and unwounded HBEC.
The table shows mean fold increase of two replicates per donor of two donors (2
-dCt
) normalized to
0hrs.
Donor 1
Mean fold increase of two replicates in 2
-dCt
as a percentage normalized to 0hr (range)
Donor 2
Mean fold increase of two replicates in 2
-dCt(
as apercentage normalized to 0hr (range)
Time
post-
injury
(hours)
Wounded Unwounded Wounded Unwounded
0 100 100 100 100
24 40.4 (35.1-45.7) 10.1 (4.7-15.4) 3803.9 (3000-4607.8) 231.6 (222.6-240.5)
48 19.7 (6.3-33.1) 41.6 (37.5-45.6) 1392 (1156.9-1627) 412.1 (374.2-450)
72 21.7 (19.8-23.9) 6.9 (6.7-7) 2436.4 (1164.7-3708.1) 733.1 (250-1216.)
Chapter 4 Secretory profile of wounded differentiated HBEC
139
4.5 Discussion
The aim of the studies described in this chapter was to investigate the expression
of a panel of cytokines and chemokines (Table 4-1), potentially involved in
airway inflammation, in the wounded HBEC model. The major findings are listed
in Table 4-18 with a comparison of the results from the data presented in this
chapter using the HBEC scrape-wounded model and previous studies of epithelial
cell-derived cytokines in asthma and COPD using tissue samples. In summary, a
trend of increase was seen in IL-6, IL-8, ENA-78, G-CSF, VEGF, RANTES, IL-
1ȕ, and MIP-1ȕ protein expression in wounded cultures. There was not a clear
increase in IP-10 protein. Interestingly, some of the above mediators have
previously been shown to be up-regulated in the epithelium of patients with
COPD or asthma patients.
There were not sufficient data points to carry out statistical analysis. This is due to
the fact that these commercially available HBEC are technically challenging to
differentiate and the procedure is both expensive and time consuming. Thus
during the course of this study, there was insufficient time to work with more than
two donors. Currently, epithelial cells from biopsies are being investigated which
could be used in the future instead of the commercially available cells, allowing
the investigation of patient and normal samples. Moreover, due to the variation in
both donors, the data was presented in tables to identify potential trend increases
in both donors in spite of the differences amongst them. Another limitation for
this work was the limit of detection for all the cytokines (e.g some of the
cytokines were above that limit of detection). This could be potentially solved by
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using more than one dilution of the sample during the experiment. Finally, it
proved very difficult to extract RNA from the polyester membranes and thus the
amount and quality of the RNA was poor and thus the data at this point is not
conclusive for the mRNA expression. Another RNA extraction protocol could be
carried out to see if the results are clearer in the future.
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Table 4-18: Epithelial cell-derive cytokines in our scrape-wounded model, compared to
previous findings involving the epithelium in patients with asthma and COPD
¥: Expressed. ¥¥: Increased expression. ?: Not definite. Ļ'HFUHDVHGH[SUHVVLRQ
The data presented in the table were collected from a number of previsous studies, and the
references are provided in the text.
Analyte Asthma COPD Major functions
Wounded Unwounded
IL-8 ¥¥ ¥ ¥¥ ¥¥ Neutrophil chemoattraction
lL-6 ¥¥ ¥ ¥¥ ¥¥ Macrophage and epithelial cell activation
IL-1ȕ ¥¥ ¥ ¥¥ ¥¥ Macrophage and epithelial cell activation
ENA78 ¥¥ ¥ ¥¥ ¥¥ Eosinophil activation in asthma
Neutrophil chemoattraction in COPD
G-CSF ¥ ¥ ¥ ¥ Blood neutrophil chemoattractantion
RANTES ¥¥ ¥ ¥¥ ¥¥ Lymphocyte activation in asthma
Eosinophil activation in COPD
IP-10 ¥ ¥ ¥¥ ¥¥ Lymphocyte activation
VEGF ¥ ¥ ¥¥ ¥¥? Th2 an Th1 activation
Leukcyte accumulation
MCP-1 __ __ ¥ ¥¥ Neutrophil chemoattraction
IL-2 __ __ __ __ Growth and differentiation of T cells
Eosinophilia
IL-4 __ __ __ __ Increase in Th1 cells and IgE levels
Eosinophil growth
IL-5 __ __ __ __ Increase in Th2 cells
Eosinophil maturation
IL-7 __ __ __ __ T cell homeostasis
IL-10 __ __ __ __ Inhibitory cytokine
IL-12 P40 __ __ ¥¥ ¥? Th1-dependant immunity
IL-12 IL70 __ __ ¥? ¥? Produced by antigen presenting cells Th1-
dependant immunity
IL-13 __ __ __ __ Induction of proliferation of airway epithelial
cells
IL-17 __ __ __ __ Produced exclusively by activated T-
lymphocytes to activate epithelial cells,
endothelial cells, and fibroblasts
Increases T-cell proliferation
FGF-basic __ __ ¥¥ ¥¥ Stimulation of proliferation and
differentiation of fibroblasts and endothelial
cellsNGF __ __ ¥¥ ¥? Stimulation of proliferation and
differentiation of nerves
Leptin __ __ љ ? Re-epithelisation processes in skin wounds
Eotaxin __ __ ¥¥ ¥¥ Eosinophil chemoattraction
MIP-1ȕ ¥¥ ¥ ? ? Promotion of accumulation of lymphocytes ,
macrophages, monocytes, and natural killer
cellsMIP-1Į __ __ ¥¥ ¥¥ Eosinophil chemoattraction
Macrophage activation
TNFȕ __ __ ¥? ¥? Induction of GM-CSF, G-CSF, IL-1,
collagenase, and prostagladin E2 synthesis by
fibroblasts
TNFĮ __ __ ¥¥ ¥¥ Eosinophil activation and survival
GM-CSF __ __ ¥¥ ¥? Eosinophil activation and proliferation
Maturation of heomatopoeitic cells
Endothelial migration
IFN-gamma __ __ ? ? Decrease in eosinphil and Th2 cell numbers
Activation of epithelial and endothelial cells
Lower IgE levels
Scrape wound
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Nine mediators were identified to be secreted in our wounded HBEC model in
vitro, with some being elevated after injury, as shown in Table 4-18. These will
now be discussed below in turn.
4.5.1 Interleukin 6 (IL-6)
The pro-inflammatory and anti-inflammatory cytokine, IL-6, has been observed to
be 30-fold higher in supernatants collected from asthmatic children epithelial cell
cultures compared to non asthmatic subjects (Kicic, Sutanto, Stevens et al. 2006),
suggesting that despite the lack of inflammatory stimuli, epithelial cells of
asthmatic patients appear to be producing higher levels of this anti-inflammatory
mediator. It has also been previously shown that IL-6 release was higher in TNF-
Į-exposed primary human bronchial epithelial cells extracted from COPD
patients, at 6, 24, and 48 hrs post-treatment (Patel, Roberts, Lloyd-Owen et al.
2003). In the studies described in this thesis, scrape-wounded HBEC cells
produced potentially higher levels of IL-6 compared to uninjured cultures
especially at 72 hrs post-wounding (Table 4-4). A hint of increase was also seen
in IL-6 mRNA expression in wounded cultures correlating positively with the
protein level. On the other hand, IL-6 could have been preformed and the increase
in protein may not have been due to increased transcription of the IL-6 gene, or
there might have been altered breakdown of IL-6 by the cells following
wounding.
IL-6 is involved in T cell and B cell growth, as well as induction of IgE
production (DiCosmo, Picarella and Flavell 1994), all of which are features of
airway inflammation. This could in theory be manipulated by blocking IL-6
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pathways, which could potentially reduce the inflammatory response seen in
asthma and COPD.
4.5.2 Interleukin 8 (IL-8)
A number of cell types present in the asthmatic airways including epithelial cells,
are thought to produce the chemokine IL-8. IL-8 has been reported to be elevated
in the airway epithelium from asthmatic patients compared to normal bronchial
epithelium (Marshall, Perks, Ferkol et al. 2001) (Marini, Vittori, Hollemborg et
al. 1992). However, in one study by Kicic et. al., IL-8 levels were determined in
supernatants collected from epithelial cell culture supernatants from asthma (n=7)
and non-asthma (n=12) patients. There was no difference between IL-8 levels
compared to normal subjects (Kicic, Sutanto, Stevens et al. 2006). In epithelial
cells extracted from COPD patients, cultured, and stimulated with TNF-Į, IL-8
secretion was observed to be higher at 6 and 24 hrs post-treatment compared to
unstimulated cultures, and higher IL-8 production was seen in epithelial cells
obtained from COPD patients compared to normal subject(Patel, Roberts, Lloyd-
Owen et al. 2003). IL-8 gene expression and release by bronchial epithelium was
also higher in human bronchial epithelial cells exposed to cigarette smoke (a risk
factor of COPD) in a concentration and time-dependant pattern (Mio, Romberger,
Thompson et al. 1997). IL-8 plays an important role in inflammation by attracting
neutrophils to the site of infection or inflammation, as seen in asthma and COPD
(Nocker, Schoonbrood, van de Graaf et al. 1996). In addition, IL-8 is thought to
have growth factor properties and might have a potential involvement in airway
epithelial wound repair. In an attempt to study the cellular and molecular
mechanisms during events of airway epithelial reconstitution, there was an
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increase in IL-8 expression during cell migration and proliferation steps and a
progressive decrease during airway epithelial differentiation (Coraux, Hajj,
Lesimple et al. 2005).
Interestingly, following scrape-wounding human bronchial epithelial cells grown
at ALI, IL-8 levels in supernatants appear to be higher at 72 hrs post-wounding in
wounded cultures in both donors used. As for the IL-8 mRNA expression, again
the variability was high between the samples during the course of the experiment,
but there was a trend towards increased mRNA expression by 24 hrs post-
wounding in wounded cultures. In conclusion, therefore, there is a suggestion that
IL-8 may be elevated post-wounding. But it’s involvement in wound repair of the
HBEC model remains to be investigated.
4.5.3 Epithelial-neutrophil activating peptide 78 (ENA-78)
In addition, ENA-78 secretion was observed to be increased in our wounded
HBEC model compared to unwounded cultures, especially at 72 hrs post-
wounding. ENA-78 mRNA levels were also seen to be elevated in the wounded
cultures at 24 hrs compared to normal cultures. The protein and gene expression
of the neutrophil chemokine ENA-78 has been observed to be 3-fold increased in
bronchial epithelium treated with Rhinovirus, and therefore it is thought to play a
role in virus induced inflammation in the airways (Donninger, Glashoff, Haitchi
et al. 2003). Epithelial ENA-78 expression by asthmatic subjects was observed to
be higher than non asthma subject controls when exposed to ozone (Bosson J.
2003). This increase could explain in part the neutrophilia that is seen in some
patients with asthma. Moreover, ENA-78 is a monocyte chemoattractant, and may
be important in sustaining airway inflammation through monocyte recruitment,
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further implicating its role in the pathology of airway disease (Kawaguchi,
Kokubu, Matsukura et al. 2003). ENA-78 has also been thought to be an pro-
angiogenic factor possibly contribute to the high angiogenic activity seen in
idiopathic pulmonary fibrosis (IPF) patients (Thannickal, Toews, White et al.
2004).
4.5.4 Regulated upon activation, normal T-cell expressed, and secreted
(RANTES)
RANTES is a chemokine for eosinophils, T cells, and monocytes/macrophages.
Production of RANTES was observed to be higher in differentiated HBEC
cultures when wounded compared to unwounded cells. When RANTES mRNA
levels were previously examined in patients with mild asthma, no difference was
seen compared to normal patients, although RANTES was seen to be
constitutively expressed in airways by epithelial cells, smooth muscle cells, and
sub-epithelial cells (Berkman, Krishnan, Gilbey et al. 1996). However, RANTES
mRNA expression was 5-fold elevated in patients with chronic bronchitis
compared to healthy non-smoking subjects, with strong expression in the
epithelium and sub-epithelium compartments (Zhu, Qiu, Majumdar et al. 2001).
4.5.5 Interleukin 1ȕ (IL-1ȕ)
IL-1ȕ is a pro-inflammatory cytokine involved in the activation of macrophages
and epithelial cells, and may play an important protective role against
inflammation. Its expression was seen to be elevated in bronchial epithelium of
asthma patients correlating with the number of IL-1ȕ producing macrophages
(Sousa, Lane, Nakhosteen et al. 1996). However, when the amount of IL-1ȕ was
measured from supernatants from asthmatic children human bronchial epithelial
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cell cultures, similar amounts were observed compared to normal epithelial
cultures (Kicic, Sutanto, Stevens et al. 2006). IL-1ȕ secretion was also seen to be
elevated by the epithelium, 24 hrs after exposure to cigarette smoke in COPD
patients compared to healthy never smoker subjects (250.0% mean increase and
383.3%, respectively) (Rusznak, Mills, Devalia et al. 2000). IL-1ȕ levels, when
measured in our HBEC wounded cultures, showed a an increase compared to
uninjured cultures, although the concentration levels were relatively low in all
conditions.
4.5.6 Macrophage inflammatory protein 1ȕ (MIP-1ȕ)
The macrophage and T lymphocyte chemoatractant, MIP-1ȕ, is said to be
produced by a number of cell types including the bronchial epithelium. In one
study, MIP-1ȕ levels in the broncheoalveolar lavage fluid (BALF) of 12 smokers
affected by chronic bronchitis and 14 smoking, 15 non-smoking and six ex-
smoking healthy subjects, were investigated. Significantly higher levels were seen
in patients with chronic bronchitis compared to smokers, non-smokers, or ex-
smoker subjects (Capelli, Di Stefano, Gnemmi et al. 1999). The studies on MIP-
1ȕ to date are limited since this chemokine has rarely been associated with
disease, and thus its role in inflammatory disease remains to be clarified. In our
differentiated HBEC cultures, MIP-1ȕ was only detected in donor 2 in our
studies. A possible increase could be observed in the scrape-wounded cultures
compared to unwounded cells at 72 hrs post-wounding in these samples where it
could be detected, but the significance remains unclear.
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4.5.7 Granulocyte colony stimulating factor (G-CSF)
The colony stimulating factor hormone G-CSF that stimulates the bone marrow to
produce granulocytes and stem cells (Petit, Szyper-Kravitz, Nagler et al. 2002),
did show higher levels in supernatant collected from scrape-wounded
differentiated HBEC compared to unwounded cells especially at 72 hrs post-
wounding. Significant increase, however, was observed at the mRNA level. G-
CSF expression by epithelial cells exposed to bacterial infection has been thought
to prolong polymorphonuclear leukocytes (PMN) survival by delaying apoptosis.
This is thought to be particularly important in the inflammation observed in cystic
fibrosis (Saba, Soong, Greenberg et al. 2002). GM-CSF is thought to be more
involved in airway inflammatory diseases rather than G-CSF, and especially in
asthma, where it plays a role in eosinophil activation and growth; however it was
not detected in our scrape-wounded HBEC cultures. Higher levels of GM CSF in
supernatants collected from asthmatic epithelial cells was observed to be elevated
when compared to normal samples (0.88 ± 0.09 vs. 0.21 ± 0.105 (SD) ng/5 x 10
5
cells). An increase in GM CSF mRNA from asthmatic epithelial was also
observed in the same study compared to normal samples (Soloperto, Mattoso,
Fasoli et al. 1991), suggesting a possible role in eosinophil infiltration and
activation in asthmatic airways. Another study confirmed these results when
epithelial cells from asthma patients were obtained by brushings and investigated
through their expression of GM-CSF. A higher percentage of cells compared to
normal epithelial cells (39% vs. 0% respectively) (Vachier, Chiappara, Vignola et
al. 1998) were observed to be expressing GM-CSF. However, in the experiments
described in this thesis, we were unable to detect GM-CSF production by airway
epithelium. The reasons for this remains unclear but could be partly explained
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either as technical errors during the course of the assay or GM-CSF expression
requires a more complex inflammatory environment than our HBEC scrape-
wound model can provide.
4.5.8 Interferon-inducible protein 10 (IP-10)
Although chemokine IP-10 was seen to be expressed by HBEC grown at ALI, no
clear difference was observed between scrape-wounded cultures compared to
normal unwounded cells in our current study. IP-10 is known to be produced by a
number of cell types, particularly epithelial cells (Sauty, Dziejman, Taha et al.
1999). It acts as a chemoattractant for Th1 and natural killer cells. Increased
levels of IP-10 have been observed in both COPD (Saetta, Mariani, Panina-
Bordignon et al. 2002) and asthma (Miotto, Christodoulopoulos, Olivenstein et al.
2001). In an attempt to take this finding forward, Spurrell et. al. infected primary
human epithelial cells with human rhinovirus type 16 (HRV-16), and observed an
increase in IP-10 levels in collected supernatants (Spurrell, Wiehler, Zaheer et al.
2005). Rhinovirus type 16 (HRV-16) infections trigger exacerbations of both
asthma and COPD (Spurrell, Wiehler, Zaheer et al. 2005).
4.5.9 Vascular endothelial growth factor (VEGF)
A slight increase was seen in the expression of VEGF in our wounded and
unwounded HBEC in vitro at 48 hrs post-wounding. But there was a very high
concentration being produced by HBEC in general and thus the values were
above the limit of detection. However, VEGF is thought to be overproduced by
the epithelium in asthmatic subjects activated with Th2 driven inflammation,
leading to leukocyte accumulation, causing angiogenesis and leakage, goblet cell
metaplasia, and myocyte hyperplasia, causing tissue remodelling (Rothenberg
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2004). VEGF has also been shown to be up-regulated in Th1-associated states
(such as COPD), albeit at lower levels. However, in another study, serum VEGF
levels were the same in samples from COPD and normal patients (Cheng, Wang,
Yu et al. 2008).
4.5.10 Other undetected cytokines
On the other hand, some of the cytokines, previously thought to be epithelial
derived and overproduced in asthma and COPD, were below the detection range
in our cultures or were very close to the concentration seen in the negative control
sample. This could be explained in several ways. First, epithelial cells do not
produce these mediators at all in differentiated cell cultures. Secondly, physical
wounding did not prove to be a relevant stimulus, and these mediators need
another stimulus to be produced such as interaction with inhaled irritants. Finally,
it is possible that there is a need for inflammatory cells to be present in order to
stimulate the epithelial cells to produce these mediators. The model used portrays
the involvement and response of only the epithelial cells in isolation. Examples of
such cytokines are MCP-1, eotaxin an TNF-Į.
MCP-1 has been shown previously to be present in asthmatic epithelium (Folkard,
Westwick and Millar 1997), whereas 1.5-fold higher levels of MCP-1 were seen
in epithelial cells from COPD patients, recruiting mast cells and macrophages into
the epithelium (Capelli, Di Stefano, Gnemmi et al. 1999). Another important
factor with a role in asthma and COPD is TNF-Į, thought to be mostly produced
by macrophages and epithelial cells (Devalia, Campbell, Sapsford et al. 1993),
whereas TNF-ȕ is mainly produced by activated lymphocytes. Higher levels of
TNF-Į from epithelial cells in asthma have been previously reported in human
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lung (Ohkawara Y 1992). Eotaxin was another cytokine not detected in our
differentiate HBEC cultures, contrary to previous findings in asthma and COPD.
Eotaxin protein and mRNA expression was seen in the airways of asthmatics,
mainly in the epithelium (Mattoli, Stacey, Sun et al. 1997) suggesting its role in
eosinophil recruitment in asthma, but also in T lymphocytes, macrophages and
eosinophils.
To conclude, the epithelium has been previously suggested to be a target and
source of release of a number of inflammatory cell mediators and cytokines. This
suggests a role for the airway epithelium in the inflammatory changes seen in a
number of airway diseases including asthma and COPD. Investigation of the
secretory profile of human bronchial epithelial cell (HBEC) wound repair model
provided a clear profile for mediators produced in this in vitro model, and allowed
assessment of the effect of wounding on the epithelial derived cytokine profile.
Although this physical wound might be different than the damage occurring in
asthma and COPD, further research to determine if modifying the epithelial
response to this mechanical wound, or carrying out functional repair studies by
targeting some of the cytokines involved above, or possibly using co-culture
models, would be of value in evaluating inflammatory airway responses.
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Chapter 5. Identification of Potential Airway Epithelial
Cell Progenitors
5.1 Introduction
In the last two chapters, I described some of the key mechanisms underlying the
control of repair of wounded epithelial cells in the human airway. These processes
potentially involve a population of resident stem cells in the airway, as discussed
in Chapter 1 and Chapter 3, and as in other adult organs(Weiss, Berberich, Borok
et al. 2006). Stem cells can be defined as multipotent undifferentiated cells able to
reconstitute the various tissues of an organ, depending on where they reside. Stem
cells give rise to transient amplifying (TA) cells with self renewal and
regenerative characteristics (Figure 1-5). In the lung, both basal cells and variant
Clara cells present in neuroepithelial bodies, are thought to function as the stem
cell population (Engelhardt 2001), (Hong, Reynolds and Giangreco 2001). More
recently, ‘side population’ cells, characterised by their ability to efflux Hoechst
dye, have been identified in the lung. This population of cells is thought to
contain a primitive stem cell population (Summer, Kotton, Sun et al. 2003) with
mesenchymal and epithelial phenotypes. However, to date, no single lung stem
cell has been fully characterised with the ability to give rise to the full range of
epithelial lineages. It is also thought that local regional niches regulate the
phenotype and expansion of stem cells. Distinct sub populations of the
epithelium, thought to acquire ‘stemness’, are discussed in the following sections.
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5.1.1 Clonogenic potential of the airway epithelial cells
The lung contains a diverse number of cell types, and as discussed earlier, a
number of in vivo and in vitro models have been developed to facilitate the
investigation and identification of stem cells. One method of studying the putative
airway epithelial stem cell populations is the in vitro colony forming efficiency
(CFE) assay, developed by Randell et. al. (Randell 1992). This method was
adapted from a tracheal xenograft model with recombinant retroviral markers
used to assess the clonal expansion of airway epithelial cells (Zepeda, Chinoy and
Wilson 1995) (Engelhardt, Schlossberg, Yankaskas et al. 1995). One
disadvantage of the CFE in vitro model is less efficient differentiation, than that
which is seen in vivo, but it was used primarily to asses the proliferative potential
of stem or progenitor cell populations and not the progenitor-progeny relationship
in the airway epithelium. The CFU assay index was used by Schoch and
colleagues to evaluate the clonal growth potential of murine tracheal epithelial
cells (Schoch, Lori and Burns 2004). Briefly, a single cell suspension of mouse
tracheal epithelial cells was derived from ȕ-galactosidase-expressing ROSA26
mice into non-ROSA26 tracheal epithelial cells and then grown at air liquid
interface (ALI) for 3 weeks. X-Gal staining revealed ROSA26 LacZ-positive
colonies within the airway epithelium, indicating a population of cells with
progenitor capabilities resides in the basal layer. 1.7% of the epithelial cells
formed colonies of different sizes, demonstrating high proliferative capacity and
suggesting this subset may be good candidates for a stem or TA cell population.
Many attempts have been carried out to try and identify the progeny-progenitor
relationship, and to study the different epithelial cell types in the mouse trachea
responsible for reconstituting a pseudostratified epithelium following damage.
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One such method is to isolate and purify various rat tracheal epithelial cell types,
inoculating them into denuded rat tracheas which are then subcutaneously grafted
onto the backs of immunodeficient mice (Hook, Brody, Cameron et al. 1987). It
was observed that purified Clara cells could reconstitute an epithelium similar to
the bronchiolar epithelium in native rat tracheas, while a mixed population of
tracheal cell types could generate a mucociliary epithelium resembling the
pseudostratified tracheal lining seen in normal conditions in vivo.
5.1.2 A distinct ‘side population’ resides in the lung
In 1996, Goodell et. al. used the vital DNA binding dye, bisBenzimide H
trihydrochloride (Hoechst) 33342 (Arndt-Jovin and Jovin 1977), to identify and
isolate replicating and quiescent cell populations from murine bone marrow in
order to study hematopoietic stem cells (HSC) (Goodell, Brose, Paradis et al.
1996). While experimenting with staining the murine bone marrow cells using the
vital dye, Hoechst 33342, a complex fluorescence pattern of Hoechst staining was
observed in the whole bone marrow, where Hoechst fluorescence was detected by
simultaneous monitoring at two emission wavelengths (Hoechst blue versus
Hoechst red). A small subset of cells (named the side population (SP)), with low
fluorescent intensity according to the above dual wavelength, was isolated,
containing murine HSC surface markers (stem cell antigen (Sca)-1). Their HSC
activity was 1000 fold increased compared to other cells present (as determined in
repopulation experiments), and by measures of enrichment (CFU index). It was
concluded that this distinct pattern of staining was due to high and rapid Hoechst
efflux mediated by ABCG2, which is blocked by the voltage dependant calcium
channel inhibitor verapamil (Figure 5-1). This was the first use of a single dye to
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define a stem cell population. Subsequently, similar studies in human adult bone
marrow, umbilical cord blood and porcine bone marrow using Hoechst 33342
produced very similar results to those observed with murine bone marrow.
Side population identification has proven important in studies in stem cell biology
of renewing tissues, including the lung, since there is a lack of surface stem cell
markers to date which accurately define this cell population. SP have been
identified in a number of other tissues including human and murine mammary
epithelial cells (Alvi, Clayton, Joshi et al. 2003), rabbit limbal epithelial cells
(Umemoto, Yamato, Nishida et al. 2006), human epidermal keratinocytes
(Terunuma, Jackson, Kapoor et al. 2003), mice lungs (Summer, Kotton, Sun et al.
2004), mice airway epithelium (Giangreco, Shen and Reynolds 2004), and human
tracheobronchial epithelium (Hackett, Shaheen, Johnson et al. 2008).
Figure 5-1: Murine bone marrow side population.
(A) shows the Hoechst efflux side population ( red circle) which was inhibited by verapamil in (B)
accounting for 0.1% of the total population. Taken from (Goodell, Brose, Paradis et al. 1996).
Cells with a SP phenotype were identified in the adult mouse lung by Summer et.
al. Enzyme digested mouse lung suspension was stained with Hoechst 33342 dye
before flow cytometry analysis, and a SP representing 0.03-0.07% of all cells was
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present: the efflux was inhibited by verapamil (Summer, Kotton, Sun et al. 2003).
To examine the additional phenotypic characteristics of this SP, various
antibodies were also used to stain the cells after Hoechst incubation. It was
observed that the SP was heterogeneous consisting of 65-75% CD45-positive
cells (an HSC marker): these cells co-expressed the endothelial marker CD31.
However, the CD45-positive and C45-negative populations expressed Sca-1. To
further characterise the origin of the SP, an antibody against Į-smooth muscle
actin (Į-SMA) was used to immunostain the SP, but no detected expression was
observed. Giangreco et. al. then investigated the hypothesis that intrapulmonary
conducting airways contain a verapamil-sensitive Hoechst-effluxing population
that is enriched with lung-specific epithelial stem cells (Giangreco, Shen and
Reynolds 2004). Enzyme-dissociated mouse lung cell suspensions contained a SP
comprising 0.09% of CD45-positive cells and 0.87% CD45-negative population.
CD45-negative SP cells were also positive for stem cell antigen (Sca)-1. CD45 is
a transmembrane protein present on all known differentiated haematopoietic cells
except for erythrocytes and plasma cells, and is considered as a reliable HSC
marker.
Bone marrow SP contains 60–70% CD45-positive cells and 30–40% CD45–
negative cells (Liang, Summer, Sun et al. 2005). It was concluded that the CD45-
negative lung SP includes two populations: one with mesenchymal
characteristics, and another with airway epithelial characteristics (shown by
positive staining with an antibody against clara cell secretory protein, CCSP).
Summer et. al. then set out to examine the origin of the lung SP cells and
characterise the difference between the CD45-negative and CD-45 positive
subsets. They showed that these two distinct subsets have different roles in lung
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tissue homeostasis (Summer, Kotton, Sun et al. 2004). SP, comprising 0.09% of
cells and containing both CD45-negative and CD-45 positive cells, were
identified where most of the former was seen to be derived from the host
pulmonary tissues and the latter originated from bone marrow. They also showed
that the CD45-positive lung SP cells were cytokeratin positive/Į-SMA positive
while CD45-negative SP cells were cytokeratin negative but Į-SMA positive.
More recently, in an attempt to identify and isolate SP cells from human
tracheobronchial epithelium, it was found that CD45-negative SP cells comprised
0.12% of the total epithelial population in normal lung but 0.4% of the epithelium
from asthmatic subjects, providing evidence of a dysregulated epithelium in
asthmatics and suggesting a role for progenitor cells, if not stem cells, in repair
mechanisms in the asthmatic epithelium (Hackett, Shaheen, Johnson et al. 2008).
Moreover, these investigators observed that a very small number (< 100) of
CD45-negative SP was sufficient to proliferate and differentiate into a
pseudostratified epithelium when grown in vitro at ALI, compared to the need for
up to 5 x 10
6
non-SP cells to form the differentiated multi-layer in culture. It is
also worth noting that the Hoechst-effluxing SP has been shown to be an enriched
source of lung tumour-initiating cells with stem cell properties (Ho, Ng, Lam et
al. 2007).
5.1.3 How and why do these cells efflux Hoechst 33342 dye ?
Now that it has been determined that SP have the ability to efflux the DNA
binding dye, Hoechst 33345, at a greater rate than other cell types in the tissue, it
is necessary to understand what initiates this efflux.
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Hoechst 33342 stain has been used as an index of DNA content and chromatin
conformation (Arndt-Jovin and Jovin 1977), and it binds to the A-T regions of the
minor groove (Lalande and Miller 1979). The ability of Hoechst dye efflux to be
used as a stem cell isolation method resides in the ability of the dye to be effluxed
by the ATP-binding cassette (ABC) transporter superfamily, in particular the
multidrug resistance 1 (MDR1) and breast cancer resistance protein 1 (Bcrp1),
also referred to as ABCG2 (Zhou, Schuetz, Bunting et al. 2001). The ABCG2
gene was first isolated from human tumour cell lines and has been shown to play
a role in drug resistance. It has also been noted that the activity of this membrane
transporter is blocked by the calcium channel inhibitor, verapamil. When Zou et.
al. disrupted murine mdr1a and mdr1b genes (homologues of the human MDR1),
they saw no difference in the SP cell number, whilst the expression of ABCG2
was highly conserved in primitive stem cells from a variety of tissues (Zhou,
Schuetz, Bunting et al. 2001). This was further confirmed by observing a higher
number of Hoechst-effluxing SP cells when enforced expression of ABCG2 was
applied to bone-marrow cells, with the protein directly correlating to the SP
phenotype. (Maliepaard, van Gastelen, de Jong et al. 1999). ABCG2 expression
has been observed to be a widely conserved marker for Hoechst-dye-effluxing
stem cells (Zhou, Schuetz, Bunting et al. 2001).
Many possibilities have been suggested as to why SP use these efflux pumps. It
has been proposed that these pumps provide a protective function, since stem cells
reside in the adult body over a lifetime (Scharenberg, Harkey and Torok-Storb
2002). ABCG2 could help maintain and regulate these unique stem cells
(Bunting, Galipeau, Topham et al. 1998). Another possibility could be that
ABCG2 expression interferes with stem cell homing and thus leads to
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engraftment defects , possibly by conferring a toxic effect on stem-cell
metabolism leading to an increase in apoptosis, as well as influencing stem cell-
microenvironment interactions (Zhou, Schuetz, Bunting et al. 2001). However,
the mechanism of ABCG2 and its relation to SP cells remains to be determined.
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5.2 Objectives
The aim of the present study was to identify and if possible isolate distinct side
populations from human bronchial epithelial cells grown in vitro, either in an
undifferentiated or a differentiated (ALI) state. The approaches used included
single cell cloning, either using FACS or limited dilution cloning, and the FACS-
based Hoechst efflux method of SP isolation. Epithelial cell biopsies were
expanded in culture to compliment the use of commercially available epithelial
cells, and in order to establish a model to evaluate the comparison of diseased and
normal samples in the future. Single cell sorting was also carried out in order to
investigate the clonogenic potential of epithelial cells in vitro. This could be
useful in reaching a better level of understanding of stem cell populations using
an in vitro HBEC model, with the potential of studying diseased samples in this
context.
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5.3 Methods
Single cell sorting was carried out on undifferentiated HBEC at p3 following the
protocols in section 2.1.3, using either FACS or limited dilution. Digital images
were captured using a Nikon Diaphot epifluorescence microscope with a mercury
lamp with SPOTCam software.
The FACS-based Hoechst efflux method detailed in section 2.3 was carried out on
differentiated HBEC (p4) and undifferentiated HBEC (p3) from donor 1 only to
investigate SP. The SP sorting gate was established as follows: after collecting
around 250 000 events, a gate was defined using forward vs. side scatter to
exclude dead cells. Both Hoechst Red and Blue fluorescence were then shown on
a linear scale. A gate was defined around the SP which consisted of small cells
with the lowest fluorescence profile and which disappeared with the verapamil
control. When a verapamil control was not included, it was difficult to identify the
SP, however, a gate was put around the very smallest cells with low fluorescence
profile. Examples of the gates are shown in the results following this section.
Immunofluorescence techniques were employed as described in section 2.2.1 to
characterize the epithelial cells expanded from biopsies by investigating the
expression of CD44 and CCSP.
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5.4 Results
5.4.1 Isolated single human airway epithelial cells from undifferentiated
HBEC cultures do not have the ability to grow in vitro in the standard
culture environment
One characteristic of many stem cell populations is their ability to expand in
culture from a single cell. Therefore, single cell sorting of undifferentiated HBEC
was carried out using dilution cloning (section 2.1.3) and FACS, into 96-well
plates to assess the clonogenic and differentiation potential of individual cells.
Single cells were observed in some wells of the plates but did not survive long on
plastic in serum-free BEGM. After ten days, all cells were seen to be granulated
and dead. Wells were checked for cells usually 3 days after seeding, and then at
10 day intervals for formation of colonies. Figure 5-2 below is representative of 3
experiments using dilution cloning, and shows wells early after seeding (3 days),
and 10 days post-seeding. Attempts were also made to isolate single cells sorted
using FACS (n=3 plates) since it would be less time consuming, but the majority
of wells became infected early in the culture period due to the difficulty in
maintaining sterility following FACS, and hence this approach was not pursued.
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Figure 5-2: Epithelial single cell sorting using dilution cloning.
Images of random fields from 96-well plates showing a single cell 3 days post seeding (A, arrow)
and 10 days post-seeding (B, arrow), with no cell division occurring. In some wells following
dilution cloning, more than one cell was found (C): these wells were excluded from further
analysis. Most cells looked granulated and dead when left in culture for 10 days (D). These images
are representative of 3 experiments each performed in a single 96-well plate, Images are shown at
a magnification of x20.
5.4.2 Side population in undifferentiated HBEC
Given that with single cells isolated from growing undifferentiated cultures
(without first sorting into populations), enriching for a stem cell population failed
to give rise to clonal cultures, attempts were next made to determine if a side
population of cells was present, using the Hoechst-efflux method described
above. SP cells were identified on the basis of verapamil-sensitive Hoechst-efflux
p3 cell suspensions were incubated with 5 µg/ml Hoechst 33342 for 90 min (as
described in 2.3). In a total of seven experiments, SP cells were identified in
three, accounting for 0.05-1.15% of all cells present in these positive experiments.
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Figure 5-3 represents SP characteristics with inhibition by verapamil of Hoechst
efflux, in cultured undifferentiated HBEC.
Figure 5-3: FACS analysis of SP present in cultured undifferentiated HBEC at p3.
(A) shows a representative positive culture showing presence of SP, detected at dual wavelength
of Hoechst excitation and emission at 670/30-nm band pass and 450/65-nm band-pass filters.
Hoechst efflux was inhibited with verapamil (B). (C) is a negative example of cultures with no SP
where in (D) pre-treatment with verapamil was also carried out. Experiments were repeated 7
times with 3 positive cultures for SP.
Having demonstrated the presence of SP in at least some populations of primary
human airway epithelial cell cultures, attempts were then made to investigate
whether the number of SP cells was increased in response to injury in a single
experiment. Cultured undifferentiated HBEC were wounded (as described in
section 2.1.1.7) and then analysed for the presence of SP. In these wounded
cultures, a SP was identified and efflux was inhibited by both verapamil and
another ABCG2 inhibitor, Fumitremorgan C (FTC) (Rabindran, Ross, Doyle et
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al. 2000) (Figure 5-4), with 2-fold higher number compared to the unwounded
cultures (0.06% vs. 0.03% of total cells, respectively). However, for reasons
which are unclear, the potential SP in the unwounded cultures was inhibited by
FTC but not verapamil. Given the lack of a marked increase in the size of the SP
in the undifferentiated cultures despite wounding, I proceeded to try and
investigate this SP in differentiated epithelial cell cultures.
Figure 5-4: FACS analysis of SP in wounded undifferentiated HBEC.
(A) shows FACS analysis data for undifferentiated HBEC with 0.02% SP inhibited by only
fumitremorgin C but not verapamil. This SP was 4 fold higher in wounded undifferentiated HBEC
24 hrs post-wounding (B) accounting for 0.08% of total cells in culture and inhibited by both
verapamil and FTC. This experiment was carried out once.
5.4.3 SP in cultured differentiated HBEC grown at ALI
Since a SP was identified in some cultures of undifferentiated HBEC, the FACS-
based Hoechst-efflux method of stem cell purification was then carried out to try
and identify SP in differentiated HBEC cultures grown at ALI. This was repeated
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five times with a SP identified in one experiment comprising 0.14% SP. Figure
5-5 shows the identified SP where the efflux was inhibited by verapamil, and an
example of cultures that had no SP.
Figure 5-5: FACS analysis of SP in differentiated HBEC grown at ALI.
The SP was identified once out of five experiments, accounting for 0.14% of the cells present (A)
and was inhibited by verapamil (B). A representative negative result is presented where no SP was
seen (C) and with (D) pre-treatment with verapamil. Apparent cells gated in green (C+D) were
observed to be debris according to PI staining.
5.4.4 SP in epithelial cells expanded form lung biopsies
During the course of these studies, it was possible to perform FACS based
Hoechst efflux experiment using tracheal epithelial cells expanded from cells
isolated from bronchial biopsies from a normal individual. These biopsies were
carried out by Dr. Claudia Ceresa as described in section 2.1.2. After epithelial
cells were obtained in culture, they were characterised to determine the phenotype
of the cells. These expanded cells had an epithelial morphology in culture
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(Spindle-shaped cuboidal, Figure 5-6), and stained positive for basal and Clara
epithelial markers expression (CD44 and CCSP, Figure 5-7). Biopsy epithelial
cells characterisation was only carried out once since there were not sufficient
cells for repeat characterisations and FACS analysis of Hoechst dye efflux ability.
Figure 5-6: Brightfield images of epithelial cells grown from lung biospsies.
Both images show a cuboidal spindle-like epithelial phenotype. Random fields were captured at
10x and 20x magnifications.
Figure 5-7: Immunofluorescence images of epithelial cells expanded from lung biopsies.
(A) shows positive expression of CD44 (an epithelial basal cell marker, green), and (B) shows
positive expression of clara cell secretory protein (Clara cell marker, red). Images were taken at
x20 magnification and are representative of 4 random fields captured from the single cultured cell
population described.
Chapter 5 Identification of Potential Airway Epithelial Cell Progenitors
167
Hoechst-efflux analysis of SP was then carried out on the harvested cells at p1;
and a SP was identified accounting for 0.15% of all cells (Figure 5-8 A). Because
of the limited number of cells which could be expanded from this biopsy, it was
not possible to perform either the verapamil control or a repeat of the experiment
during the time course of this study. A further experiment was performed on cells
at a latter passage (p4) and again a SP was observed accounting for 0.04% of all
cells (Figure 5-8 B). By p4 sufficient cells were available to include a verapamil
control (Figure 5-8 B and C), and as would be expected, Hoechst exclusion was
inhibited by verapamil. As a preliminary conclusion, it seems therefore that SP
numbers are higher when the cells are expanded straight from biopsies than when
cultured for a few passages in culture, and this could explain why SP
identification in cultured HBEC using late passaged cells is less robust.
Figure 5-8: FACS analysis SP from epithelial cells derived from lung biopsies.
(A) shows FACS analysis data with 0.15% of SP from epithelial cells at passage 1 (no verapamil
control was carried out due to insufficient cell numbers). (B) shows a FACS analysis of SP
(0.04%) when the cells are passaged further (passage4), inhibited by verapamil (C, 0.01%).
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5.5 Discussion
This chapter describes a series of experiments where the identification of potential
progenitor cell populations, in human airway epithelial models, was attempted.
Epithelial single cell cloning was first carried out from commercially obtained
human bronchial epithelial cells (HBEC). However, it did not prove feasible to
expand these single cells in culture on plastic using serum free BEGM. The cells
looked granulated and were non-viable early after culture (10days) in all
experiments. Therefore, identification of a side population (SP) as previously
used in studies in other cell types was then pursued in order to look for the
presence of potential progenitor cells in this HBEC model.
A SP was identified in at least some cultures, accounting for 0.1-1% in
commercially purchased cultured HBEC (undifferentiated and differentiated at
ALI), and also in epithelial cell populations expanded from lung biopsies. It
proved very difficult to grow these SP cells in culture and maintain sterility of
FACS-separated cells, and on the two occasions where the isolation was
successful, infections were seen in resultant cultures.
As mentioned above, a SP was also seen in epithelial cells expanded from lung
biopsies, when passaged in vitro in culture media. Adequate number of cells to
perform FACS analysis was only obtained once since the supply of biopsies was
limited and the number of cells to start with was very low: in one other
experiment, epithelial cell cultures were obtained but expansion in culture was
inadequate to undertake FACS studies. Similar results have been recently reported
using human tracheobronchial epithelium, where SP investigation was done on
fresh cells isolated from transplant donor lungs by protease digestion, with 0.12%
Chapter 5 Identification of Potential Airway Epithelial Cell Progenitors
169
±0.01 SP present (Hackett, Shaheen, Johnson et al. 2008), similar to the SP
percentage observed in our cultures when it was present. Although these results
have to be considered preliminary in nature, they suggest that SP are present in
early cell culture but appear to decline in number with repeated cell passage.
The observation that epithelial cells could be isolated from biopsies and expanded
in culture is of interest and provides a potential model for future studies. These
epithelial cells from lung biopsies were characterised by the expression of the
basal cell marker CD44 and Clara cell marker CCSP. The cells were also
differentiated at ALI as described in chapter 2 and a multi-layered epithelium was
generated, where mucus production on the surface of cultures was observed. This
was carried out only once during the course of this study, since there were not
many biopsies available. However, this could be useful in the future to allow the
study of cells from different disease states such as asthma and COPD, by
comparing differentiation potential of disease and normal samples.
Technical limitations emerged during the course of these experiments; infections
were often seen in SP experiments and single cell cloning in the cultures early
post-seeding. Moreover, it proved difficult to carry out single cell manipulation of
epithelial cells using our culture conditions. Most previously published work to
investigate the clonogenic potential of epithelial cells was done in xenograft
animal models in vivo or using feeder cell layers (Hong, Reynolds and Watkins
2004) (Hitoshi Kitamura 1993). It may be worth trying these approaches, or using
a potentially suitable substratum such as collagen in the future.
The main value in identifying SP in biopsy derived cultures would be to allow the
study of progenitor cell biology in the context of disease. Moreover, SP has been
observed to be a more general feature of malignant disease than previously
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thought (Hirschmann-Jax, Foster, Wulf et al. 2004), (Ho, Ng, Lam et al. 2007),
and thus the approaches described here could provide a model for the further
understanding of lung cancer.
It has previously been observed when investigating SP activity that this
population is associated with the expression of stem cell antigen 1 (sca-1), for
example in mouse mammary gland (Welm, Tepera, Venezia et al. 2002), mouse
heart (Oh, Bradfute, Gallardo et al. 2003), and mouse liver (Bryon E. Petersen
2003). Sca-1 is an 18-kDa mouse glycosyl phosphatidylinositol-anchored cell
surface protein of the Ly6 gene family which has been associated with tissue-
resident stem and progenitor cells (Holmes and Stanford 2007). Sca-1 and SP
relationship has been reported in the lung (Summer, Kotton, Sun et al. 2003)
(Giangreco, Shen and Reynolds 2004), however, it was not seen to be present in
the airway epithelium or alveolar type II cells, both of which are suspected to
exhibit progenitor activity. On the other hand, sca-1
+
broncheoalveolar cells with
in vitro multilineage differentiation capacity have been isolated from murine lung
(Kim, Jackson and Woolfenden 2005). Although an ortholog for sca-1 has not yet
been identified in humans, the data identified in sca-1 null mice demonstrate a
number of important concepts in stem cell biology including: the association of
degenerative diseases and altered stem cell pool, the importance of stem cell
responses to tissue damage and maintenance. Thus identifying a human sca-1 and
understanding its function and pathways will potentially facilitate the
understanding and manipulation of resident stem/progenitor cell populations in
order to apply new therapies and regenerative medicine applications.
In summary, therefore, it appears that a SP is present in at least some culture
model systems of primary human airway epithelial cells. These cultures proved
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technically demanding to undertake, but with further development, this approach
holds considerable promise for the study of airway epithelial repair.
The SP has been identified in several other organs including the heart, limbal
epithelium. Cardiac SP have been identified in adult mouse heart with the ability
to efflux the Hoechst 33342 and expression of ABCG2, containing both
“vascular” and “non-vascular” cells; and were observed to differentiate into
cardiomyocyte-like cells with spontaneous contraction (Yamahara, Fukushima,
Coppen et al. 2008).
This could be implicated in myocardial regeneration and in the pathogenesis of
cardiac diseases. Moreover, a SP has also been identified in the human limbal
epithelium (0.2%), with the expression of ABCG2 in the limbal basal epithelial
cells, although they were not consistently distributed (Watanabe, Nishida, Yamato
et al. 2004). These SP findings could be exploited for new tissue engineering
approaches to try and reconstruct damaged surfaces, including the eye, heart, and
lung epithelium.
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Chapter 6. Summary and Conclusions
As the first contact with the outer environment, the airway epithelium is
constantly susceptible to damage from a wide range of inhaled toxins and
particles. As described in chapter 1, the airway epithelium has a number of
specific functions to ensure lung homeostasis either in health or under disease
conditions. In the studies described in this thesis, two main functions of the
airway epithelium were highlighted. First I concentrated on identifying the role of
resident epithelial stem/progenitor cells thought to be involved in wound healing
(described in chapter 3 and chapter 5 respectively). Secondly, I investigated the
potential role of these epithelial cells in regulating inflammation (discussed in
chapter 4). The main objective of this study was to reach a better understanding of
the role of epithelial cell involvement in wound repair. This is particularly
important given the observation that the epithelium is seen to be subject to
inappropriate repair cycles in a number of lung diseases for example, epithelial
dysfunction is considered to be a feature underlying asthma and COPD (Holgate
2008) (Puchelle, Zahm, Tournier et al. 2006).
6.1.1 Human bronchial epithelial cell (HBEC) wound repair model
As discussed in chapter 3, although a number of in vitro and in vivo models of
both human and animal airway epithelium have been developed over the years
(Table 3-1 and Table 3-2), relatively little is known about the control of airway
epithelium repair mechanisms, due in part to the complexity of the respiratory
tree, and the lack of appropriate models to mimic wound repair of the human
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airway epithelium in vitro. I adapted a human bronchial epithelial cell (HBEC)
model (Dupuit, Gaillard, Hinnrasky et al. 2000) to allow the study of repair
mechanisms following wounding. Initially, I characterised this model using
differentiation markers for the epithelial cell types present. HBEC were grown on
polyester porous membranes using specialised bronchial epithelial growth and
differentiation media. The cells were differentiated for three weeks at air liquid
interface (ALI). It was observed that the model contained basal, ciliated, and
secretory cells in vitro. Differentiated epithelia demonstrated mucus production
and ciliated cells expressed beating cilia, much like the airway epithelium in vivo
(see section 3.4.1). Having established a multi-cellular functional epithelium in
vitro, epithelial disruption was studied by scrape wounding the cell layer using a
sterile p200 pipette tip, to mimic the epithelial dysfunction that might occur in the
adult body during daily exposure to inhaled toxins and pathogens resulting in
epithelial desquamation, as well as the damage seen to the epithelium in
respiratory diseases such as asthma and COPD. The scrape-wound was monitored
in vitro in both undifferentiated and differentiated HBEC by measuring the wound
area over a 48 hrs time period. It was observed that differentiated HBEC repaired
more rapidly than undifferentiated cells. By 20 hrs post-wounding, the wound was
completely healed in all differentiated cultures, whereas the wound was 87%
healed in undifferentiated cells by 48 hrs post-wounding (see section 3.4.2).
These studies were followed by the investigation of the underlying wound repair
mechanism in this model. It has previously been shown that dedifferentiation and
migration of cells are the first events that take place after injury, followed by
proliferation of new cells to compromise for the loss of cells, then de-
differentiation and re-epithelisation (Puchelle 2000). It has also been previously
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observed that migration does occur shortly after injury in this HBEC model; this
was apparent both by light microscopy and also by studies where lamellopedia
were seen at the edge of cells migrating to close the wound (Wadsworth, Nijmeh
and Hall 2006). This migration is a separate event from proliferation where the
latter occurred at a distant site from the wound edge. In the studies described in
this thesis, proliferation was monitored using the marker Ki-67. It was observed
that the number of Ki-67 positive cells was significantly higher in differentiated
wounded HBEC compared to unwounded cells at 24 hrs post-wounding,
suggesting an increase in proliferation at that time point after injury, which was
after the wound was completely healed (section 0). Interestingly, this was not the
case with undifferentiated wounded and unwounded HBEC, where no significant
difference was seen between both. The explanation for this is unclear but may be
due to the lack of relevant pro-proliferative features released by differentiated but
not undifferentiated cell types. Moreover, slower rates of proliferation/migration
in the undifferentiated model (as seen by the delayed wound closure as well),
might be another reason for the described observation. It was also observed that
Ki-67 positive cell numbers were significantly higher in wounded cultures at 0hrs
post-wounding compared to unwounded cells. The reason remains unclear and
needs further investigation.
It was important to then move on and address which cell types might be involved
in this wound repair mechanism. It has previously been proven that resident stem
or progenitor cells are involved in repair events of the respiratory epithelium
(Emura 1997). The cells classically suspected to be the stem or progenitor cells
are basal and mucus-secretory cells of the trachea and bronchi, Clara cells of the
bronchioles, and alveolar type II cells in the alveoli (Otto 2002) (Bishop 2004). In
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this differentiated HBEC model, cells were immunofluorescently stained with Ki-
67 and a number of epithelial-cell specific markers, to try and identify which cell
type(s) are proliferating after injury. Immediately after wounding (0-4 hrs), an
increase in CD44 staining was seen at wound edges compared to the rest of the
layer (section 3.4.4). Moreover, all Ki-67 positive cells were also CD44 and
CK14 positive and were seen to be present in the basal layer. As CD44 and CK14
are markers for basal cells, this provided strong evidence that basal cells contain
the subpopulation of progenitor cells responsible for re-epithelisation (section
3.4.4). Interestingly, CD44 has previously been seen to be increased in the airway
epithelium of subjects suffering from asthma (Leir, Baker, Holgate et al. 2000),
suggesting a role for CD44 in disease pathology. When images of the Clara cell
marker CC-26 were captured, the positive cells (i.e. secretory cells) were not the
same as the cells seen to be proliferating following wounding; these cells were
seen (as would be expected) to localize to the apical layer of the surface (section
3.4.4). On the other hand, previous findings (at least in this HBEC model) showed
ciliated cells to be responsible for wound repair of murine airway epithelium
(Park, Wells, Zorn et al. 2006). After mice were treated with naphthalene
(resulting in selective injury of non-ciliated cells), it was observed that ciliated
cells were capable of remarkable plasticity, and were responsible for the repair of
the bronchial epithelium. When CD44 mRNA relative expression was measured
post-wounding from HBEC cDNA, no significant difference was evident between
wounded and unwounded cells, which suggests that the increase in CD44 staining
was not due to new synthesis of the protein (section 3.4.5).
Although the data presented in this thesis all relate to using the HBEC wound
model to study repair of the acute wound, it has also proven possible to repeatedly
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injur the epithelium in vitro, mimicking a chronic wound such as the damage seen
in asthma and COPD, following repeated inflammatory insults (Wadsworth,
Nijmeh and Hall 2006).
6.1.2 Secretory profile of wounded human bronchial epithelial cells
(HBEC)
Wound healing is a complex process, but what is known thus far is that it involves
the three overlapping events of an inflammatory reaction, proliferation, and
remodelling. The clinical conditions, asthma and COPD, both involve a disruption
of these three processes (discussed in more detail in sections 1.2.1.1 and 1.2.1.2).
In COPD, both inflammation and structural changes have been observed in small
airways and lung parenchyma, contributing to the development of airway
obstruction. Increased release of pro-inflammatory mediators has been seen in the
lungs of patients with COPD. Infiltration of the small airway wall by CD8
+
and
CD68
+
T cells takes place, as well as an increase in macrophages in airway and
alveolar lumen (Saetta, Di Stefano, Turato et al. 1998). This leads to fibrosis and
emphysema, thickening of the airway wall, luminal narrowing, and an increase in
smooth muscle mass (Kuwano, Bosken, Pare et al. 1993), which are all present in
some COPD patient’s airways. Similarly, infiltration of CD4
+
Th2 cells and
eosinophils has been demonstrated in the small airways and surrounding alveolar
walls of patients suffering from asthma (Hamid, Song, Kotsimbos et al. 1997). As
well as inflammation, asthma is characterized by mucous metaplasia, an increase
of wall thickness (due in part to increase in mass of smooth muscle cells)
especially in the large airways (Carroll, Elliot, Morton et al. 1993), and an
increase in the thickness of the reticular basement membrane. One of the major
roles of the epithelium is the production of a wide range of cytokines and other
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mediators including chemokines and growth factors. In airway disease however,
inappropriate secretion of certain cytokines and chemokines by epithelial cells of
subjects suffering from asthma and COPD can be seen (reviewed in (Chung,
Barnes. 1999) (Chung 2001)). Thus, inappropriate activation and recruitment of a
number of inflammatory cells such as neutrophils and eosinophils takes place to
the epithelial layer, resulting in a cycle of inflammatory cell recruitment and
airway damage.
The secretory profile of the wounded HBEC model was investigated in this study
in two ways. Initial experiments concentrated on measurement of a number of key
cytokines and chemokines involved in airway diseases in supernatants collected
from the in vitro HBEC model where two donors were used. Secondly the relative
expression of mRNA for the cytokines and chemokines that were of interest at the
protein level was assessed. The results are discussed in detail in section 4.4.1 and
4.5. Briefly, it was observed that IL-6, IL-8, ENA-78, G-CSF, RANTES, IL-1ȕ,
and MIP-1ȕ secretions were increased in wounded HBEC cultures especially at
72 hrs post-wounding. This was reflected at the mRNA level for IL-6, IL-8, ENA-
78, and G-CSF potentially at 24 hrs post-wounding. Finally, no clear difference
was seen in IP-10 secretion between wounded and unwounded HBEC. A
comparison of the epithelial cytokine secretion in asthma, COPD, and this HBEC
wound model is presented in Table 4-18.
Interestingly, IL-8 and ENA-78 are key chemokines for neutrophils (Engelhardt,
Toksoy, Goebeler et al. 1998). An increased concentration of IL-8 as well as the
number of neutrophils have been observed in the sputum of patients suffering
from COPD compared to normal and asthmatic subjects (Keatings, Collins, Scott
et al. 1996) (Yamamoto, Yoneda, Yoshikawa et al. 1997). IL-8 has also been
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observed to be secreted by epithelial cells, attracting neutrophils which in turn
produce neutrophil elastase. Neutrophil elastase induces IL-8 gene expression by
epithelial cells (Nakamura, Yoshimura, McElvaney et al. 1992), leading to an
‘inflammatory cycle’ which may in part participate in the airway obstruction in
both asthma and COPD. IL-6 is also involved in inflammation, in part via
inducing an increase in circulating neutrophil numbers, (Benjamini E. 2000). IL-6
has also been observed to be produced by epithelial cells (Stadnyk 1994) and has
been observed to be elevated in sputum from patients with frequent exacerbations
of COPD compared to those with stable disease (Bhowmik, Seemungal, Sapsford
et al. 2000).
Similarly asthma is characterised by eosinophilia and neutrophilia in the airways,
releasing mediators that cause bronchial epithelial damage and airway
obstruction. Eosinophils have been proven to have a central role in the
inflammation seen in asthmatic airways, with the number of eosinophils
correlating with the severity of the disease. However, this cell type has proven to
be insufficient by itself in explaining all the inflammation occurring in the
asthmatic airway (Macdowell and Peters 2007). Additionally, neutrophils may
play a role in the pathogenesis of asthma, but this remains controversial
Neutrophil numbers were not observed to be increased in biopsies obtained from
patients suffering from asthma compared to normal subjects (monitored by
neutrophil elastase positive cells (Azzawi, Bradley, Jeffery et al. 1990). On the
other hand, there is evidence suggesting that neutrophils are not only associated
with acute asthma exacerbations but are found to be present in high numbers in
the airways of patients suffering from chronic severe asthma (Sampson 2000). It
is likely that neutrophils are involved in wound healing, chronic inflammation,
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and the remodelling events seen in asthma (Wenzel 2001), however their overall
importance remains unclear. IL-8 also plays a role in asthma by attracting not
only neutrophils but also eosinophils to the epithelium, as observed in one study
where IL-8 was measured in the sputum of patients suffering from either COPD
or asthma (Yamamoto, Yoneda, Yoshikawa et al. 1997). Another eosinophil
chemoattractant is RANTES: Berkman and colleagues have observed an increase
in RANTES mRNA expression when they investigated bronchial biopsy and BAL
cells from patients with mild asthma (Berkman, Krishnan, Gilbey et al. 1996),
thus supporting a role for RANTES in normal and asthmatic airways.
In addition, the granulocyte colony-stimulating factor (G-CSF) is a survival factor
for granulocytes, promoting their growth (Benjamini E. 2000). G-CSF has been
observed to be produced by T cells and monocytes, as well as epithelial cells, and
it has been observed that induced expression of G-CSF by airway cells constantly
exposed to bacteria (as seen in cystic fibrosis (CF)) promoted the growth and
survival of leukocytes (Saba, Soong, Greenberg et al. 2002). G-CSF has been
particularly used in the past to treat neutropenia arising from for example
chemotherapy, via escalating the rate of natural growth of haematopoietic cell
lineages (Benjamini E. 2000).
Inflammation is a complex process initiated by tissue damage caused by a wide
range of factors. Asthmatic inflammation for example is induced at least in part
by allergens including airborne pollens, dust, viral and bacterial infections, as
well as various irritant chemicals. Shedding of the epithelial layer has also been
observed in some patients suffering from asthma (Goldie, Fernandes, Rigby et al.
1988). Thus, although the HBEC model investigated in this study, employed a
physical injury and is not a fully appropriate representation of asthma and COPD,
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the cytokines secreted by the epithelial cells correlated with the important factors
that have previously been seen in airway disease. This could be taken further by
exposure of the HBEC model to various other insults such as chemical injuries,
biologic injuries (e.g. infection by microorganisms), and immunologic injuries
(e.g. exposure to lipopolysaccharide(LPS)), followed by investigating the
secretory profile of the epithelium. Moreover, the HBEC model contains only
epithelial cells, and as described earlier, asthma and COPD are diseases involving
a range of cell types, characterised by complex events involving for example the
vascular endothelium, fibrocytes, and smooth muscle cells. This could be taken
further, however, by trying to attempt co-culture containing epithelial cultures
grown on inserts and monolayer cultures of for example airway myofibroblasts or
inflammatory cells.
6.1.3 Identification of Potential Airway Epithelial Cell Progenitors
In order to reach a better understanding of the epithelial progenitor cell
populations in airway repair, the in vitro HBEC wounding model was investigated
using single cell cloning, and a FACS-based method to attempt and isolate
putative progenitor/stem cells. Airway epithelial cells were also expanded from
lung biopsies in vitro, to assess their differentiation potential, and identify if a side
population (SP) was present. Single cell cloning failed to identify a true stem cell
population in our standard conditions. A SP was identified in some cultures
accounting for a small percentage of the total cells. These cells might be the
transient amplifying cells rather than the more primitive stem cells. To really be
sure this SP represented stem cells, one would want to show their ability to
expand and self-renew indefinitely in culture and exhibit further markers (such as
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the ability to differentiate into all epithelial cell lineages). However, this was
technically difficult to study and despite extensive attempts I was unable to clarify
these issues. The major difficulties encountered were as follows. First, it was very
difficult to keep the cultures free from infection at the times when the SP was
identified due to problems mainitaing sterility during cell handling with FACS.
Second, due to the very small percentage of the SP and the small number of cells
available from a single biopsy, it was difficult to generate sufficient cell numbers
perform all the studies one would ideally pursue. One possible solution for that is
trying to obtain bronchial brushings (where a high sufficient number of cells
could potentially be available) followed by isolation of SP and their ability for
expansion and differentiation. Finally, it is also possible that these cultures might
not actually contain true stem cells, and the re-epithelialisation seen in vivo could
be due to circulating stem cells as some previous reports have suggested
(discussed in section 1.3.2.2). Moreover, this injury model might not provide a
suitable stimulus for the stem cells to expand in culture: for example they may
require the presence of additional growth factors derived from other cell types
present in the airways but absent from the culture model.
The role of epithelial stem cells in the lung has been discussed in section 1.3.2,
and the cells classically thought to have stem cell properties are subpopulations of
basal cells, Clara cells, and alveolar type II cells. Two putative stem cell niches in
the bronchioles have been identified thus far (see Figure 1-7), albeit in mice
models where chemical injury by naphthalene was carried out. The first resided in
close proximity to neuroepithelial bodies (NEB). Proliferative populations were
found, expressing-CCSP and were termed variant CCSP-expressing Clara cells
(vCE) (Reynolds, Giangreco and Power 2000) (Reynolds, Hong and Giangreco
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2000). The second microenvironment seen to replace the naphthalene-depleted
Clara cells was observed to be located near the broncheoalveolar duct junction
(BADJ), where proliferative cells were present co-expressing CCSP and SPC
(alveolar type II marker) (Giangreco, Reynolds and Stripp 2002) (Hong, Reynolds
and Giangreco 2001). These were also seen to be positive for stem cell antigen-1
(Sca-1) and CD34. This led to the conclusion that those cells had the capacity to
differentiate into cell populations which could promote the epithelial elements in
both the bronchioles and alveoli, and these were therefore called
broncheoalveolar stem cells (BASC) (Kim, Jackson and Woolfenden 2005). Thus
far, however, there have not been any studies comparing the features of vCE and
BASC populations and hence the relationship between them remains uncertain.
A recent report by Hacket et. al. (Hackett, Shaheen, Johnson et al. 2008)
described a SP in human tracheobronchial epithelium with proliferative potential
and the ability to generate a differentiated epithelium in vitro. They also observed
a higher percentage of SP in asthmatic airways, potentially providing evidence
that the SP is altered during disease. These data suggest that the stem cell
population in asthmatic airways is expanded possibly to enable enhanced repair
following airway epithelial damage. The non-hematopoietic SP cells exhibited
epithelial cell markers: cytokeratin (CK)-5, E-cadherin, the tight junctional
protein ZO-1, tissue factor (TF), CD151, and p63, but were negative for the
mesenchymal marker vimentin. One future direction to study these questions
would be to try to differentiate epithelial cells obtained from bronchial biopsies
from normal or diseased patients and use these as model to characterise stem
cell/side population derived cells. These experiments will undoubtedly prove
technically difficult but with further development, this approach holds promise for
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the study of airway epithelial repair, especially if it proves possible to expand
epithelial cells from biopsies obtained from patients suffering from asthma and
COPD, after which comparison to normal samples could provide more in-sight
into the pathophysiology of these diseases.
The application and values of identifying stem cells in the lung and their potential
application in disease treatment was discussed in section 1.4. The concept that the
airway epithelium is maintained though multiple resident stem/progenitor cell
populations, suggests that a more in-depth knowledge of their behaviour in
normal and diseased states could shed light into understanding the mechanisms
behind common respiratory diseases. To achieve this, further work is required.
First, basic knowledge of the airway progenitor cell behaviour needs to be
obtained, followed by clearly defining the molecular signature of these cells and
their response to injury. Moreover, identifying a stem cell population in the lung
could prove useful in developing in vitro culture models (such as those used in the
studies described in this thesis). These models could be used to investigate the
mechanism of action of existing and novel therapies.
An interesting recent piece of work by investigators in Spain and the UK
described how they were able to produce a cellular, tissue-engineered airway with
normal properties and functions, and transplant it back to a patient with severe
bronchial/tracheal disease, without the risk of rejection (Macchiarini P. 2008).
Briefly, they were able to colonize recipient’s epithelial cells and chondrocyte
mesenchymal stem cells onto a donor matrix which was hence matched for HLA
expression. This matrix was used to prepare an airway graft and transplanted back
to the patient who was suffering from left main bronchus malacia. Interestingly,
the epithelial and chondrocytes were observed to be deeply embedded in the
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matrix by 24 hrs, suggesting the matrix provided an ideal environment for these
cells. 100% adherence was observed after 24 hrs, with the cells functioning
appropriately in vivo as well. These observations provide new evidence that
autologous cells and the use of appropriate matrices provide potential functional
solutions for serious clinical disorders.
These observations raise the question of whether or not the approaches described
in this thesis could be adapted for tissue regeneration approaches such as this. It is
likely that if it proves possible to isolate populations of airway epithelial cells
enriched for stem cells (perhaps from side population) this would facilitate this
kind of approach. At present, the need for manufactured airways such as this is
limited, being reserved for rare cases of tracheal or bronchial malacia, although
bronchial grafts could potentially be useful to manage bronchial stenosis (e.g.
such as these seen in some pulmonary vasculitis cases) or for reconstructive
surgery following tumour resection.
In summary, the in vitro differentiated human bronchial epithelial cell wounding
model described in this thesis should prove a valuable tool in the field of
respiratory research. Reaching a better understanding of airway epithelial injury
and repair mechanisms, both by defining the progenitor cell populations involved,
and the key cytokines secreted could lead to a better understanding of airway
diseases, and provide models for potential therapeutic applications in regenerative
medicine, tissue engineering, and cell-based therapies.
6.1.4 Future directions
Future work will include an attempt to co-culture differentiated epithelial cells
with a number of other cell types such as smooth muscle cells, macrophages,
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fibroblasts, etc. Moreover, epithelial cells from biopsies are currently being used
instead of commercially bought cells since they are more physiologically relevant.
This will include investigating intrinsic and extrinsic differences between
epithelial cells obtained from asthma patients compared to normal samples. An
attempt to differentiate these cells into a pseudostratified epithelium will also be
carried out, followed by investigating the wound repair mechanisms in both
asthma and normal samples, looking into migration, proliferation and
differentiation potential of both samples.
The secretory profile of the airway epithelium will also be investigated again
using other stimuli that are more relevant to lung diseases. LPS, cigarette smoke
extracts, and bacteria are examples of the different stimuli that can be used to treat
the ALI cultures, which are thought to be some of the major risk factors for
diseases such as asthma and COPD, since the physical model used in this study
does not completely portray the damage occurring in asthma and COPD.
Finally, SP studies will be followed up by trying to investigate their presence in
asthma and normal samples and if there are portrayed differently in those two
samples. Differences between SP and non-SP groups will be investigated to see if
there are any potential gene differences between both which might facilitate their
isolation.
.
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Appendix A: Sources of materials and chemicals
T25 and T75 cell culture flasks Costar, Corning, SchipholRijk, Netherlands
1 kb DNA ladder Invitrogen, cat# 15615-016
12-well cell culture plates with polyester
inserts (0.4µm pore size)
Costar, Corning, SchipholRijk, Netherlands
Agarose Fischer Scientific, Loughborough, UK
All trans retinoic acid (RA) Sigma-Aldrich, Gillingham, UK
bisBenzimide H 33342 trihydrochloride
(Hoechst 33342)
Sigma-Aldrich, Gillingham, UK
Bovine serum albumin (BSA) Sigma-Aldrich, Gillingham, UK
Bronchial epithelial cell basal media
(BEBM) and singlequots bulletkits
Cambrex, Lonza, Wokingham, UK
Calcium chloride (CaCl2) Fischer Scientific, Loughborough, UK
Cell culture plates (96, 24-well plates) Corning, SchipholRijk, Netherlands
Cryovials Nunc, Fisher Scientific, Loughborough, UK
Diethylpyrocarbonate (DEPC)-treated
water
Invitrogen, Paisley, UK
Dimethyl sulphoxide (DMSO) Sigma-Aldrich, Gillingham, UK
Dulbecco's modified eagle medium
(DMEM)
Sigma-Aldrich, Gillingham, UK
Ethanol (100%) Fisher, Loughborough, UK
Ethidium bromide (EBr) Invitrogen, Paisley, UK
Fetal Calf serum (FCS) Sigma-Aldrich, Gillingham, UK
Formaldehyde (37% ) Phillip Harris, Cheshire, UK
Glacial acetic acid Fischer Scientific, Loughborough, UK
Goat serum Sigma-Aldrich, Gillingham, UK
Hank’s balanced salt solution (HBSS) Gibco, Invitrogen, Paisley, UK
L-glutamine Sigma-Aldrich, Gillingham, UK
Magnesium chloride (MgCl2) Sigma-Aldrich, Gillingham, UK
Appendix A
187
N-2-Hydroxyethylpiperazine-N’-2-
ethanesulfonic acid (HEPES)
Sigma-Aldrich, Gillingham, UK
Orange G loading dye Sigma-Aldrich, Gillingham, UK
Phosphate buffered saline (PBS) Oxoid, Hampshire, UK
Primers Invitrogen, Paisley, UK
Procarta® Cytokine Assay Kit Panomics, cat# PC1028 Vignate-Milano,
Italy
Propidium iodide (PI) Sigma-Aldrich, Gillingham, UK
QIAshredder Qiagen, Cat# 79654, UK
RNase-Free DNase Set Qiagen Cat# 79254, UK
RNeasy Mini Kit Qiagen, cat# 74104, UK
Soybean trypsin inhibitor (0.5 mg/ml) Invitrogen, Paisley, UK
ß-mercaptoethanol Sigma-Aldrich, Gillingham, UK
Superscript 1st Strand System Fischer Scientific, Invitrogen, Loughborough,
UK, (Cat# VX11904018)
Taqman Probes Eurogentec, Hampshire, UK
Taqman
®
PCR Universal Master mix Applied Biosystems Cat# 4304437,
Warrington, UK
Triton X-100 Sigma-Aldrich, Gillingham, UK
Trypsin-EDTA (10x) Sigma-Aldrich, Gillingham, UK
vaccum filtration system, Millipore (P/M MAVM0960R and
WP6111560),
Verapamil hydrochloride Sigma-Aldrich, Gillingham, UK
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